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1Abstract
Recently, the introduction of nanotechnologies into medical applications has become
more frequent due to the growing of several diseases originating from alteration of bio-
logical processes at molecular and nanoscale level (e.g. mutated genes, cell malfunction
due to viruses or bacteria).
The nanomedicine combines the innovation of the nanotechnology materials (shape and
size of nm scale) to health care, providing new promising techniques for the diagnosis,
the prevention, the tissue regeneration and therapeutic fields.
Disorders like cancer, Alzheimer’s, Parkinson’s disease, cardiovascular problems or in-
flammatory diseases are serious challenges to be dealt with. For this reason researches
are focusing their attention to the nanomaterials unique properties [Murty et al., 2013,
Xia et al., 2009]. The progress in nanomedicine ranges from nanoparticles for molecular
diagnostics, imaging and therapy to integrated medical nanosystems [Nune et al., 2009,
Shi, 2009] to act at the cellular level inside the body. For a recent review on challenges,
opportunities, and clinical applications in nanomedicine an interesting review is the
one of Wicki et al. [Wicki et al., 2015]. Despite the concerns raised by the authors in
their review, the expert opinion on clinical opportunities finds a generalized consensus
on stimuli-responsive systems for targeting the compound (drug, gene, biomolecule) at
the site of interest and on the use of lipid based nanosystems for the biocompatible
platform to be used in clinical trials.
In this scenario is placed the main activity of this Ph.D. thesis whose aim is to provide
a multiscale and multidisciplinary approach to demonstrate the capability to activate
lipid-based nanosystems by means of electromagnetic fields (EMFs). Specifically, the
attention will be focused, on a first part, on the liposome-based systems mediated by
EMF to provide a proof-of-concept of EMF stimuli-response systems for applications of
drug delivery. This aspect will be approached both form a theoretic, technological and
experimental point of view. Moreover, because proteins are considered a fundamen-
tal pattern as bio-sensors for signaling cell processes, a molecular dynamics simulation
approach will be provided to study the interaction mechanisms between EMFs and
proteins structures for potential protein activation.

Chapter 1
Introduction and purpose of the
research
During the last years the global trend to improve the efficacy of medical treatments
to prevent the patient safety by the use of nanotechnologies, became of fundamental
importance for the overall scientific community.
It is since 2005 that the European Technology Platform for Nanomedicine (ETPN)
[KM Weltring et al., 2016] defined, through vision papers, the scope of Nanomedicine
in Europe and by create international networks with the aim to integrate innovation
aspects for the further development of Nanomedicine both in the academia and industry
panorama. The Strategic Research and Innovation Agenda (SRIA) of the ETPN offers
the opportunity to assess the state of the art and to provide the larger nanomedicine
community focused on the clinical needs in selected diseases, highlighting the potential
of the current and future nanomedical products to provide new and efficient solutions for
health care. In particular the road-map highlights future applications in nanomedicine
up to 2030 and as reported in Fig. 1.1 research is mainly focused in developing new
promising approaches and prototypes for nanomedicine applications in the areas of
therapeutics, diagnostics and regenerative medicine. It explores different area from the
nanoparticles for therapeutic and imaging systems to the 3D printing cells for the new
regenerative medicine.
In the following a schematic diagram is proposed with the purpose of the classifi-
cation of the different research areas present in Nanomedicine: the nanodiagnostic, the
nanotherapeutic and the nanotheranostic as reported in Fig. 1.2.
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Figure 1.1: Current applications of Nanotechnologies in Medicine.
The first principal area is related to Nanodiagnostic. In particular, non-invasive imag-Nanodiagnostic
ing can be used to provide feedback on the tissues circulation properties, the target site
accumulation and the off-target localization of therapeutic drugs, also to report on the
efficiency of drug release at the target site, and to monitor therapeutic efficacy. Among
the different applications nanoparticles can be used in patients for the MR monitor-
ing of the perfusion of tumor blood vessels and coronary arteries [Fink et al., 2003,
Wagner et al., 2002, Chiribiri et al., 2008], the imaging of labelled stem cells [Politi
et al., 2007] and the visualization of primary and/or metastatic liver lesions [Reimer
and Balzer, 2003]. For the cancer imaging, is increasing the use of paramagnetic iron
oxide nanopartiles (SPIONs) injected into patient to detect the cancer cells or to de-
tect possible lymph-node metastases [Harisinghani et al., 2003, Perrault et al., 2009].
Moreover, nanoparticles are also used for the in-vitro diagnostic assays as for pro-
tein markers [Posthuma-Trumpie et al., 2009], or for genetic mutations [Lefferts et al.,
2009] thanks to a particular gold coating depending on the genetic sequence. Several
5Figure 1.2: Scheme of the basics principles of Nanomedicine applications, focusing the attention on the
therapeutic area and on liposomal drug delivery system.
additional studies in these and other pathological settings are currently ongoing as
the labeled nanoparticles with contrast agents which is highly useful for better under-
standing the properties and the potential of the formulations developed in order to
treat different diseases [Duncan and Gaspar, 2011]. Moreover, in recent years the use
of nanodiagnostics for visualizing tumors and receptor structures over expressed by
tumor blood vessels, it has growth by giving idea of the tumor distributions [Takahashi
et al., 2015, Azmi et al., 2014, Jackson et al., 2017].
By the combination of drugs and imaging agents, one has the so-called nanotheranos- Nanotheranostic
tic which couples the disease diagnosis and the therapy. Theranostic strategies start
from a selection of a set of preselected patient, based on initial studies using a given
diagnostic radionuclide-labeled antibody, and then followed by a radio-immunotherapy
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with the same antibody coupled to a therapeutic radionuclide [Imhof et al., 2011]. In
this way it is possible to monitor the treatment efficacy providing the diagnosis and the
treatment with the same nanoformulation. It is important to take into account that
theranostic does not means to have a simultaneously imaging and treatment of the dis-
ease, but firstly it is important to find a prediction of potential therapeutic responses,
in this way the drug is personalized and based on the diagnosis study the monitor of
the treatment occurs. Nevertheless, the advantage of theranostic is that can be used
to have a non-invasive monitoring of the target site, visualize bio-distribution, assess
therapeutic efficacy and also a possible tumor-targeted drug delivery as showed from
the use of polymers or liposomes both in patients and animals [Lammers et al., 2008b,
Mura et al., 2013].
As therapeutic agents the aim of nanomaterials is, in order to overcome biologic bar-Nanotherapeutic
riers, to enhance the efficacy of medical treatments. Nanotherapeutics are able to
improve the action of a therapeutic agents, by increasing their accumulation at patho-
logical sites and their therapeutic efficacy, reducing also the incidence and possible side
effects [Lammers et al., 2008a, Davis et al., 2008, Ganju et al., 2017]. The nanother-
apy can assess in different ways as shown in fig. 1.2. One branch is the regenerative
nanomedicine. It is since 1960s and 1970s that the first generation of materials was de-
veloped for the use inside the human body. Biomaterials involve tailoring of resolvable
polymers at the molecular level to elicit specific cellular responses. These materials
show great promise as scaffolds or matrices in tissue regeneration which means the
use of a combination of cells, engineering and materials methods to improve or replace
biological tissues. Tissue engineering involves the use of a scaffold for the formation
of new viable tissue for a medical purpose [Nasseri et al., 2001, Neves et al., 2017].
Also biomarkers can be used as therapeutics agent like esosomes for dermatology ill-
nesses [McBride et al., 2017].
Nanomedicine mainly acts improving the efficiency of drugs to pathological sites with aDrug Delivery
systems local release on the diseased tissues. This process takes the name of targeted drug deliv-
ery (see Fig. 1.2). The incorporation of external or internal stimulus as a remote control
to trigger the release of therapeutic payloads has received much attention in this recent
years [Rahoui et al., 2017]. Drug delivery refers to approaches for drugs transporting in
a specific site to have a localized action of the pharmaceutics, reducing side effects for
the healthy tissues. As showed in Fig. 1.2 the drug delivery can be achieved trough the
use of different nanocarriers or nanoparticles. A large number of nanomaterials have
7been designed and evaluated over the years, relying e.g. on lipid based nanocarriers (li-
posomes, solid lipid nanoparticles), polymer based liposomes (e.g. polymers, micelles),
drug conjugates (polymer-protein conjugate, antibody conjugate), viral nanomarticles
and inorganic nanoparticles (e.g. metal or silica nanoparticles) (see Fig. 1.2). Nanopar-
ticles have the peculiarity that can be engineered in shape and size from 1 to hundred
nanometers depending on the biological need. Basically they can be used as bio-sensors
for the detection of a particular disease or as a drug delivery nanocarrier for treatment
purpose. Nanocarriers have unique properties such as nanoscale size, high surface-to-
volume ratio, and favorable physico-chemical characteristics. They have the potential
to modulate both the pharmacokinetic and pharmacodynamic profiles of drugs, thereby
enhancing their therapeutic index. Loading of drugs into nanocarriers can increase in
vivo stability, extend a compound’s blood circulation time, and allow for controlled
drug release. Thus, nanomedicine compounds can alter the biodistribution of drugs
by allowing them to accumulate preferably at the tumor site. The advantage consists
due to the smaller size (around 10 nm) to be taken more easily from the tumor cells
and ejected from the body after a long time, permitting to be distinguished on MRI
for a longer period [Enochs et al., 1999]. For the nanoparticles use there are two main
aspects that need to be considered, one is the possible toxicity of nanoparticles and
their bio-compatibility and the other one is the invasiveness of the technique used as
external agent for the illness treatment (i.e thermal, magnetic or electric). Moreover,
nanocarriers have also the advantage to protect the drug from degradation and, reduce
the renal clearance, allow the control of the release kinetics of the anticancer drugs and
improve the solubility of those insoluble [Danhier et al., 2010, Xu et al., 2016, Song
et al., 2017].
Among all nanoparticles that can be used, liposomes represent one of the most used
nanocarriers [Vahed et al., 2017] and hold a great promise in the drug delivery panorama
as will be explained in details in chapter 2. Liposomes are self-assembled colloidal
vesicles with a characteristic lipid bi-layered membrane composed of amphilic phos-
pholipids, that not only allow the encapsulation of numerous hydrophilic anticancer
drugs and siRNAs in its aqueous core, but also can host hydrophobic cytotoxic agents
in its hydrophobic membrane. On liposomal drug delivery systems is focused the main
part of this Ph.D. thesis (see Fig. 1.3) by focusing the attention on a remote liposomal
drug delivery system by the activation of external electric or magnetic fields.
As shown in fig. 1.3 and as will be discussed later (see Ch. 2), there are mainly three
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Figure 1.3: Scheme of this Ph.D. thesis, focusing the attention on liposomal drug delivery systems
mediated by electromagnetic fields (EMF) and a possible direct action of the EMF on protein activation.
kind of targeted drug delivery systems (see Fig. 1.3):
• passive targeting drug release which means non functionalized nanoparticles that
release the drugs a prior;
• active targeting release by using functionalized particles depending on the target
tissue treated;
• triggered release which means a physiological or a remote controlled system that
triggers the drug release in a specific site.
Specifically, remote controlled drug delivery systems can be activated from physically
or external stimulus [Rahoui et al., 2017], in detail there are endogenous (pH variation,
9redox responsive liposomes) or exogenous stimulus (thermal stimulus, magneto-thermal
activation, acoustic or ultrasound) as will be discussed in the next chapter (see Ch. 2).
Among the different external stimuli that can be used, an innovative scenario is opening
on the use of ”non-thermal” low intensity magnetic fields and also on ultra short and
intense electric pulses (see Sec 2.2) as external trigger, on which I focused the main
part of my Ph.D. thesis.
Recently with the wide spread of the technological progress the use of magnetic field Magnetic fields
applicationsas external stimulus for inflammatory and neuronal disease therapies and drug delivery
systems for nanomedicine has considerably increased [Ross, 2013, Rodzinski et al.,
2016]. Highly interesting applications of magnetic fields have been developed concern-
ing the non-invasive stimulation of the central nervous system, such as the Transcranial
Magnetic Stimulation (TMS) technique [Di Lazzaro et al., 2013] or the low-intensity
pulsed magnetic field stimulation [Varani et al., 2008, 2017] for inflammatory illness
as will be discussed in the section 2.4. Besides, the use of magnetic nanoparticles as
contrast agent combined with the MRI is more often used [Idiyatullin et al., 2017, Jog
et al., 2016], an innovative upcoming technique is the magnetoliposome drug delivery
system, which combines the action of magnetic nanoparticles loaded into liposomes
(vesicles of nm dimension) core with the application of an external low intensity mag-
netic field [Nappini et al., 2010, Spera et al., 2014, Cheng et al., 2014, Spera et al.,
2015] without generating secondary effects. The advantage of the use of a low intensity
magnetic field is its non-invasive action and no thermal secondary effects are caused
to the treated tissues as will be discussed in the chapter 2. This innovative technique
could give more comfort to the patient during the treatment, since with low intensity
magnetic field no thermal effects could be perceptible and it will be localized on the
diseased tissue.
Moreover, in the scientific community an increasing interest towards the possibility to Electric fields
applicationsuse ultra short pulsed electric fields in different medical applications has been developed
(as the cancer therapy [Miklavcˇicˇ et al., 2012, Cadossi et al., 2014], gene electrotransfer
[Mir et al., 1999, Calvet et al., 2014] and food processing [Saulis, 2010]). The biological
effects at cellular and sub-cellular levels of ultra short electric pulses (usPEFs), with
duration between few microseconds (µsPEFs) and nanoseconds (nsPEFs) and ampli-
tudes from kV/m up to few MV/m, are at the basis of various promising and powerful
applications of electromagnetic (EM) fields to medical treatments, as underlined in
recent papers and reviews [Vernier et al., 2006, Craviso et al., 2009, Joshi and Schoen-
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bach, 2010, Neal, 2012, Zorec et al., 2013, Breton and Mir, 2012, Weaver et al., 2012,
Silve et al., 2014]. This technique takes the name of electroporation. It is based on the
use of short nanosecond electric pulses (nsPEF), which due to their wider frequency
content (first lobe up to one GHz, see section 2.3), are able to pass the cell membrane
and penetrate into the cell core [Schoenbach et al., 2007, Nuccitelli et al., 2006, Ibey
et al., 2011, Nuccitelli et al., 2013, Tolstykh et al., 2013]. The internal membranes elec-
troporation triggers secondary bio-responses as genes modulation expression, action
potential activation and apoptotic marker expression, Ca2+ release [Joshi and Schoen-
bach, 2010, Schoenbach et al., 2001, Pakhomova et al., 2014] based on the application
of a short electric pulse (10 nanosecond). The mechanism of coupling of nsPEFs and
cells is still under study. The E pulses cause primarily a kind of cell membrane rear-
rangement evidenced by transient (reversible) or permanent (irreversible) permeability
changes, as firstly evidenced by Neumann and coworkers in the early 1972 [Neumann
and Rosenheck, 1972] identifying such membrane defects as aqueous pores [Tieleman,
2004, Tarek, 2005, Casciola et al., 2014]. Since cell membranes can be thought to be
very similar to the membrane of liposome in terms of lipid composition, an upcoming
interest is arising in the development of new drug delivery systems mediated by the
coupling of nsPEFs and liposomes for a controlled drug release.
In this context different network cooperation have been active during the present re-
search project. In particular I had the opportunity during my first year of Ph.D. to
participate to two different calls of two associations that gave me the opportunity to
work for three months at the Oncology Institute Gustave Roussy in Paris. One of
the association, is the COST EMF-MED that provides a cooperative framework to
support the research on beneficial biological effects of non-ionizing EMFs and their
use in biomedical applications. This Action focuses on beneficial effects, aiming for
breakthrough results, new discoveries and innovative biomedical technologies. Another
action more focused on the electroporation phenomena is the COST-European Coop-
eration in Science and Technology which is focused on building connection between the
different scientific communities throughout Europe and worldwide and provide net-
working opportunities for early career researchers.
Finally, one of the main question often discussed in the scientific community (seeDirect EMF
effects Fig. 1.3) but not yet fully elucidated is about the effects generated by a direct elec-
tromagnetic fields application on molecular structures (e.g. proteins) and what is the
basic mechanism of this interaction. Recently experimental techniques have been used
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to investigate the effects of electromagnetic fields on biological structures [Azan et al.,
2017b,a, Carr et al., 2017, Marklund et al., 2017]. Among these, Azan et al. [Azan
et al., 2017a], investigated about different regions of interest around the nucleus of the
cells and the dose-effect relationship related to different electric pulse parameters using
the confocal Raman microspectroscopy.
On this question is focused the last part of my Ph.D. thesis (see Part V) where by
the means of molecular dynamics simulations the effects of the application of an elec-
tric and a magnetic fields have been investigated on the superoxide dismutase and the
adenosine A2A receptor respectively. Indeed the aspect to take into account is that
biological effect can be also achieved by acting on proteins (e.g. receptors, enzymes,
etc.), which can respond to the exposure of an external electric or magnetic stimuli and
they can enhance or reduce the cells activity or biological functions [Varani et al., 2002,
2008, Capelli et al., 2017, Beebe, 2015] as will be detailed explained in the chapter 3.
The purpose of the presented Ph.D. research project wants to be a multidisci- Purpose of the
research: thesis
outline
plinary and multiscale approach for the investigation of both low level magnetic fields
and nanosecond electric pulses interactions with biological structures. This research
has been carried out both from a theoretical, technological and experimental point of
view focusing the attention on liposomal drug delivery systems mediated by electro-
magnetic fields and on the understanding of the interactions between electromagnetic
fields and proteins (see Fig. 1.3).
Following a briefly overview of this Ph.D. thesis is given.
In the part I, an overview will be given concerning the liposomal drug delivery system
research area (see Sec. 2.2). Drug delivery systems will be explored by giving a general
knowledge and then focusing the attention on the actual liposomal drug delivery sys-
tems mediated by the application of electric and magnetic fields (section 2.2).
Not only liposomes but also proteins are often used as biosensors to mediate cellular
functions. Proteins as potential biosensor will be discussed in the chapter 3, both
under the action of magnetic or electric fields, starting from experiments with proteins
in cell culture.
In the part II an entire chapter will be dedicated to the modeling tools used for perform-
ing this project as molecular dynamics simulations (section 4.2) and microdosimetry
models (section 4.3). After that, the thesis will be divided into three part:
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• Liposomal drug delivery systems activated by low intensity magnetic fields
• Nanosecond pulsed electric fields for liposomal drug delivery systems
• Direct EMF effects investigation on proteins structure using MD simulations
In the part III experimental work will be presented about magnetoliposomes (MLs)
exposure to a low magnetic field intensity for testing the feasibility of MLs drug delivery
systems (see chapter 5). The last chapter of this part will be dedicated to the project
and a design of a new exposure magnetic setup able to produce magnetic field with
intensity of mT in a frequency range up to 20 kHz (see chapter 6).
Concerning the nsPEFs applications (Part IV), two different studies have been carried
out for a proof of concept of possible liposomal drug delivery systems mediated by
10 nsPEF by the use of microdosimetry models considering both the theoretical (see
chapter 7) and technological and experimental aspects (chapter 8).
In the Part V we firstly performed a modeling work regarding magnetic molecular
dynamics simulations on the adenosine receptor A2A to explore the interactions between
a low intensity magnetic field and a protein structure (see chapter 9). In the last chapter
we investigated the ability of 100 ns electric pulses to possibly interact with the enzyme
superoxide dismutase by the means of molecular dynamics simulations (see chapter 10).
Part I
Electromagnetic fields on
nanomedicine applications
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As mentioned in the introduction, the use of electromagnetic fields for therapeutic
purposes is becoming highly interesting due to the possibility to optimize medical treat-
ments taking attention to the patient safety.
Recently, one of the new nanotechnology used for the treatment of inflammations and
diseases is the new liposomal drug delivery approach. This kind of application, as will
be reported, is a kind of active targeting drug release system, where the delivery of the
drug comes after the application of an endogenous or exogenous stimulus. Due to the
peculiarity of the electric pulses, in this part firstly a general knowledge will be given
concerning liposomal drug delivery systems. The liposomes as nanocarriers will be de-
scribed and the kind of liposomal drug delivery systems will be presented moving form
the more traditional use of endogenous stimuli to the more innovative one related to
exogenous stimuli. The applicability of nanosecond pulsed electric fields as external
trigger to activate a potential liposome drug delivery system will be discussed. Besides,
another promising external trigger for this kind of application, can be the use of low
intensity magnetic field, due to their use in the clinical treatment of inflammations and
due to their good penetration in the human tissues. On this aspect is also focused, this
part, by proposing the use of magnetoliposomes as nanocarriers for a controlled drug
release activated by low intensity magnetic fields.
Moreover, since electromagnetic fields are currently adopted for the treatment of differ-
ent inflammations diseases as neurodegenerative diseases, in this case trans-membrane
and internal cell proteins could play a fundamental role. For this reason the last chap-
ter of this part is dedicated to an overview on the present use of proteins as biosensors
and their potential to be used as sensor in cells, responding to an external electric or
magnetic fields.

Chapter 2
Drug delivery systems: from
endogenous to external stimuli
activation
2.1 Introduction
In recent years, we are witnessing a growing applications of new nanotechnology tech-
niques in traditional medicine, improving the efficiency and precision in the treatment
of a broad category of disease. Among all the possible application of nanomedicine
the one related to the delivery of a certain drug or molecule in situ at the target site
is becoming more and more attractive. In this context stimuli-response release of a
drug from an ad hoc designed nanocarrier, at a specific time and location is one of
the most aimed results of the drug delivery research. The goal is to design, engineer
and introduce into the body molecular nano-scale carriers (1-1000 nm, nano-carriers)
capable to carry the drug and release it in the place where it must act. In this way
to avoid any damage to the surrounding healthy tissue, thus acting locally only on the
site where the disease it has been developed.
Generally, the drug release is obtained by changing environmental conditions as pH,
temperature, an higher redox potential [Koo et al., 2008, Li et al., 2011], ultrasound,
etc. [Ganta et al., 2008, Karanth and Murthy, 2007]. Among the different trigger
methods, recently an integrated control release has been approached combining the
temperature and magnetic fields as triggering agent using magnetoliposomes (MLs),
17
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which are vesicles containing super-paramagnetic iron oxide nanoparticles [Pradhan
et al., 2010, Preiss and Bothun, 2011] that release the content next to the magnetic
field application.
In this chapter an overview both of the electroporation phenomena associated to the
drug delivery mediated by nsPEF and the use of magnetic fields as trigger agent for
drug delivery purpose will be given. The aim is to define the scientific area in which will
take place the part of this Ph.D. thesis concerning the drug delivery systems mediated
by electric or magnetic fields.
2.2 Liposomal Drug delivery systems
Smart drug delivery systems are multi-targeted, stimuli sensitive, delivery carriers thatDrug delivery
systems can release drugs to the infected cells in the body avoiding the need for frequent and
massive drug doses, reducing systemic secondary effects [Mirza and Siddiqui, 2014,
Yatoo et al., 2014, Allen and Cullis, 2013]. The aim of smart drug delivery technologies
is to deliver drugs at the right time and with a controlled dose enhancing the efficiency
of the therapy. Basically, there are three different way to achieve the drug delivery
(Fig. 2.1):
• passive targeting
• active targeting
• triggered targeting
Passive targeting (Fig. 2.1a) is based on the release of the drugs by the recognition ofPassive targeting
the diseased tissue based on the morphological differences between the healthy and the
ailing tissues. In case of tumor cells, pathophysiological characteristics of cancers and
their environment have been exploited for passive targeting. In particular, the perme-
ability and retention (EPR) effect promotes accumulation of nanomedicine drugs in the
tumor based on the presence of leaky intratumoral blood vessels. For example, Kaposi
sarcoma is a tumor type with fenestrated vasculature [Lammers et al., 2012] and by
convection and diffusion processes, passive directing of nanomedicine therapeutics into
tumors can occur without any specific ligand attached to the surface of the nanocarrier.
However, the passive targeting is not sufficient to control the side effects of cytotoxic
drugs and fully exploit the benefits of targeted delivery, because of the heterogeneity of
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Figure 2.1: Illustration of the targeted strategies: passive targeting, active targeting and triggered
targeting.
the diseased tissues [Prabhakar et al., 2013] and the increased interstitial fluid pressure
of tumor cells [Jain and Stylianopoulos, 2010].
Active targeting (Fig. 2.1b) requires the conjugation of specific receptor ligand that can Active targeting
promote the site specific targeting. A wide range of ligands can be used including small
molecules such as folic acid and carbohydrates, or macromolecules such as peptides,
proteins or antibodies. The ligand must allow binding to the target diseased cells while
minimizing binding to healthy cells. Moreover, a prolonged circulation of the drug is
vital to avoid unwanted interactions with serum proteins or the immune system [De-
tampel et al., 2014]. However, actively targeted nanoparticles delivery can enhance
drug retention in the tumor due to increased cellular binding, minimize non-specific
uptake, and also circumvent mechanisms of resistance from biological barriers [van der
Meel et al., 2013].
The last method to achieve a drug release is to use an endogenous or exogenous stimulus Triggered
targetingto trigger the release of the drug in a specific target site. Stimuli-responsive systems,
on which we will focus the attention, act in response to physical, chemical, or biological
triggers that promote release of drugs by modifying the structure or conformation of
the nanocarrier. The advantage of using stimuli-responsive systems is that the drug
is released through a trigger thus minimizing the exposure of the surrounding healthy
tissues to the pharmaceutic. In all of these scenarios, the drug is previously loaded into
a nanocarrier and then released. At this purpose one of the classical carriers used in
medicine for drug encapsulation and delivery [Xiang and Anderson, 2006, Seigneuric
et al., 2010, Stuart et al., 2010] are the liposomes.
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Figure 2.2: Liposomal drug delivery design. Liposomes can be surface functionalized to endow stealth
through PEGylation and to promote receptor-mediated endocytosis by using targeting ligands such as
antibodies, peptides, proteins, carbohydrates, and various other small molecules.
Liposomes are one of the most studied nanocarriers [Lee and Kataoka, 2011]. They
consist of a biocompatible phospholipid bilayer and they can protect amphiphilic, hy-
drophilic, and/or hydrophobic drugs (see Fig. 2.2) against a variety of threats that
lead to immediated vesicles degradation [Kulkarni et al., 2011].
Liposomes nanocarriers
Liposomes consist of an aqueous core surrounded by a lipid bilayer, much like a mem-
brane, separating the inner aqueous core from the bulk outside. Depending on the
preparation methods [Petralito et al., 2012, Hope et al., 1985, C¸ag˘das¸ et al., 2014], li-
posomes can be distinguished in multilamellar or unilamellar liposomes (see Fig. 2.3).
Unimellar vesicles are of special interest to researchers due to their well-characterized
membrane properties and facile preparation in a laboratory. Multimellar vesicles show
a greater range of physical properties and general behavior when compared to unil-
amellar vesicles, and are more used with industrial applications like drug delivery.
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Figure 2.3: Liposoms classification depending on the size and the lipid unilamellar or multilamellar
bilayer.
The use of liposomes for drug delivery started shortly after their invention by Bang-
ham and coworkers in 1965 [Bangham et al., 1965, Lindner and Hossann, 2010]. The
first liposome-based drugs (Myocet and Doxil) were approved by USA Food and Drug
Administration (FDA) for cancer treatment in 1995 [Pinheiro et al., 2011]. Since then,
a wide range of therapeutics small molecules have been incorporated in liposomes to
improve their efficacy.
The main advantage of using liposomes is their biocompatibility and biodegradability
since they are made with naturally occurring lipids [Oh and Park, 2009, Alhajlan et al.,
2013]. Moreover, some of the first demonstrations of the improved in vivo activity of
liposome-entrapped drugs in animal models, used the anti-cancer drug cytosine arabi-
noside to demonstrate significant increases in the survival times of mice bearing L1210
leukemia [KOBAYASHI et al., 1975]. The stability of liposomes in the circulation with
retention of their contents has long been recognized as a desirable liposome characteris-
tic for successful drug delivery to diseased tissues. Besides, it has been also recognized
that being able to trigger the release of liposomal contents once they reached the target
site, would lead to improvements in therapeutic outcomes. Indeed, new strategies in
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liposomal research have gained interest, and some clinical trials based on the combi-
nation of different chemotherapeutic agents and stimuli-responsive release approaches
have been started [Dicko et al., 2010, Malekigorji et al., 2014].
Due to this, liposomes can be used as triggered nanocarriers through internal (e.g.
pH variation, enzyme action) or external (e.g. temperature,electric or magnetic field)
stimuli. Consequently, the release of loaded drugs can be controlled and concentrated
at the target site [Zhu and Torchilin, 2013]. A briefly knowledge of different kind of
endogenous or exogenous triggers will be given in the following sections.
2.2.1 Endogenous stimuli-responsive liposomes
Endogenous stimuli arise from the different environment between normal and dis-
eased areas, such as higher redox potential [Koo et al., 2008, Li et al., 2011], reduced
intra/inter-cellular pH, ionic strength, and increased levels of certain enzymes as the
lysosomal enzyme cathepsine B, overexpressed in several malignant tumours [Lee et al.,
2011].
Among these, liposomes responding to a potential difference can be utilized for the con-
struction of stimuli-sensitive liposomes [Ganta et al., 2008, Saito et al., 2003]. Their
structure is maintained under normal condition by the disulfide bonds until its enter-
ing in the intracellular area, where the disulfide bonds is perturbed, destabilizing the
liposomes and releasing the encapsulated cargo [Deshpande et al., 2013].
Moreover, a micro-environment that can serve as a trigger for drug release is the hy-
poxic area of tumors exhibiting low oxygen pressure and poor nutrient levels. The low
oxygen level can be used for triggered release from redox-responsive nanocarriers [Fleige
et al., 2012].
Another kind of destabilization is a possible intracellular pH variation (see Fig. 2.4).
The pH of intracellular organelles (e.g., liposomes,endosomes or lysosomes) differs from
that of the cytoplasm or blood. This condition can be used to enhance intracellular
release of drugs. This is the case of pH-responsive liposomes that are used to trig-
ger the release of the drug and therefore increase the therapeutic efficacy (Fig. 2.4).
pH-responsive liposomes are stable in physiological condition (pH = 7.4) but they are
destabilized in acid environment which are common in some pathological tissues such
as tumors [Gao et al., 2012]. In this way the liposomes under a repulsion pressure, due
to the pH variation, can release the cargo in the tumor cells next to the increase of the
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Figure 2.4: Liposomal drug delivery system mediated by a pH variation of the cell with respect to a
physiological level.
membrane fluidity (Fig. 2.4).
2.2.2 Exogenous stimuli-responsive liposomes
Exogenous stimuli relate to stimuli that are applied externally such as heat [Tagami
et al., 2011, Al-Ahmady et al., 2012], the ultrasounds [Schroeder et al., 2009, Kheirolo-
moom et al., 2010], magnetic [Plassat et al., 2011] or also an electric field [Lu et al.,
2014, Liu et al., 2008].
When the exogenous stimuli is applied to the nanocarrier the drug is released in a cer-
tain amount and in a short period of time [Kikuchi and Okano, 2002]. The advantage
of the exogenous stimulation is that stimuli are generated by machines protocols can
be easily standardized to achieve regulated release [Mura et al., 2013].
Thermoresponsive drug delivery is among the most investigated stimuli-responsive Thermoresponsive
drug deliverystrategies widely explored in oncology. The response from the nanocarriers to the tem-
perature variation is expressed in terms of a non linear sharp change of the nanocarrier
material. Thermosensitive liposomes (TSLs) are one of the most advanced thermore-
sponsive nanosystems, as shown by their use in several clinical trials. They respond
to the temperature variation with a phase transition of the constituent lipids and
the associated conformational variations in the lipid bilayers. The response from the
nanocarriers triggers the release of the drug following a variation in the surrounding
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Figure 2.5: Activation of the liposomal drug delivery system mediated by the temperature increase.
temperature (Fig. 2.5). Ideally, thermosensitive liposomes retain their load at body
temperature (∼ 37 ◦C), and rapidly deliver the drug within a locally heated tumor (∼
40−42 ◦C) to counteract rapid blood-passage time and washout from the tumor [Tagami
et al., 2011, Al-Ahmady et al., 2012]. Neverthless, the drug release can also occur on
a brief temperature decrease (also called cold shock or cryotherapy) and in this case, a
thermally reversible swelling or de-swelling of the nanocarrier leads to a free diffusion
of the encapsulated drugs as a consequence of increased porosity [Lee et al., 2008]. The
main concern about the temperature is a possible heating that could cause damages to
the surrounding healthy tissues.
Magnetic field and ultrasound have been the major strategies investigated due toMagnetic and
Ultrasound
stimulus
their ability to penetrate into deeper tissue enhancing their potential in translating
from bench to bedside [Schroeder et al., 2009, Kheirolomoom et al., 2010, Plassat
et al., 2011]. Ultrasound has been used to trigger the release of drugs (mainly contrast
agents) from responsive systems for cancer diagnosis [Rapoport et al., 2011]. Ultra-
sound waves can trigger the release of the drug from a variety of nanocarriers through
the thermal and/or mechanical effects generated by cavitation phenomena or radiation
forces [Schroeder et al., 2009, Kheirolomoom et al., 2010]. In fig. 2.6 an illustration of
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Figure 2.6: Activation of the liposomal drug delivery system mediated by ultrasound triggers.
the ultrasound drug release is presented, where the bubbles are formed through acous-
tic droplet vaporization and are subjected to cavitation leading to the drug release to
the tumor tissue.
Although, another external stimulus that has been investigated is the applica- Electric field
stimulustion of an external electric pulse to activate the drug release previously loaded into
a nanocarrier which can be conducting polypyrrole nanoparticles [Ge et al., 2011] or
liposomes [Denzi et al., 2017].
In the next sections ( 2.3 and 2.4) details will be given about the potential applica-
tion of nanosecond pulsed electric fields or of low intensity magnetic field to induce a
controlled release of the cargo loaded into liposomes.
This aspect has been explored in my Ph.D. both theoretically and experimentally in
the chapter 5 and 7.
2.3 nsPEF for liposomal drug delivery systems
Low electric fields (typically about 1 V) can be used to achieve pulsed or sustained
drug release through a variety of actuation mechanisms [Liu et al., 2008, Im et al.,
2010]. One of these mechanism can be an oxidizing voltage activated by the splitting
of a vesicle membrane into smaller organelles like micelles releasing the cargo and then
reassemble on the application of a reductive voltage [Kim et al., 2011].
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Figure 2.7: Active iontophoresis drug delivery.
Iontophoresis, which uses an electric field to enhance the transdermal delivery of
charged compounds, is a particularly versatile approach [Ita, 2016, Malinovskaja-Gomez
et al., 2017]. In fig. 2.7 an example is reported of active iontophoresis, where basically
the charge applied to the skin changes the flow of ions through the skin, reducing it’s
resistance and enhancing the amount of and type of medication that can travel below
the skin’s surface to produce a therapeutic dosing effect. It has been recently applied
to various types of nanoscaled systems, including liposomes containing insulin [Chen
et al., 2009].
Lately the scientific research on electropulsation techniques, which causes the forma-nsPEF
applications tion of pores in cell membranes increasing its permeability to molecules that otherwise
cannot cross them, has significantly improved the practice of medicine by the use of
electric pulses of shorter duration (nanosecond) and higher intensity (in the order of
MV/m) (nanosecond pulsed electric elds, nsPEF) which allows to directly interact with
internal cell organelles (e.g. nucleus, endoplasmic reticulum, mitochondria, etc.) [Denzi
et al., 2013, Beebe et al., 2003b, Scarlett et al., 2009, Breton and Mir, 2012, Weaver
et al., 2012] and also with the plasma membrane [Napotnik et al., 2012, Chopinet and
Rols, 2015].
Since 2003, nsPEF effects related to the plasma membrane have been reported [Vernier
et al., 2003a]. Among these, the application of a single 30 ns pulse with intensity of
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25 kV/cm has been shown to permit the translocation of phosphatidylserine (PS) from
the inner leaflet of the lipid bilayer to the outer leaflet, involving a membrane effect
and causing cell apoptosis [Vernier et al., 2004]. Recently Napotnik et al. [Napotnik
et al., 2016], reviewed different papers regarding in-vitro applications on eukaryotic
cells exposed to nsPEF, highlighting how the plasma membrane is more affected with
longer pulses than with short pulses, leading to the best uptake of dye molecules after
applying single pulses. Several works have also shown a release of calcium indepen-
dently of intra-cytoplasmic membrane calcium channels, which was directly linked to
the destabilization of organelle envelopes by pulses shorter than 100 ns [Vernier et al.,
2003b].
One aspect to take into account is the cell viability next the application of nsPEF. Be-
cause of their very short duration, nsPEF do not transfer a large energy to the sample
and thus the observed effects are probably non-thermal. Anyhow, the destabilization
of the cell membrane could cause, depending on the duration and pulse intensity, the
cell death. The first work [Beebe et al., 2003a] focusing on cell survival has shown that
for very high intensities of 300 kV/cm and duration of 300 ns, apoptotic phenomena
were observed on up to 90 % of cell population in less than 10 min following the appli-
cation of the pulses. Despite of this, it has been demonstrated that reducing the pulse
duration to 10 ns or less with intensity in the order of kV/cm could help to destabilize
cell membranes (internal and external) without causing cell death [Chopinet and Rols,
2015]. At this regard, Napotnik et al. [Napotnik et al., 2012] investigated about the
effects of 4 ns electric pulses duration with intensity of 10 MV/m at 1 kHz of repetition
rate and a loss of the mitochondrial membrane potential and a plasma membrane per-
meabilization has been highlighted, possibly due to the permeabilization of the inner
mitochondrial membrane by the nsPEF application.
Due to the present research activity on the use of electroporation on cells for different nsPEF for
liposome drug
delivery systems
medical applications and due to the similarity of the cell and liposome membrane com-
position, recently the attention is going on the use of liposomes. In detail the ability of
nsPEF to interact with small internal structures has been the starting point for inves-
tigations of nsPEF applicability for drug delivery using liposomes of small dimensions
with respect to the cells [Tekle et al., 2005, Allen and Cullis, 2013]. The use of nsPEF
for potential drug delivery applications can be a promising technique (Fig. 2.8) because
it might allow the controlled release of drugs encapsulated in a nanocarrier (e.g. lipo-
somes) by the application of an appropriate electrical stimulus that allows a controlled
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Figure 2.8: Drug delivery inside a single cell (a) mediated by permeabilization of the cell membrane
next to the application of an electric field in a very small region of the cell membrane area (b).
release and uptake of drugs from liposome to the cell, thanks to the accumulation of
charges on both sides of the plasma membrane and consequently the formation of an
induced transmembrane voltage (TMP) which causes the pore formation and the drug
uptake.
Indeed, electroporation it has been applied to nucleic acid delivery against cancer, ei-
ther by using PEG-coated silica nanoparticles with opposite polarities to enhance gene
transfection [Kim and Lee, 2011] or by using liposomes loaded with exogenous oligonu-
cleotides [Wang et al., 2010] in order to obtain the drug release.
As will be detailed explained in the chapter 7, the main concern about the use of the
nsPEF for drug delivery applications is the difference between the liposome dimension
(nanometer range) and the cell (micrometer range). Firstly, vesicles larger than 500
nm of diameter could be recognized as a pathogen agents by the immune system, while
at the same time liposomes of smaller size would require an higher electric field inten-
sity to the one needed to porate the cell membrane while compromising cell viability.
Moreover, it is also important to underline how not only the dimension but also the li-
posomes composition is important when an immunologic response is generated [Perrie
et al., 2001, Watson et al., 2012]. The classical electroporation serves of rectangular
pulses of micro or millisecond duration with amplitudes in the range of kV/cm. These
pulses have a frequency content in the range of kHz which will be able to destabilize
the cell membrane but not the one of nanometer liposomes. Taking a look to the Fig.
2.9 it can be noticed how by the application of a 10nsPEF the TMP accross the cell
and liposome membrane becomes comparable leading to a possible simultaneously elec-
troporation of both membranes. This aspect will be fully explained in the chapter 7
where a proof of concept of the liposomal drug delivery system mediated by nsPEF is
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Figure 2.9: Proof of concept of liposomal drug delivery systems mediated by nsPEF.
given thanks to dosimetric models.
Moreover the engineering of a 10 nsPEF exposure setup (chapter 8) will be pre-
sented and preliminary experiments of electroporation on liposomes population will be
discussed.
2.4 Low intensity magnetic fields for a controlled drug
release
The applications previously discussed on the use of nsPEF for medical treatments, have
the disadvantage of being limited to the penetration of the electric field thinking about
the treatment of a deep tumor or inflammations, due to the difficulty to reach deep
tissues. This would result in using invasive instrumentation like needles. In this case
the magnetic field has the major advantage of to easily penetrate in the human tissue
without loosing any transmission power.
Due to this, recently with the technological progress the use of magnetic field to
treat inflammatory and neuronal diseases, therapies and drug delivery systems for
nanomedicine has considerably increased [Ross, 2013, Rodzinski et al., 2016]. The pro-
gresses in nanomedicine ranges from nanoparticles for molecular diagnostics, imaging
and therapy to integrated medical nanosystems [Nune et al., 2009, Shi, 2009] to act at
the cellular level inside the body.
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The advantage of using a magnetic field relies on the different nature that the magnetic
response can take, which can be a magnetic guidance under a permanent magnetic field,
a temperature increase when an alternating magnetic field is applied, or both of them.
Furthermore, in medicine there is the possibility of performing magnetic resonance
imaging, and hence to associate diagnostics and therapy within a single system, the
so-called theranostic approach [Yang et al., 2011].
In recent years, a great number of investigations have been reported on exploiting pos-
sible role of magnetic nanoparticles (MNPs) in enhancing magnetoliposomes delivery
of the drug. In most cases hybrid liposomes composed of thermo sensitive phospho-
lipids and magneto-heating mediators, such as iron oxide MNPs, were shown to have
enhanced release of a model drug when exposed to an external alternating current mag-
netic field (AMF) and negligible release without exposure to an AMF [Pradhan et al.,
2010, Preiss and Bothun, 2011]. The enhanced release was essentially attributed to the
to the magnetocaloric effect resulting in the liposome phase transition [Plassat et al.,
2011].
The heat generation efficiency of MNPs heavily depends on the particle size and fre-
quency of external AMF, in particular, when exposed to appropriate magnetic fields
of proper strength (1-10 kA/m) and frequency (10-100 kHz), MNPs embedded into
liposomes are able to convert magnetic field into heat, either from hysteresis losses or
from Neel or Brownian relaxation processes [Guardia et al., 2012]. The magnetically
induced heat is transferred to the entire magneto-carrier causing temperature increases
from 25 ◦C to tolerable hyperthermia (41-46 ◦C) with structural changes in the lipid
bilayer (that is designed to shift from a gel to liquid phase at a characteristic transition
temperature, Tm) which may act as a smart trigger for the drug release [Yatvin et al.,
1978, Pradhan et al., 2010, Preiss and Bothun, 2011].
Despite the heat generation is the main pattern of AMF energy consumption, a mag-
netic field can also induce vibration or rotation of iron oxide particles, hence the oscillat-
ing MNPs can mechanically damage membrane of nanoscale actuators (e.g. liposomes).
In particular, researchers [Nappini et al., 2010, Spera et al., 2014] proposed an alter-
native mechanical explanation based on MNPs oscillation induced by external AMF:
MNPs motions in AMF could improve the bilayer permeability and it could contribute
to the magnetocaloric effect, allowing for cargo release. This hypothesis arises from
the finding that AMF-induced oscillation of MNPs was proved to be able to mechani-
cally damage cancer cells in vitro [Cheng et al., 2014]. The magneto-mechanical effect
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Figure 2.10: Magnetoliposomes drug delivery process
produced by the oscillation of the MNPs was extensively addressed to find efficacy for
trigger a mechanical disturbance to the cells and therefore inducing cell death in a
non-chemotoxic way, but it could find application also for the control of drug release.
In order to support this purpose, researchers have deliberately selected field frequen-
cies and strength that are several orders of magnitude lower than those needed for the
magnetic thermal approach [Nappini et al., 2010, Spera et al., 2014]. It will allow to
reduce the heating contribution of the MNPs in the AMF to negligible levels with the
objective to evaluate the peculiarities and advantages of a non- non-heating action of
MNPs in AMF in the drug delivery control. Magnetic guidance is typically obtained by
focusing an extracorporeal magnetic field on the biological target during the injection of
a magnetically responsive nanocarrier. This concept has demonstrated great potential
in experimental cancer therapy because of improved drug accumulation inside solid-
tumor models. Nanosystems for such a therapeutic approach can be magnetoliposomes
(Fe3O4 or maghemite (Fe2O3) nanocrystals encapsulated in liposomes) [Plassat et al.,
2011].
An example of this technique can be, as reported in [Hoare et al., 2011], a compos-
ite membranes containing thermoresponsive nanogels and magnetic nanoparticles that
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enable on-off drug delivery on de-swelling or swelling of the polymer.
Not only for the drug delivery, an AMF can also remotely regulate protein production,
as insulin, by using a modified temperature-sensitive channel (TRPV1) decorated with
iron oxide nanoparticles [Stanley et al., 2012]. Moreover, some studies suggested that
magnetic fields of low intensities (A/m) are a good trigger to control the releasing of
the drugs [Nappini et al., 2010, Spera et al., 2014] but without heat generation. Via
the application of an external magnetic field, the idea is to induce a mechanical stress
on the liposome membrane, due to MNPs oscillations, in order to obtain the drug re-
lease (Fig. 2.10). In Spera et al. [Spera et al., 2014] an experimental study is reported
concerning the exposure of HSPC liposomes loaded with magnetic nanoparticles to an
AMF of 60 A/m of intensity. A 20 % of the fluorescent dye release is detected up to 9
hours of exposure due to the magnetic field application.
In the chapter 5 of this Ph.D. thesis, experiments on magnetoliposomes will be pre-
sented both applying an AMF or pulsed electromagnetic fields (PEMFs) considering
different intensities (up to 100 µT).
Besides, starting from an existing exposure system consisting of two coaxial magnetic
coils of square shape that can release magnetic fields of low intensity ( ≤ 100 µT), and
based on the experimental results, we numerically performed a new magnetic exposure
setup consisting of two squared Helmholtz coils, by analyzing all parameters involved
to reach a magnetic field with intensity in the order of mT in a frequency range between
1-20 kHz (see chapter 6).
Chapter 3
Electromagnetic fields and
protein interaction
3.1 Introduction
One of the major challenges in medicine, is the accurate measurement of cells signals in
order to possibly prevent the upcoming of inflammations or serious illnesses as cancers
or cardiac disorders. For this reasons, researchers started to perform methods to mea-
sure protein biomarkers, cells, and pathogen agents in biological samples. A number
of new diagnostic platforms have recently been developed to measure biomolecules and
cells with high sensitivity that could enable early disease detection or provide valuable
insights into biology at the molecular level [Cheng et al., 2006, Wulfkuhle et al., 2003].
Fluorescent-protein biosensors have become an important tool as reagents to extract
data from living cells which express parameters concerning some upcoming molecular
processes related to illnesses or stresses (Fig. 2.10). Recent applications of fluorescent-
protein biosensors to biological problems have provided a foundation for their use in
biotechnology [Senutovitch et al., 2015]. This kind of biosensors evolved by combining
sensitive fluorescent dyes with proteins in order to monitor specific physiological events
such as production of metabolites, changes in various ion concentrations, and the dy-
namic interaction of proteins. Fluorescence-based reagents have been used extensively
to elucidate and quantify fundamental biological processes within and between cells
both in vitro [Giuliano et al., 1995, Zhang et al., 2002] and in vivo [Provenzano et al.,
2009, Niesner and Hauser, 2011].
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Figure 3.1: Fluorescent-protein biosensors and high-content screens in drug discovery. A multiple-
well drug screening platform containing living cells is treated with a combination of drug types and
concentrations. In figure referring to a the single-cell level different examples of the processes that can
be measured with fluorescent-protein biosensors are reported.
In order to detect protein signaling a fluorescent marked is linked to the protein
sending fluorescent signals in correspondence of the occurring of a biological effect.
Some recently described fluorescent protein biosensors designed to report chemical
events occurring at or near the plasma membrane [Gonzalez and Tsien, 1995]. Be-
sides fluorescent-protein biosensors have become powerful tools when applied to the
processes involved in cytoplasmic signal transduction as for example the identification
of the cAMP involved in converting transient signals into long term gene expression
within the nervous systems [Hempel et al., 1996].
Proteins have the role to mediate the chemical reactions within cells. When converted
to sensors proteins have the potential to report not only the dynamic distribution of
specific reactions but also data concerning reaction kinetics and protein interactions.
One way to define the activity of proteins is through the environmental changes that
occur either internally or on their surface, including binding to other proteins [Giuliano
et al., 1995].
Not only as detector but also as mediator of chemical reactions, proteins respond to
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external stimuli by enhancing or decrease their activity and their interaction with living
cells [Wetzel et al., 2001, Capelli et al., 2017]. In the next paragraph a briefly overview
will be given about the exposure of proteins to electromagnetic fields and their role in
biological effects.
3.2 Protein activation from Electric or Magnetic fields
The enhancing of enzymes activity under specific physiological conditions or under ex-
ternal stimuli, represent the proteins response and their eligibility to be used as drug
target or as illnesses sensors.
Recently, researchers investigate the effects of EM fields on intra-cellular and transmem-
brane proteins exposed to nanosecond pulsed electric fields (nsPEFs) [Beebe, 2015] or
low frequency low energy pulsed electromagnetic fields (PEMFs) [Varani et al., 2002,
2008, Capelli et al., 2017].
Recently, it has been highlighted that different physiologic systems seem to be in- PEMFs action
for medical
treatments
fluenced by PEMFs exposure. Many studies have aimed to identify the biophysical
stimulation induced by PEMFs as potential alternative to the pharmacological treat-
ments in several inflammatory related diseases [Cadossi, 2011, Di Lazzaro et al., 2013].
It has been reported that PEMF exposure could act on modulating cartilage and
bone metabolism, stimulating chondrocyte and/or osteoblast cells proliferation [Cha-
lidis et al., 2011] reporting a positive effect in the treatment of fracture healing [Lin
and Lin, 2011]. The action of PEMFs has been also investigated in various pathological
conditions such as in cancer cells where the electromagnetic fields with intensity around
3 mT were able to reduce tumor growth and proliferation for breast cancer cells up to
60 minutes of stimulation at low frequency of 20 Hz, growing its effects after three days
of daily treatment [Crocetti et al., 2013]. Nevertheless PEMF therapy significantly
reduced postoperative pain and narcotic use in the immediate postoperative period by
a mechanism that involves endogenous IL-1β in the wound bed [Rohde et al., 2010].
Not only on cancer cells or in bone healing but also in neurological diseases the use
of PEMFs is widely spread to map the brain human activity and could affect al-
most all cerebral functions such as motor control, sensory perception, cognitive ac-
tivities [Di Lazzaro et al., 2013]. The molecular pathways underlying the previous
medical treatments are all related to the involvement of a transmembrane protein of
the adenosine receptors (ARs) family.
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Figure 3.2: Representation of the adenosine A2A proliferation under PEMFs action by enhancing the
anti-inflammatory effect.
Increasing evidence suggests that the beneficial effects of PEMFs on neurologicalProteins under
the PEMFs
action
system are mediated by the modulation of adenosine receptors (ARs), specifically in-
creasing the expression of A2A subtypes [Varani et al., 2017]. The adenosine receptor
A2A is an important G-coupled protein regulator of neurotransmission signals released
from cells next to a metabolic stress. From a study of Varani et al. [Varani et al., 2002,
2008] it has been experimentally proven how the application of low intensity magnetic
field in the range of 0.5 - 3.5 mT is able not only to enhance the ant-inflammatory
effects of the adenosine receptor A2A on neutrophilis cells but also to increase its enzy-
matic activity and a reduction of the superoxide anion has been reveled probably due
to the density increase of the adenosine receptor on cells surface when exposed to the
magnetic field action (Fig. 3.2).
Not only magnetic field but also electric field pulses (PEF) may affect protein re-nsPEFs applied
on proteins sponse and its activity. It has been experimentally proven how pulsed electric fields
of 3.6 MV/m with duration higher than 150 µs are able to induce secondary struc-
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tures changes and inactivation of protein structures as lysozyme [Zhao et al., 2007] and
pepsin [Yang et al., 2004]. However, studies of the effect of PEF on protein structure
are limited in number [Van Loey et al., 2001], although PEF treatments of soybean pro-
tein isolates [Li et al., 2007] purified horseradish peroxidase and pectin esterase [Zhang
et al., 2006] have shown interesting effects on protein denaturation, aggregation and
structure depending on the protein examined.
As mentioned in the previous chapter, effects related to conventional electroporation
with long pulse duration (µs - ms range) and and low electric fields (up to 1 MV/m)
are mostly focused on the lipid bilayer of the plasma membranes. Nevertheless, elec-
troporation pulses with short duration (ns) and high intensity (MV/m) may have some
effects on intracellular membranes and could be able to directly interact with inter-
nal cell organelles (as nucleus, endoplasmic reticulum, mitochondria,etc.) [Esser et al.,
2010]. This was initially hypothesized and demonstrated by breaching vesicular mem-
branes in human eosinophils [Schoenbach et al., 2001]. Distinct effects of nsPEFs have
also been observed to rapidly and transiently release Ca2+ from the intracellular cav-
ity [Vernier et al., 2003b, Semenov et al., 2013].
The correlation of nsPEFs and intracellular structures is related to their frequency
content. Indeed a 1 ns pulse has a spectral frequency content of 1 GHz and thus it
appears that high frequency components, residing in the rapid rise and fall times of
ns pulses, maximize electric field interactions with intracellular structures [Schoenbach
et al., 2001, Beebe et al., 2012]. In the study of Beebe [Beebe, 2015], it has been
evaluated how nsPEF can act not only on the membrane permeabilization but also on
proteins. They analysed the dissipation of the mitochondria membrane under nsPEF
actions directly related to the Ca2+ presence. Since, the Ca2+ dependent events require
proteins, to determine if nsPEFs could have direct effects on proteins, they showed the
inactivation of the C-subunit of PKA, a prototype for all protein kinases, which have
highly conserved catalytic mechanisms. This inhibition was correlated to the inhibition
of the mitochondria membrane and thus indication of the nsPEFs effects on protein.
Moreover, by Pakhomov et al. [Pakhomov et al., 2014] the effects on CHO cells that
express actine protein have been presented, highlighting cells swelling and actin disrup-
tion when an electric field of 600 ns pulses and 1.92 MV/m of intensity and a frequency
of 2 Hz are applied as shown in Fig. 3.3. Also an experimental study has been con-
ducted on different type of superoxide dismutase enzymes, the SOD1 [Shi et al., 2015],
to evaluate the behavior under electric field of physiological strength (104 V/m), a
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Figure 3.3: CHO cells exposed to 4 pulses at 19.2 kV/cm (600 ns,2 Hz).The side views (left column)
are intended to demonstrate cell reshaping by nsPEF. Two different 3D views (center columns) and
one X-Y slice (right) were selected to provide the best observation of the structured actin.
monomerization and partial unfolding was reached only for the A4V-SOD1 protein.
Not only through experimental setup but also using molecular dynamics simulations,
the protein interaction with electric fields have been explored. Through the simulation
of a ”virtual” experiment, MD simulations give the possibility to observe the electric
field action on microscopic structures in an accurate and rigorous way. In different
simulation studies with MD, high intensity pulses were shown to disrupt secondary
structures of proteins as myoglobin, the soybean hydrophobic protein and the insulin
β-chain [Marracino et al., 2013b,a, Singh et al., 2013, Budi et al., 2005]. The loss of
secondary structures suggest changes in the protein activity and it means that the pro-
tein differs from its physiological condition. The changes predictable using molecular
dynamics simulations could give information in order to explain the protein response
and the interaction mechanism when a protein, or in general a biological sample, un-
dergoes to an external forces. Indeed, Wang et al. [Wang et al., 2014] investigated the
effects of strong electric field applied on the insulin enzyme by the means of MD simu-
lations. They explored electric field with strength from 1.5 to 6x108 V/m, highlighting
a disruption of secondary structure and a loss of hydrogen bond for electric field higher
than 2.5x108 V/m.
Molecular dynamics (MD) simulations have been used during my research project both
concerning the application of nsPEFs on the superoxide enzyme and studying the ac-
tion of a magnetic field on the adenosine A2A receptor as will be discussed in the 10 and
the 9 chapter respectively. In the next chapter a brief overview will be given regarding
MD simulations in order to understand one of the adopted modeling approach.
Part II
Modeling approach: from
molecular dynamics simulations
to microdosimetric models
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In this part, the methodology used in the present Ph.D. research project will be re-
ported.
Usually to perform a modeling analysis, different methods can be adopted depending
on the levels of the biological complexity going from the microscopic one of atoms
and molecules, up to the macroscopic one of the whole organism, going through sub-
cellular structures, cells, tissues, organs and systems. The interaction of the EMFs with
nanosystems can occur at any of these biological levels, and to model all the possible
interactions different and specific tools are needed.
In the following chapter, a multiscale approach will be presented from the molecular
dynamics simulations level (nm scale) to the microdosimetric models for the cellular
level analysis (up to mm scale).
Theoretical methods and computational approaches applied to predict the behavior of
biological compound at the atomic level are all part of the molecular modeling cate-
gory. In this case, Molecular Dynamics(MD) simulations provide atomic details of the
structures and motions of a classical biological structures allowing the computing of its
structural, dynamic and thermodynamic properties. By applying the Newton’s equa-
tion of motion, from given initial conditions the evolution of the system in time can be
predicted. In this context, in the following chapter the integration algorithms and the
different force fields usually used in MD simulations will be reported to understand the
modeling used for the study of the electromagnetic fields action on protein structures,
presented in the Part V.
Furthermore, when dealing, with nanosystems as liposomes interacting with biological
cells the mesoscale and finite element method have to be adopted. Thanks to these
methods is possible to perform a dosimetric analysis to assess the amount of the EMF
induced in a target structure in different exposure conditions. On these aspects is fo-
cused the section 4.3 in the following chapter, to explain the method used in the Part
III and Part IV for the modeling study of the electromagnetic fields effects on cell and
liposomes under the EMFs action.

Chapter 4
Modeling Methods
4.1 Introduction
In order to understand and possibly predict the interaction mechanisms between elec-
tromagnetic fields and nanosystems interacting with the human body, modeling tools
can be adopted. By Apollonio et al. [Apollonio et al., 2013], a schematic representation
of possible multiscale methodologies, for modeling the interactions between electromag-
netic fields and a biological system, has been proposed (see Fig. 4.1). On the scheme
reported in Fig. 4.1, based on the biological effects (right side) different methods (left
side) can be used to predict possible effects and functions evidenced by experimental
investigations (e.g., in-vitro, in-vivo, and on humans) when cells are exposed to ex-
ogenous EM fields. Different levels of biological structures can be modeled, such as
molecules, cells, tissues, organs, and organisms as represented in details at the right
branch of the Fig. 4.1 with the inclusion of the dimension. Regarding the modeling
methods (left side) the inputs for the smallest models depends on the quantities in-
duced in the upper level, while for the biophysical one the functionality of a level is
related to those of all the lower levels.
Now, depending on the nanosystem that we want to study and depending on its
interactions with cells dimension, in this chapter two different methodologies will be
presented: molecular dynamics simulations and microdosimetry models.
To analyze at molecular level (dimension up 10-8 m) possible interactions, molecular
dynamics (MD) simulations provide atomic details of the molecular structures and
hence allow for computing dynamic and thermodynamic properties. The first section
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Figure 4.1: Scheme of a multiscale methodology for modeling the interaction between an exogenous
EM field and a biological system.
of this chapter will be dedicated to a general overview of the molecular dynamics algo-
rithm to understand its functions and potentiality to predict the behavior of biological
molecules.
Moreover, when cells complex want to be explored MD simulations because of the
limit in the computational costs depending on the structure size (ns time and up to
nm) cannot be used, but microdosimetry models (range dimensions from 100 nm to
µm) can be adopted to achieve information of dose dependent effects generated by the
application of an exogenous electric or a magnetic field. The microdosimetry models
permit the quantification and the assessment of fundamental parameters involved in
biological processes in order to understand the basic mechanism of the phenomenon
(as electroporation or magnetic field action) and becomes a predictive tool that could
be use to set the experimental parameters.
4.2. Molecular dynamics simulations 45
Figure 4.2: Molecular structure investigation techniques from the femtosecond to the continuous range.
4.2 Molecular dynamics simulations
The molecular structures can be investigated with different techniques, measured es-
sentially according to the degree of accuracy and size of microscopic systems treated.
The choice of the appropriate technique depends on the particular application, and
then by the ability to produce reliable results. There are several methods based on the
analysis time and the size of the molecule (Fig. 4.2). The use of quantum mechanical
(QM) methods allows the explicit treatment of electronic distribution of microscopic
systems, essential in the rigorous description of processes such as enzymatic reactions
and mechanisms of binding / unbinding. The quantum methods represent a fundamen-
tal tool for a rigorous study of the electronic transitions of the underlying biochemical
phenomena, such as the process of binding / unbinding or enzymatic reactions. The
main disadvantage is that it does not allow the study of complex systems such as the
investigation of biochemical reactions; analysis QM is only applied to the reaction cen-
ter isolated, without considering the whole protein and the environment in which it is
immersed, which is crucial in the re-activity of chemical processes [D’Alessandro et al.,
2004, Amadei et al., 2007].
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Instead, the molecular dynamics is used to model and study the physical phenomena
from a realistic point of view and provide a dynamic framework at the microscopic
level, laying the foundation for the theoretical treatment or for the interpretation of
experiments. It models the motion of the group of particles (e.g. atoms) present in the
simulation box by solving the classical Newton’s equations of motion. Firstly, as input
conditions the energy potential is expressed in function of the velocities and positions
of all atoms present in the system. Then the force on any atoms is computed (Eq. 4.1)
by calculating the force between non-bonded atom pairs (Eq. 4.2).
F = −∇V (r) (4.1)
Fi =
∑
i 6=j
Fij (4.2)
Subsequently, the update of the configuration is done by solving the Newton’s equation
of motion (Eq. 4.3 ) with a finite difference algorithm:
~ri(t+ ∆t) = ~ri(t) + ~vi(t)∆t+
1
2
~ai(t)∆t
2 (4.3)
Finally, the output are written as velocities, positions, pressure and temperature of
the system. It’s the most widely used method to do simulation in condensed matter
physic. The MD performs a calculation and the deterministic trajectory is uniquely
determined by the form of the potential energy function that describes the interactions
between the atoms in the system. The simulations always require the definition of a
model (force field) for the interactions between the various components of the system.
Each simulation requires a set of initial coordinates and optionally the initial velocity
of the particles involved. Before the start of a simulation, the system must be defined
and must be loaded with an empirical force field. Empirical force fields, indeed, are col-
lective of several energy terms to describe the interactions between atoms (bonded like
energy of bonds, valence and dihedral angles, etc.; non bonded as electrostatic and van
der Waals terms), implemented to reproduce the structural properties of biomolecules
and parameterized accordingly. All information associated with the force field are static
in the sense that remain unchanged during the generation of the MD trajectories and
include: type of atom, mass and charge, potential function, the parameters of binding
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and non-binding, constraints.
The Protein Data Bank (PDB) provides the initial coordinates and the 3D structure of
the molecular system that needs to be simulated; it is an archive of three-dimensional
structures of biomolecules obtained from experimental techniques. The pdb files for a
given molecule provides the atomic coordinates, information on the structure of pri-
mary and secondary data on the experimental techniques applied and references. In
many cases, the 3D structure is not available or not suitable for the problem being
treated. In this case, molecular modeling techniques are applied to provide the topol-
ogy (e.g. connectivity chemistry) as input to run an MD simulation to explore the
conformational changes of a complex molecule and map the biochemical phenomena at
the molecular and atomistic level. The initial speeds are generally randomly assigned
by the Maxwellian distribution, relative to the desired temperature (∼ 300 K). The
main actions are common to all protocols, such as the preparation of data, for an MD
run, by assigning the initial coordinates and the initial speeds. Then the heating of the
system goes up to the desired temperature, associated with a short dynamic equilib-
rium achieving balance for the simulation is stable and free from unwanted fluctuations.
This step takes from tens to hundreds of ps. Finally production of the trajectory and
its analysis is done.
This method suffers from some limitations, such as only allows classical description of
the motion of the particles thereby not allowing the study of phenomena such as quan-
tum processes of electron transfer or training / breaking of bonds. Another limitation
is related to the electrons that are in the ground state, preventing an analysis of the
electronic motions to finally allow a maximum observable time scale of the order of hun-
dreds of ns. Molecules in MD simulation by default also lack polarizability. Although
the effects of polarizability can be introduced by various methods such as adding virtual
sites (Drudeparticles) or effective pair potential,the treatment of polarizability is often
ignored in order to reduce computing cost. Nevertheless several physical phenomena
can be described with a good approximation neglecting the electron wave functions.
Despite its limitations, MD opens the way to a better understanding of the relationship
between molecular structure and biological function of the essential components in the
vital processes such as proteins and peptides.
In the next section an overview of the force field, boundary conditions and tempera-
ture/pressure ensemble will be given to understand parameters we used to perform our
simulations.
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4.2.1 Integration Algorithms
One of the most used integrator in molecular dynamics simulations is the Velocity
Verlet algorithm [Verlet, 1967].
r(t+ ∆t) = r(t) + ∆tv +
∆t2
2m
F(t) (4.4)
v(t+ ∆t) = v(t) +
∆
2m
[F(t) + F(t+ ∆t)] (4.5)
The equation 9.2 and 9.3 represent the update of positions and velocities choosing a
∆t small enough, leading to an overall better approximation of the whole integration
process. As lower limit one can consider highest frequency proper of the system, namely
the vibrations of bonds involving hydrogen atoms in solvated biological macromolecules.
The bond stretching frequency of an O-H bond is typically about 1014 Hz, so the average
period would be of the order of 10 fs [Schlick et al., 1997]. This limits the time-step
tobe taken in MD simulations to about 0.5 fs. For our simulations concerning the
magnetic field applications on the adenosine A2A receptor we employed the velocity
verlet algorithm as will be explained in the chapter 9.
Moreover, to increase the time step to a typical value of 2 fs usually algorithms (SHAKE
[Ryckaert et al., 1977], RATTLE [Andersen, 1983], LINCS [Hess et al., 1997], SETTLE
[Miyamoto and Kollman, 1992]) are employed to constrain all covalent bonds,i.e. the
distance between mass points is maintained constant. In general, the algorithm is
constructed by following procedures:
• choosing novel unconstrained coordinates (internal coordinates)
• introducing explicit constraint forces
• minimizing constraint forces implicitly by the technique of Lagrange multipliers
or projection methods.
These approximations are acceptable as these bond vibrations can be considered un-
coupled from all other vibrations in the system so that the dynamics of the system is
not altered.
For the simulations concerning the enzyme superoxide dismutase (SOD1) exposed at
nsPEF (see Ch. 10), we used the leapfrog integration algorithm with an integration
time-step of 2 fs. With the leapfrog algorithm positions and velocities leap over each
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other. The velocities are updated at half time steps and leap ahead the positions. The
positions (Eq. 4.6) and velocities (Eq. 4.7) can be obtained from:
r(t+ ∆t) = r(t) + ∆tvi
(
t+
∆t
2
)
(4.6)
v
(
t+
∆t
2
)
= vi
(
t− ∆t
2
)
+
∆t
mi
Fi(t) (4.7)
4.2.2 Force fields and boundary conditions
As mentioned in 4.2 in order to compute forces MD simulations require a potential
energy function, which describes the interactions among all the atoms in the system.
Once the potential energy of the system is known, given the coordinates of a starting
structure and a set of velocities, the force acting on each atom can be calculated.
A force field is characterized by a specific functional, implemented to reproduce the Force fields
structural properties of biomolecules and parameterized accordingly. The force field it
is composed by a set of equations, the so-called potential functions, which are used to
generate the potential energies and their derivatives (e.g. the forces) correlated with
a set of parameters empirically tuned to reproduce the properties of biomolecules. A
general potential energy function,commonly used in the most know force fields,is:
U total = Ubond + Uangles + Udihedrals + Unb (4.8)
These four contributions account for bonded and non-bonded interactions. The first
three terms of Eq. 4.8 define the bonded interactions corresponding to two (stretching),
three (bending), and four (torsion) body interactions, respectively.
Ubond = kb
1
2
(l − l0)2 (4.9)
Uangles = kθ
1
2
(θ-θ0)
2 (4.10)
Udihedral =
∑
n
vn
1
2
(1 + (−1)n+1 cos(nφ− ψn)) (4.11)
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These interactions are represented by harmonic potentials for the bond lengths b
(Eq. 4.9), for the bond angle θ (Eq. 4.10) with kb and kθ their harmonic force constants,
for the dihedral angle ψ (Eq. 4.11) with n, ψn and vn the torsion, multiplicity, phase
angle and barrier height respectively. The final term of the Eq. 4.11 is meaningful of
the interaction between non-bonded atom pairs. This term is split into 1-body, 2-body,
3-body, ...subterms. Interactions between particles separated by more than three co-
valent bonds are usually represented by two components: by Coulomb’s law for the
electrostatic interactions (Eq. 4.12) and by a Lennard-Jones potential for the Vander
Waals interactions(Eq. 4.13). The Coulomb potential is described by:
Uqq =
∑
i<j
∑
j
qiqj
4piijrij
(4.12)
where the qi is i
th atomic charge, rij is the distance between the i
th an jth point charges,
and  is the permittivity of the medium between this two. The Lennard-Jones poten-
tial(Eq. 4.13) can be written as:
UvdW =
∑
i<j
∑
j
4piij
[(
σij
rij
)12
−
(
σij
rij
)6]
(4.13)
where σij and ij are the collision diameter(the finite distance at which the inter-particle
potential is zero) and the well depth respectively. The Lennard-Jones potentials de-
scribe the van der Waals (vdW) interactions, that differ from covalent and ionic bonding
because they are caused by correlations in the fluctuating polarization of nearby par-
ticles.
In addition to the force fields, other parameters are included as values for atomic
mass,Van der Waals radius, partial charge for individual atoms, equilibrium values
of bond lengths, bond angles, dihedral angles for pairs. Popular force fields for MD
simulations of biomolecular systems are AMBER [Cornell et al., 1996], CHARMM
[MacKerell Jr et al., 1998],GROMOS [Oostenbrink et al., 2004] and OPLS-AA [Jor-
gensen et al., 1996]. In this work, we considered GROMOS45 force field [Oostenbrink
et al., 2004] to model the SOD enzyme and the adenosine A2A receptor (see Ch. 10 and
9, respectively).
In order to compute MD simulations we used the software GROMACS [Hess et al.,Gromacs
2008] v. 4.6 and 5.1.
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GROMACS is a versatile package designed for biochemical molecules like proteins,
lipids and nucleic acids including a lot of complicated bonded interactions. It is the
aim of GROMACS to provide a versatile and efficient MD program with source code,
it is designed especially for the simulation of biological molecules in aqueous and mem-
brane environments, and able to run on single processors as well as on parallel computer
systems using MPI or threads. It is very fast due to algorithmic and processor specific
optimization, typically running 3-10 times faster than many simulation programs. It is
operated via the command line using file for input and output and provides calculation
progress, a trajectory viewer, and an extensive library for trajectory analysis.
Anyway, due to computational limits, a typical simulated system contains hundreds Boundary
conditionsof thousand of atoms, and hence is quite small compared to macroscopic matter. This
means that, if the molecules are arranged in a cubic box, are latively great part of
them will lie on the surface and will experience quite different forces from molecules
in the bulk. Usually, periodic boundary conditions (PBCs) 4.3 are adopted to reduce
the surface effects. PBCs are a set of boundary conditions which are often chosen for
approximating a large (infinite) system by using a small part called a unit cell. In
Fig. 4.3 the shaded box represents the system we are simulating, while the surrounding
boxes are the exact copies of each particle in the simulation box. Even the velocities
(indicated by the arrows) are the same. This arrangement is imagined to fill the whole
of space. A result of this is that whenever an atom leaves the simulation cell, it is re-
placed by another with exactly the same velocity, entering from the opposite cell face.
So the number of atoms in the cell is conserved.
Moreover, when a simulations is settled one of the most important parameter is the Thermodynamics
ensemblestype of thermodynamic ensemble that can be chosen, with particular statistical charac-
teristics and in statistical mechanics. Three important thermodynamic ensembles can
be considered:
• NVE ensemble, a statistical ensemble where the total energy E of the system, its
volume V and the number N of particles in the system are each fixed to particular
values. The system must remain totally isolated (unable to exchange energy or
particles with its environment) in order to stay in statistical equilibrium.
• NVT ensemble, a statistical ensemble where the energy is not known exactly but
the number of particles N, its volume V , and the temperature T are maintained
constant. The canonical ensemble is appropriate for describing a closed system
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Figure 4.3: Schematic of PBCs. The simulation cell (central) is replicated throughout the space,
forming an infinite lattice with images of atoms. In such scheme each atom interacts with all the other
atoms of its cell and also with their images, thus this interaction is limited to the closest image of other
atoms as shown by the blue dashed box.
which is in, or has been in, weak thermal contact with a heat bath.
• µVT ensemble, a statistical ensemble where neither the energy nor particle num-
ber are fixed. In this case the chemical potential mu, the volume V and the
temperature T are specified.
• NPT ensemble, were the number of atoms N, pressure P and temperature T are
constrained.
In this Ph.D. project an NVT ensemble has been used both for the electric ( chapter
10) and magnetic fields (chapter 9) simulations.
4.3 Microdosimetry numerical models
As mentioned in the introduction to this chapter, when the final target that needs
to be simulated has dimensions major than 100 nm, the MD simulations require high
computational costs that are not affordable if you are not working on parallel computer
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Figure 4.4: Molecular structure investigation techniques from the femtosecond to the continuous range.
clusters.
In this case to simulate the behavior of a biological system or for the design of electrical
or magnetic exposure systems, mesoscale model and finite element models, including
microdosimetry, can be adopted (see Fig. 4.4).
In recent times, the study of the amount of EMF that is absorbed by humans and the
related effects has acquired more importance. In particular, the term dosimetry sum-
marized all the techniques aimed to the assessment of the amount of the EMF induced
in a biological structure in different exposure conditions; this assessment can be used
both for prevention as well as for the study of the possible effects of electromagnetic
fields and for the design of new applicators. Microdosimetry employs geometric and
electric models of single cells and small cell or liposomes clusters under the action of an
external force which can be electric, thermal or magnetic using circuital, analytically,
or numerical approaches. Microdosimetry models permit to compute a dose dependent
analysis to predict cells behavior before proceeding to the experiments setup.
Concerning the electroporation phenomena, as mentioned in the section 2.3 the actual
mechanisms underlying the membrane electroporation caused by ultra-short electric
pulses (nsPEF) is not yet fully understood and it has been shown that membrane rear-
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rangement or even ruptures, fundamentally depend on the level of the electric potential
induced across the cell membranes [Krassowska and Filev, 2007], referred to as trans-
membrane potential (TMP). Microdosimetric models are of fundamental importance
when the interaction between an exogenous E field and biological matter is to be in-
vestigated [Apollonio et al., 2013, Gowrishankar et al., 2013]. Furthermore, the local E
field applied to cells can be used to relate the observed effects of in vitro experiments
to the macroscopic E ”dose” delivered to the biological sample. In vitro research can
be used as an initial test of the therapeutic efficacy of novel medical treatments. Mi-
crodosimetry is of major importance to hypothesize and quantitatively study plausible
interaction mechanisms at the molecular level that take place in the cell membrane and
the intracellular environment [Tarek, 2005, Hu et al., 2005, Marracino et al., 2013b].
Moreover, microdosimetry can predict the microscopic E-field threshold for an effect
to occur and so can be useful as technological support in the design of pulse appli-
cators and the choice of appropriate pulse generators for experiments. Moreover not
only electric but also a magnetic field can be simulated using appropriate software to
perform both the dose dependent analysis and to validate the project of an exposure
setup as will be explained in the chapter 6.
The electromagnetic solution (EM) usually, when dealing with microdosimetric mod-
els, can be obtained either in time or in the frequency domain, turning back into time
through the inverse Fourier transform, depending on the specific formulations for the
boundary EM conditions at the cell interfaces. Indeed, as highlighted in [Kotnik et al.,
2010], for a spherical cell, using the steady-state Schwan equation [Pauly and Schwan,
1959] as an approximation, is valid only for pulses longer than hundreds of µs, whereas
a first order approximation [Pauly and Schwan, 1959] is possible for pulses longer than
1 µs. Moreover, when dealing with shorter E fields, or when the extracellular medium
has a conductivity well below the range of physiologic values [Kotnik et al., 2010], a
complete formulation of the boundary conditions, accounting for both conductivity and
permittivity of cell compartments, needs to be considered [Kotnik et al., 2010].
Usually a microdosimetric model can be approached with an analytic, circuital or
a numerical model. The analytic solutions are often used for single cell model or forAnalytic models
simplest geometry. Analytic approaches were first developed in microdosimetric studies
for electroporation and are still largely used since they provide simple solutions and
allow the complete spatio-temporal characterization of the E field within different cell
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compartments [Merla et al., 2011, Hu and Joshi, 2009, Hu et al., 2005, Schoenbach
et al., 2004]. The main drawback is that only simple cell geometries can be considered
without or with concentric organelles. The analytic solution is often used to validate
numerical approaches for simplified geometries.
On the other hand, cell circuit models are very useful for rapid microdosimetric anal- Circuit models
yses since they are able to deal easily with different kinds of external E pulses. Circuit
analyses on a wide frequency band (from a few Hz up to GHz) have also been performed
allowing the definition of transfer functions of the cell response [Yao et al., 2009, Merla
et al., 2012, Denzi et al., 2013, Ellappan and Sundararajan, 2005]. Moreover, such
circuits provide the possibility of developing a relationship with more sophisticated
physical and biophysical cell descriptions. The main assumption made by the different
authors [Yao et al., 2009, Merla et al., 2012, Schoenbach et al., 2007, Croce et al., 2010,
Ellappan and Sundararajan, 2005] is that the cell model, encompassing an extracellular
medium, a membrane and an internal cytoplasm, shows a passive resistive-capacitance
(RC) behavior for each compartment. The values of the RC elements of each cell com-
partment were calculated on the basis of their static dielectric properties and conduc-
tivities, as well as from their geometric characteristics (e.g. cell radius and membrane
thickness). A five-layered cell configuration, including the nucleoplasm and the nuclear
membrane, has been considered [Joshi and Schoenbach, 2000, Denzi et al., 2013, Yao
et al., 2009].
Numerical solutions imply the discretization of the simulation domain into meshed Numerical models
grids of different shapes. The great advantage of such an approach is the possibility to
calculate the electric or magnetic field distribution in cells of any geometry, as well as
for small cell aggregates [Kotnik et al., 2010, Joshi et al., 2008, Pucihar et al., 2006,
2009]. In particular numerical approaches can be used to study non-concentric and
complex shaped intracellular organelles. Besides, numerical approaches are necessary
when dealing with realistically shaped cells, including cell organelles, and clusters of
cells. Thus they are suitable for answering recent research trends of moving towards
the tissue level and the sub-cellular level.
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4.3.1 Microdosimetry numerical models
As described above, the need to solve complex problems, has suggested the development
of a series of numerical methods for the evaluation of the induced Electromagnetic fields.
The numerical methods can be divided in methods based on differential type techniques
and methods based on integral ones. For the first case, it involves solving Maxwell’s
equations in the differential form, and the algorithms make a spatial discretization of
the equations in the space region that has to be analyzed (and possibly also a time
discretization if one operates in the time domain); the integral approach, instead, is
useful when the starting point are the integral equations for the description of the
electromagnetic quantities. For low-frequency situations, where the dimension of the
biological body are small compared to the wavelength (i.e. < 30 to 40 MHz for the
human body), a quasi-static approximation can be introduced and this fact implies
that some methods are based on simplified Maxwell’s equations. Following, the main
numerical methods used by the principal simulative software, are described:
• the method of moments (MoM) [Harrington and Harrington, 1996] has become
more popular since the 1980s. The MoM it can be defined as ”source method”
since requires to discretize only the structure in question, not the free space sur-
rounding the geometry. Boundary conditions do not have to be set and in terms
of memory requirements, these are proportional to the size of the geometry in
question and the required solution frequency. However, MOM methods are signif-
icantly computationally less efficient than volume-discretization methods (finite
element method, finite difference method, finite volume method). Boundary el-
ement discretization typically give rise to matrices that require a storage and
computational that will tend to grow according to the square of the problem size.
Moreover, this method usually involve fields in linear homogeneous media. How-
ever, the MoM cannot handle electromagnetically penetrable materials, especially
if the material is in-homogeneous, and requires the surfaces to be closed;
• the finite difference time domain (FDTD) method [Yee, 1966] is a time-domain
method; the solutions can cover a wide frequency range with a single simulation
run, it is partial differential equations based, that solves Maxwell’s curl equations
by directly modeling propagation of waves into a volume (cubical or parallelepiped
with different dimensions) containing the biological body. The components of
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electric E and magnetic H field are calculated in a specific manner on the surfaces
of the single cell alternately with half-time steps. It is a very easy method to be
implemented and the computation time limited, but it could be expensive in
terms of memory occupation because of all the space discretized;
• the finite element method (FEM) [Jin, 2015] solve the Maxwell’s differential equa-
tions in the frequency domain. By solving partial differential equations, a first
challenge is to create an equation which approximates the equation to be studied
and it needs to be numerically stable, in a way to not destroy the meaning of the
resulting output. The finite element method is a good choice for solving partial
differential equations over complex domains or when the desired precision varies
over the entire domain. It divides the simulation space into mesh grids of small
volumes of tetrahedral elements, making this method very suitable in modeling
inhomogeneities and complex geometries. For each tetrahedral volume the field is
approximated using linear extrapolation, starting from a sparse system equations
matrix; the solution is given by the inversion of this matrix. The FEM can couple
the EM solution with other physics, like, for example, mechanical and thermal
problems;
• the boundary element method (BEM) [Banerjee and Butterfield, 1981] requires
calculating only boundary values, rather than the total simulation space and it
works by constructing a ”mesh” over the modeled surface. For this reason it is
significantly more efficient in terms of computational costs. Moreover, the meshes
can easily be generated and design changes do not require a complete remeshing.
The BEM is especially advantageous in the case of problems with infinite or
semi-infinite domains, e.g. so-called exterior domain problems, because only the
finite surface of the infinite domain has to be discretized and the solution at
any arbitrary point of the domain can be found after determining the unknown
boundary data;
• the impedance method (IM) [Armitage et al., 1983] is based on the quasi-static
approximation [Armitage et al., 1983], where the region of interest is described by
a 3D network of impedances, representing each space grids in which the domain
is divided. So, the whole space is represented by a linear circuit applied to
compute the currents in the impedances; this representation bring to a system
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of Kirchhoff’s law equations, that can be solved using iterative process starting
from an initial guess.
In order to perform numerical models different software can be adopted. In this
Ph.D. thesis the software COMSOL Multiphysics v.5.0 has been used for the numerical
part concerning drug delivery systems mediated by nanosecond pulsed electric fields
(see Part IV). COMSOL Multiphysics is a commercial software that permits to solve
complex electromagnetic models, based on the finite element method (FEM) described
above. COMSOL Multiphysics, like all FEM software, makes a spatial discretization of
the system that has to be analyzed in many elements with geometry and shape known.
The fundamental steps to setup a generic microdosimetry simulations are:
1. construct the geometry defying as first the dimension of the simulation box and
then the dimension of cells or of the electrical component that is to be simulated;
2. define the materials associated to each geometries;
3. define the mesh grid for the discretization with which we want to visualize the
results;
4. define the source which means the current source or the potential and the ground;
5. impose continuity condition at the internal boundaries;
6. define the integration step to save the results;
7. visualization of results in 2D or 3D graphs.
The software consists of several modules, capable of solving different physical prob-
lems: chemical transport, heat transfer, etc.; for the present thesis the module of the
electromagnetism was chosen.
As will be discussed in the chapters 7 and 8, the Comsol Multiphysics Software has
been used to simulate a cell and a liposomes populations exposed to 12 nsPEFs.
To conclude as whole in this chapter, the multiscale approach adopted in this Ph.D.Overall
Conclusions thesis have been presented. We are faraway to build a kind of bridging domain between
the molecular dynamics simulations and the mesoscale level analysis. Anyhow Kohler at
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al. [Kohler et al., 2015] tried to link the two different methods; indeed they presented an
atomistic-to-continuum methodology, which computes and subsequently displays 3-D
spatio temporal profiles of the electric potential, field, and field gradients immediately
preceding and following the electroporation phenomena. The authors obtained a more
detailed model for the pore formation process through interactions between external
electric field gradients and the cellular membrane. With this paper the authors pro-
posed a methodology that provides a new analyses to these studies by decomposing
continuum parameters such as the electric field into discretized quantities.

Part III
Drug delivery systems activated
by low intensity magnetic fields
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The use of low-intensity magnetic fields in therapeutic applications has increased
widely during these last years. Many researchers focused their attention on the use of
magnetic field for therapeutic purposes, as cancer treatment, inflammation, and neu-
ronal diseases, even including the most recent approaches based on nanotechnology and
nanomedicine. Among the new nanotechnologies, the liposomal drug delivery system is
a novel technique that allows having a controlled release of a drugs encapsulated in a
nanocarrier (i.e. liposomes) by the application of an external (electric, magnetic, ther-
mal) stimulus. Moreover, the ability of pulsed electromagnetic fields (PEMFs) for the
treatment of inflammations status is well know and more often researchers are focusing
their attention on the capability of such pulses to generate a cell response despite the
low magnetic field intensity. In this part, firstly experiments and then the design of a
magnetic exposure setup will be presented for magneto-liposomes drug delivery applica-
tions.
In detail in Chapter 5 an experimental activity will be presented concerning liposomes
vesicles preparation loaded with superparamagnetic nanoparticles and exposed to a low
intensity pulsed magnetic fields (PEMFs), to prove the feasibility of a magnetoliposomal
(MLs) drug delivery system mediated by PEMFs. The starting point of this work has
been to firstly reproduce experimental data presented in [Spera et al., 2015] testing the
feasibility of MLs poration exposed to an alternate magnetic field (AMF). Here exper-
iments using an AMFs exposure are presented to verify the triggered MLs release with
our sample preparation, before proceeding with the PEMFs stimulation.
Pulsed magnetic fields are not only employed as trigger agent on magnetoliposomes
systems, but for other interesting biomedical applications involving stimulation of the
nervous system as the Transcranial Magnetic Stimulation (TMS) used to map possible
neuronal damages due to strokes or to treat neuronal disorders. Usually, both for drug
delivery systems or the TMS stimulation laboratory experiments are needed to prop-
erly define in-vitro and in-vivo outcomes, therefore the need of a multipurpose exposure
system for low intensity magnetic fields is demanding. In Chapter 6 of this part a
closed-form analysis and a numeric modeling approach are reported for the design of a
versatile magnetic exposure system suitable for different in-vitro applications (i.e. mag-
netoliposomes drug delivery and studies for the understanding of magnetic stimulation
action at single cell level) that could able to generate intensities of the order of mT in
a frequency range up to 20 kHz.

Chapter 5
Drug delivery systems mediated
by low intensity magnetic fields
5.1 Introduction
In recent years, a great number of investigations have been reported on exploiting pos-
sible role of magnetic nanoparticles (MNPs) in enhancing magnetoliposomes delivery
of the drug as explained in the Section 2.4. In fact as previously mentioned (see
Sec. 2.4) hybrid liposomes composed of thermo sensitive phospholipids and magnetic
nanoparticles (MNPs), such as iron oxide MNPs, were shown to have enhanced release
of a model drug when exposed to an external alternating current magnetic field (AMF)
due to the magnetocaloric effect and a negligible release without exposure to an AMF
( [Pradhan et al., 2010, Preiss and Bothun, 2011]). The release due to the thermal in-
crease depend on the magnetic field intensity (1-10 kA/m) and frequency (10-100 kHz),
at which MNPs embedded into liposomes, are able to convert magnetic field into heat,
either from hysteresis losses or from Neel or Brownian relaxation processes [Guardia
et al., 2012]. As explained in the section 2.4, researchers [Nappini et al., 2010, Spera
et al., 2014], by selecting field frequencies and strength that are several orders of magni-
tude lower than those needed for the magnetic thermal approach [Nappini et al., 2010,
Spera et al., 2014], have investigated the possibility to induce a possible release coming
from the MNPs oscillation without a thermal increase. This hypothesis arises from the
finding that AMF-induced oscillation of MNPs was proved to be able to mechanically
damage cancer cells in vitro [Cheng et al., 2014].
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Indeed, aimed to investigate only the mechanical actuation of MNPs by non-heating
alternating magnetic field , Spera et al. [Spera et al., 2015] used a low amplitude (v
70 µ, 20 kHz) alternating magnetic field (AMF) as a remote trigger for magnetolipo-
somes release. Under such conditions, no heating effect occurred and therefore, the
employed field was called ”non-heating”, and hence only non-thermal effects was taken
into account. The authors combined hydrophilic Fe3O4 nanoparticles (MNPs) with the
hydrogenated soybean phosphatidylcholine (HSPC) and cholesterol to design a suitable
carrier model. The obtained vesicles are referred as non-temperature sensitive magne-
tovesicles (Tm > 50 ◦C) since their membrane can exist only in the ordered state within
the experimental temperature interval and neither spontaneous leakage nor thermal re-
sponsiveness can occur up to 50 ◦C. It was demonstrated that these high-Tm MLs,
including in their aqueous core 5-(6)carboxyfluorescein (CF) used as hydrophilic model
drug, were able to release almost 20 % of dye fluorescent after three hours of AMF
exposure with intensity of 60 A/m. Such low amplitude non thermal AMF gives some
more supplementary advantages to the classic magneto-thermal approach (see Sec. 2.4).
Mechanical actuation of magnetic nanoparticles, by non-heating alternating magnetic
field, provides an opportunity to overcome the drawback of heating-AMF actuation an
to create conditions to consider MNPs and low amplitude AMF prospective as powerful
therapeutic tools.
By the way, non-thermal magnetic fields are already employed in therapy because of
their ability to down-regulate specific cytokines in an inflamed environment [Varani
et al., 2017, Setti et al., 2017]. In particular, biophysical stimulation with pulsed elec-
tromagnetic fields (PEMFs) has been demonstrated to exert an anti-inflammatory effect
resulted in early pain control and enhanced functional recovery in the knee diseases as
mentioned in the section 9.1. Recently, the I-ONE medical device from IGEA (Carpi,
Italy), able to generate a peak magnetic field of 1.5 mT at a frequency of 75 Hz, was
tested in order to reduce knee osteoarthritis lesion progression with long term positive
benefits for patients [Veronesi et al., 2014, Gobbi et al., 2014]. It is well known that
when loaded with a suitable therapeutic agent, an anti-inflammatory in this case, a
single-dose intra-articular administration within a synovial joint of liposomes, can be
used to treat the inflammatory process [Ramos et al., 2007, Soriano-Roman´ı et al.,
2017, Stokes et al., 2016].
In this context, the combination of magneto-carriers and PEMFs is an exciting direc-
tion of research, where synergistic properties of both modalities could be effectively
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utilized for inflammatory reduction and remotely-activated drug delivery. A novel con-
cept of combined action in multiple localized treatments could be proposed joining
the functionalities of the magneto-mechanical actuation and the healing properties of
a non-thermal magnetic field: both could work in close synergy together with drug-
loaded nanocarriers that are able to control drug release by application of a remote
magnetic field in order to maximize the efficiency of an anti-inflammatory therapy in
future medical applications.
For this purpose, in this chapter, the aim is to point out evidence of the mechanical
actuation of high-Tm MLs by a pulsed electromagnetic fields (PEMFs).
Firstly experiments of MLs exposed to an non thermal alternate (AMF) magnetic field
generated by two Helmholtz coils, have been performed to replicate the data from Spera
et al. [Spera et al., 2015] and to asses the already verified triggered release from the
MLs. Magnetoliposomes were prepared by means of incorporating commercially avail-
able carboxymethyl-dextran coated magnetite nanoparticles within the aqueous core
of the HSPC vesicles. 5(6)-carboxyfluorescein (CF), was co-incorporated in the core of
magneto-vesicles and used as hydrophilic model drug to test the release of the inves-
tigated nanosystems. Samples were exposed firstly to the AMF with B field intensity
of 70 µT in continuum modality for different time intervals and the drug release was
compared to the one obtained without the magnetic field application (sham exposure).
Subsequently, the drug release profile from high-Tm MLs and the I-One device has been
tested for its potentiality to mechanically modify the structure of the HSPC/cholesterol
high-Tm liposomes, thereby providing spatial and temporal control over drug release.
In this case the intensity increased to 100 µT and the release trends related to sequen-
tial PEMFs switching ON and OFF, were also evaluated.
The experiments have been carried out in collaboration with the research group of
Prof. Petralito, expert in liposomes preparation, from the faculty of Chemistry and
Technology of Drugs of ”Sapienza”, University of Rome. Regarding the experiments
carried out with PEMFs, the I-ONE medical device from Igea group (Carpi, Italy) has
been used, in collaboration with Dr. Ruggero Cadossi.
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5.2 Materials and Methods
5.2.1 Materials for liposomes preparation
Hydrogenated soybean phosphatidylcholine (HSPC) Phospholipon 90H from Lipoid
GmbH (Germany)was kindly gifted by AVG Srl (Italy). Cholesterol, 4-(2-hydroxyethyl)
piperazine-1-ethanesulfonic acid (HEPES), 5(6)-carboxyfluorescein (CF), Triton X-100
(TX-100), Sephadex G-50 and hydrochloric acid (HCl) were purchased from Sigma
Aldrich (Italy). Chloroform was obtained fromMerck (Italy).
Bidistilled water, thiocyanatoiron, 1,2-dichloroethane and ethanol were supplied by
CarloErba Reagents (Italy). Aqueous dispersion ofcarboxymethyl-dextran coated mag-
netite (Fe3O4) 50 nm nanoparticles fluidMAG-CMX were obtained from Chemicell
GmbH (Germany).
Calorimetric investigations with Differential scanning calorimetry (DSC131 (Setaram,
France)) was performed on HSPC/Chol/MNPs and HSPC/Chol without MNPs mix-
tures in the same molar ratio used for vesicles preparation. Samples (5 mg) were
weighted in sealable aluminum pans, 20 µl of distilled water was added, and then the
pans were hermetically sealed. At least three heating/cooling cycles in a temperature
range from 20 to 70 ◦C under nitrogen flow (20 ml/min) were performed on all the sam-
ples before thermograms were recorded at a rate of 5 ◦C/min. An empty aluminum
pan was used as reference.
Liposome preparation
Magnetoliposomes, MNPs-embedded liposomes, were prepared by the thin lipid film
hydration method (Fig. 5.1), followed by sequential extrusion. HSPC and cholesterol
(5:1 molar ratio) were dissolved in the minimum volume of chloroform and the organic
solution was poured into a round bottom flask. The organic solvent was evaporated
under reduced pressure at 60 ◦C until a thin lipid film was formed on the bottom
of the flask. The dry lipid film was then hydrated at 60 ◦C in a 10ml of 10 mM
HEPES buffer solution (pH = 7.4) containing Fe3O4 nanoparticles and 20 mM 5(6)-
carboxyfluorescein sodium salt. Final lipid concentration was 10 mM and magnetite
to phospholipid ratio was 200 g Fe3O4/mol HSPC. Control liposomes, without MNPs,
have been prepared by adding CF to the buffer used during the hydration step. The
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Figure 5.1: Thin lipid film hydration method for the magnetoliposomes (MLs) preparation.
suspensions were vigorous stirred until complete dispersion of the film. Multilamellar
polydisperse vesicles were downsized by repeated extrusion (Lipex extruder, Canada)
at 60 ◦C through Cyclopore polycarbonate membrane filters (Whatman). Two steps of
ten extrusions through membranes of 0.8 µm; 0.4 µm and 0.2 µm pore sizes allowed the
preparation of unilamellar vesicles with a narrow size distribution (peak around 200
nm) as is possible to appreciate from fig. 5.2. The unencapsulated fluorescent tracer CF
and the non-entrapped ferrofluid nanoparticles were removed by size exclusion chro-
matography (SEC, see Fig 5.1) with a Sephadex G-50 column. The eluent was 10 mM
HEPES buffer solution (pH = 7.4). All liposome formulations were stored in dark at 4
◦C and used within 1 week.
Physicochemical characterization of liposomes
The Size, size distribution and ζ-potential of both control liposomes (CLs) and MLs
were measured with a Zetasizer Nano ZS90 (Malvern Instruments Ltd., UK). Hydrody-
namic diameter and polydispersity index (PdI) were evaluated by dynamic light scat-
tering (DLS) experiments, whereas ζ-potential was measured by electrophoretic light
scattering (ELS) experiments. The DLS and ELS techniques used a photon correlator
spectrometer equipped with a 4 mW He/Ne laser source operating at 633 nm. The
70 5. Drug delivery systems mediated by low intensity magnetic fields
Figure 5.2: Dynamic light scattering (DLS) of the magnetoliposomes solution. It is possible to appre-
ciate a well uniform 200 nm liposomes population. The measure was repeated three times.
particle size diameter was determined by Stokes-Einstein relationship. All experiments
were performed at a scattering angle of 90 ◦C after diluting 10 times the samples with
HEPES buffer solution pH=7.4 and were thermostatically controlled at 25 ◦C. In figure
5.2a the DLS for the MLs sample is reported. Moreover in figure 5.2b the DLS for the
MLs sample when the Triton-X-100 is added to disrupt the vesicles and have the 100
% of CF released as will be explained in the next section; it is possible to notice how
only one peak is present at 10 nm, meaning the no entire liposomes are present in the
solution.
Measurements of the CF released from liposomes
The fluorescence intensity of CF (excitation 492 nm, emission 512 nm) was monitored
by means of the spectrofluorometer LS 50B (Perkin Elmer, USA). The purified liposome
suspension was diluted with HEPES buffer pH 7.4 (10 ml) and the fluorescence was
measured before and after treatment with 50 µl of Triton X-100 to induce vesicles lysis.
For all the fluorescence measurements the overture of the slit was settled 2.5/4 for the
excitation and emission wavelength respectively. The CF calibration curve was obtained
working with and without Triton X-100 at lithic concentration in order to evaluate the
influence of the non-ionic surfactant on the fluorescence-based measurement. In the
figure 5.3 the calibration curve of the CF is shown. With the calibration curve of
the CF, the aim is to find the highest concentration of CF that can be incorporated
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Figure 5.3: Fluorescence measurements for the CF solution from low to high CF concentration.
into liposomes in order to avoid quenching or de-quenching phenomena to be able to
read a fluorescent measure at the spectrofluorometer, which has a limit of 900 A.U.
Here, in order to have a margin for the fluorescence evaluation, the limit for the highest
CF concentration has been considered 700 A.U. In this way the concentration value
of 5x10-7 moli/L is the maximum CF concentration that can be incorporated into
liposomes. In order to reduce the influence of excitation light irradiation, all data were
obtained at the same timing as soon as the excitation and emission conditions were set
up. The released CF percentage was calculated as:
CF releasae (%) =
(Ft − F0)
(Fmax − F0) × 100 (5.1)
where Ft is the fluorescence of individual liposomal samples, F0 is the background
fluorescence of the purified liposomal solution and Fmax is the final intensity when
vesicles are completely destroyed by adding TX−100 solution at 30 %. In figure 5.4 an
example is reported for the fluorescence measurements at different lipid concentrations.
At chosen Mls sample concentration (based on the CF calibration curve) the fluorescent
is read and the percentage of the CF release is calculated by considering the fluorescence
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Figure 5.4: fluorescent release of the purified liposomal solution (blue line), exposed MLs sample to
three hours of AMF exposure (green line), the final CF intensity when vesicles are completely destroyed
by adding TX−100 solution (orange line).
value before the AMF exposure and when the Triton-X-100 is added to have the 100
% of CF loaded into vesicles.
Moreover in order to ensure that no CF release occurred next to a thermal increase,
the HSPC liposomes have been heated in a thermal bath at a temperature up to 60
◦C. In Fig. 2.5 it can be appreciated how the liposomes start to release at the lipid
transition temperature of 48◦C, ensuring no CF release in the thermal bath of 37◦C,
at which the magnetoliposomes are immersed during the magnetic exposure.
Negative staining transmission electron microscopy
The morphology of the vesicles was examined using transmission electron microscopy
(TEM). A drop of a water-diluted suspension of the Mls (0.05 mg/ml) was placed on
a copper grid, which allowed the adsorption of the vesicles. The excess of water was
removed letting the grid drying on a filter paper. Then, a drop of an aqueous solution
of uranyl acetate (1% w/v) was added and left in contact with the sample for 5 min.
After this time, the excess of the uranyl acetate solution was removed with a filter
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Figure 5.5: Thin lipid film hydration method for the magnetoliposomes (MLs) preparation.
paper and the samples were dried at room temperature before the vesicles were imaged
with a TEM (Zeiss EM 10, Germany) operating at an acceleration voltage of 60 kV.
Assay of phospholipids
Phospholipid concentration was determined using the phosphorus colorimetric assay.
Briefly, aliquots (0.4 ml) of phospholipids in 50 % v/v ethanol were added to a mixture
of 1 ml of thiocyanatoiron reagent and 0.6 ml of 0.17 N HCl. The solution was incubated
for 5 min at 37 ◦C and then the thiocyanatoironphospholipid complex formed was
extracted with 3 ml of 1,2- dichloroethane by vigorous shaking for 2 min in a vortex-
type mixer. The mixture was centrifuged for 2 min and the absorbance of the lower
layer was measured at 470 nm against a blank without substrate, using a double beam
Lambda 25 (Perkin Elmer, USA) UV-Vis spectrophotometer. The measurements were
repeated both before and after SEC purification of extruded samples.
Assay of magnetite
Magnetite content in magnetoliposomes was determined through the method described
by Belikov et al. An opportune amount of magnetite solution was added with 0.08 ml
of Triton X-100 20 % to disrupt the phospholipid vesicles. The volume was adjusted
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Figure 5.6: AMF exposure setup (a) consisting of a pulse generator, an amplifier and two squared
Helmholtz coils, generating a magnetic field of 70 µT; (b) exposure of the magnetoliposomes solutions
immersed in a thermal bath at 37 ◦C and exposed to AMF.
to 5 ml with 8.5 % HCl and the absorbance was read at 320 nm in a Lambda 25
spectrophotometer (Perkin Elmer, USA). The calibration curve was performed with
standards solutions of magnetite. The measurements were repeated both before and
after SEC purification of extruded MLs. All the data collected were used to calculate
magnetite/phospholipid ratio as µmol of magnetite by mmol of lipid.
5.2.2 AMF exposure setup
For the AMF exposure setup, we used a Hewlett Packard HP−3314A pulse generator
applying a voltage of 1.67 V at frequency of 20 kHz. Next the generator, a Krohn−Hite
7500 amplifier was connected to feed two Helmholtz magnetic coils (see Fig. 5.6a),
generating a magnetic field intensity of 70 µT. The dimension of the Coil is a length of
20 cm, thickness of 5 cm and placed at distance of 10 cm.
The magnetoliposomes samples were placed at the center, between the two coils
(see Fig. 5.6b) in a thermal bath at 37 ◦C to ensure a stable temperature during the
experiments, well below the transition temperature of the HSPC vesicles (v 50 ◦C).
Both Mls and liposomes with no nanoparticles (sham) were exposed to the AMF, in
order to possibly quantify the spontaneous leakage of the vesicles. The exposure time
was of three hours in continuum and then period of ON (3 hr) and OFF (21 hr) for the
same sample was done for a total of 12 hours of exposure. The fluorescent release was
measured for both samples next the AMF exposure as explained in the section 5.2.1.
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Figure 5.7: Magnetic fields maps of four different planes. Lower plane, center plane and upper plane.
Then a trasversal center plane in the z direction.
Characterization of the AMF exposure setup
Because the Helmholtz coils, were not characterized in terms of homogeneity of the B
field, before proceeding with the experiments we measured the magnetic field inside the
coils as follow. We performed measurements with a triaxial magnetic probe (Metrolab
THM1176-MF three axis hall magnetometer, 1.65 x 0.5 x 0.23 cm3), at the ENEA
Center ”Casaccia”. Four different planes were mapped and the results are reported in
Fig. 5.7. It is possible to appreciate an homogeneity of 60 % in the center volume of
15 x 15 x 6 cm3.
5.2.3 PEMF exposure setup
For the PEMF exposure, the medical device IGEA called I-ONE, a product that is
already CE certified, has been used. The coil generated a pulse of magnetic field with
intensity of 1.5 mT with a repetition frequency of 75 Hz.
In fig. 5.8 it is visible the system I-ONE and the following elements are shown:
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Figure 5.8: I-One coil exposure setup with the generator, the power supply and the solenoid.
1. generator;
2. power supply;
3. solenoid.
I-ONE is constituted by a generator of low frequency pulsed electromagnetic field which
generates a current pulse signal and delivers this signal to an external coil (the solenoid),
generating a pulsed electromagnetic field with specific characteristics. The pulsed signal
has the following temporal characteristics:
• duration of the active phase of the signal: 1.3 ± 0.1 ms;
• repetition frequency: 75 Hz (which is equivalent to a repetition time period be-
tween two successive pulses of 13.3 ms);
• amplitude of the peak value: 1.05 A.
In table 5.1 the geometric and electric characteristics of the I-ONE coil are reported.
The magnetoliposomes samples were placed at a distance of 13 cm obtaining a
magnetic field of 100 µT (Fig. 5.9a) on the exposed samples. The samples were placed
also in this case in a thermal bath (Fig. 5.9a) and during the exposure an aluminum
foil was used to cover the bath, in order to avoid any release due to the light. The
choice of the distance at which place the samples, has been done following a dosimetry
analysis of the I−One Coil and a sample of exposed solution as will be explained in
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Figure 5.9: (a) Exposure setup of the MLv sample and the I-One coil; the MLs samples are placed
in a thermal bath at 37 ◦C, at a distance of 13 cm from the I-ONE medical device (b) current signal
feeding the coil; (c) coil geometry used to perform dosimetric simulations in the frontal exposure view;
(d) magnetic field streamline of the coils and the magnetic field surface inside the exposed sample.
the following section. One sample was used for the experiment, repeated four times to
perform statistical analysis.
Numerical Modeling of the I−One for the choice of the B field intensity
To evaluate the intensity to which expose the sample, numerical simulations have been
performed with the Software Sim4Life 2.1 in the frequency domain for Magneto Quasi-
static simulations. In particular having fixed an intensity comparable to the one of the
experiments in CW (100 µT), the distance between the exposure samples and the coil
has been derived. The Sim4Life v2.2 (ZMT, Zurich MedTech AG) platform combine
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computable human phantoms with the most powerful physics solvers and tissue models,
for directly analyzing biological real-world phenomena and complex technical devices in
a validated biological and anatomical environment. The Sim4Life platform also offers
many physics solvers and advanced tissue models, for analyzing biological phenomena
and complex technical devices. The Sim4Life is an interactive environment for model-
ing and simulating scientific and engineering problems. Here the Magneto Quasi-static
solver has been used. The simulations were performed at frequency of 250 Hz (the
first lobe of the spectral of the signal). The model geometry is reported in Fig. 5.9c.
The cuvette has been simulated as a cylinder with 7.5 cm of height and a radius of
0.6 cm, filled for a half with a conductivity solution (0.049 S/m), which represents the
magnetoliposome solution conductivity (see Fig. 5.9c) experimentally measured. Such
solution has been measured thanks to the dynamic light scattering (DLS) instrument.
The conductivity value has been obtained as mean value on 28 measurements with a
standard deviation of 0.005.
A fine grid mesh (0.6 nm of resolution) has been adopted for the mesh of the coils and
a more accurate resolution has been chosen for the cuvette discretization (0.4 mm of
resolution). The feeding current was of 240 A, considering one simulated current wire
(Nwires = 240). The distance between the sample and the coil is, starting from the
single simulated wire, of 15.5 cm, chosen based on a linear fitting (13 cm) considering
a magnetic field of the coil of 1.5 mT plus taking into account the thickness of the
I-One device (white color in Fig. 5.9a) and the thickness of the cuvette and thermal
bath recipient.
Magnetic, electric and current density distributions
Number of Coils 240
Copper section 0.355 mm
Mean coil 49.3 cm
Resistance (nominal) 21.2 ohm
Inductance (nominal) 18.5 mH
Length 16 cm
Width 12 cm
Table 5.1: Solenoid characteristics
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Figure 5.10: (a) current density and the electric field (b) distribution inside the exposure sample is
reported.
In figure 5.9d and 5.10 the magnetic, electric field and current density are reported
for the exposure sample when a 1.5 mT of magnetic field is applied.
In figure 5.9d the magnetic field streamline and the B field distribution inside the
exposure sample is reported, showing a B field of 100 µT when 1.5 mT is applied. The
magnetic field appear to be homogeneous in the exposed sample. As expected, also the
electric field and current density are reported 5.10a and b, showing low intensities, the
range of mV/m and less than mA/m2, that determine no significant heating during the
exposure to the PEMFs.
Moreover, the dosimetry of the I-One medical device has been done experimentally
from a previous Ph.D. student, Dr. Francesca Camera (Ph.D. in Electronic Engineering
Cycle XXVIII at Sapienza University of Rome).
5.3 Results
With the regard to the liposomes characterization, no differences was observed in vesi- Physicochemical
characterization
of liposomes
cles size among control liposomes (CLs) and MLs as shown in table 5.2.
Both nanocarriers arranged in a monomodal distribution with a PdI values < 0.200.
The ζ-potential value of CLs in the buffer medium is negative, moreover the more
electronegative character of the MLs system suggests the presence of some negatively
charged MNPs absorbed onto the external leaflet of the phospholipid bilayer. Hydra-
tion step of the dry lipid film during liposome preparation was not influenced by the
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Figure 5.11: TEM images of soybean HSPC liposomes conventional (a) or iron oxide nanoparticle-
liposome hybrids MLs (b)(scale bar: 200 nm).
presence of MNPs in the hydrating medium. Finally, the drug-loading efficiency is not
limited by the co-loaded MNPs inside vesicles (Table 5.2). This finding is of paramount
importance for the possibility to use of the investigated MLs as smart drug carrier. Af-
ter SEC purification, the lipid and the magnetite content were determined. In Figure
5.11a and b the TEM images of conventional (CLs) and MLs structures are showed,
respectively. CLs and MLs exhibited similar size and structure, which indicates that
MNPs interaction did not affect MLs formation at the lipid/MNPs ratio employed. The
average diameter of all the structures observed was 200 nm, consistent with membrane
extrusion (Fig. 5.11c). TEM images (Fig. 5.11) suggest that interaction between MNps
and HSPC lipids leads to hybrid colloidal structures magnetoliposomes, the iron oxide
nanoparticle can either decorate the liposomal surface or be internalized inside the vesi-
cles as either individual nanoparticles or MNP aggregates. Sometimes, nanoparticles
are concentrated on one side of the vesicles. Unencapsulated nanoparticles were not
observed outside the liposome vesicles throughout the TEM grid, as consistent with
the efficacy in the SEC purification step.
Next to the characterization of the MLs, with the aim to replicate and assess the CFAMF exposure
release from HSPC MLs exposed to AMFs [Spera et al., 2015], firstly we performed
experiments of MLs under an AMF of 70 µT of intensity at a frequency of 20 kHz. The
experiments were carried out considering one sample of MLs and one of conventional
Sample z-average (nm) Pdl ζ-potential (mV) 5 (6)CF E.E. (µl/mg)
CL 220.9 ± 22.4 0.046 ± 0.028 -10.28 ± 1.43 2.29 ± 0.26
MLs 240.9 ± 26.6 0.131 ± 0.031 -15.42 ± 1.51 1.84 ± 0.13
Table 5.2: Physicochemical characterization of conventional liposomes (Cl) and magnetoliposomes
(MLs).
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Figure 5.12: Results of the CF release from MLs (magnetoliposomes) in time domain with a total of
12 hours of AMF exposure with OFF time of 21 hours for each 3 hours of exposure.
liposomes (CLs), with no nanoparticles, placed at the center between two Helmholtz
coils, in a thermal bath at 37 ◦C. The results in terms of percentage of fluorescent re-
lease are reported in fig. 5.12. After three hours of exposure a fluorescent release of 17
% of CF was appreciated, by confirming the data from [Spera et al., 2015]. After that,
the samples were stored at 4 ◦C for 21 hours and then exposed again for additional 3
hours with a 6 % of release. Next the AMF was turned off for more 21 hours and then
turned it on for more 3 hours and an additional release of 26 % was reached. At the
end after 3h + 3h + 3h + 3h the last 9 % of Cf was released form the MLs samples.
A total of 58 % has been obtained, by confirming the triggered release from the alter-
nate magnetic field, as proven by [Spera et al., 2015]. For the conventional liposomes
(CLs) in figure 5.13 the total percentage of CF release was about 11 % after 12 hours,
meaning that the spontaneous CLs release is negligible with the respect to the 58 %
obtained with the AMF application. Probably the 11 % of CF release is due to the
thermal shock between the liposomes storage temperature (4◦C) and the thermal bath
(at 37◦C) during the magnetic field exposure.
Moreover, with the respect to the data published in [Spera et al., 2015], here a
triggered release is achieved with the AMF application, but not in the same amount
for each ON period of 3 hours. These behavior could be addressed to the possible
aggregation of nanoparticles after the first 3 hours of AMF exposure or for the losing of
82 5. Drug delivery systems mediated by low intensity magnetic fields
Figure 5.13: Results of the CF release of CLs (conventional liposomes) after 12 hours of switching ON
(3h) and OFF (21h) the AMF exposure.
the magnetic nanoparticles from some liposomes structures. This last hypothesis has
been supported by the TEM (transmission electron microscopy) images taken after the
12 hours of AMF exposures (see Fig. 5.14). As explained 5.2.1 the TEM is a technique
that allow visualize molecular structures of nm dimensions and to possible predict the
presence, in our specific case, of nanoparticle on the vesicles surface. From the figure
5.14 the TEM images of MLs after 12 hours of AMF exposure is reported and a par-
ticular shape of the liposomes is highlighted (see Fig. 5.14b). The membrane of some
liposomes changed its shape by losing the nanoparticles (see Fig. 5.14b). Moreover,
few nanoparticles can be appreciate. This could explain how after 12 hours no release
occurred. Unfortunately no images were taken before the AMF exposure.
Once confirmed the results of the release after 12 hours of ON - OFF exposure toPEMFs exposure
AMF, the MLs samples have been exposed to a pulsed electromagnetic fields (PEMFs)
of 100 µT of intensity, by using the I-One medical device as described in 5.2.3. We
placed one samples of MLs for four different exposures in order to perform a statisti-
cal analysis (see Fig. 5.9). We did a set of exposures from 15 minutes up to 3 hours
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Figure 5.14: (a)-(b)TEM images of the MLs after 12 hours of ON-OFF AMF exposure (3h + 3h +
3h + 3h).
in continuum modality. As is possible to appreciate in fig 5.15, after 15 minutes of
magnetic field application more than 5 % of the CF is released (see Fig. 5.15). After
the three hours of exposure the CF released reached the value of 17 % (see Fig. 5.15)
with a standard deviation not higher than 0.8. These data suggest the possibility with
the PEMFs signal to obtain a liposomal drug delivery systems without disrupting the
vesicles membranes. Besides, the temperature (with a Luxtron 3100 fiber optic temper-
ature probe) was monitored inside the MLs sample during the exposure and no thermal
increase was denoted.
Moreover, MLs samples were monitored in a thermal bath of 37 ◦ (shame samples) for
a time up 9 hours in order to detect the release coming from the MLS leakage when no
B field is applied. No significant CF release was denoted, a release of 3 % after three
hours and of 4.7% after 9 hours was obtained.
In order to evaluate the capability of PEMFs to trigger the CF release with ON and
OFF periods as done in [Spera et al., 2015]), we exposed the same MLs samples to
additional 3 hours of B field application (after 21 hours of OFF state, storage at 4 ◦C)
and an extra release of 7 % was obtained (Fig. 5.16). After additional 3 hours (3h + 3h
+3h, for a total of 9 hours) no release was appreciated. The CF release saturated after
3h + 3h + 3h hours of exposure, showing almost 2 % of CF release. With the respect
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Figure 5.15: Results of the CF release from MLs (magnetoliposomes) next to the PEMFs exposure of
100 µT.
to the MLs exposed to the AMF, here with PEMFs it seems that the release was not
repeatable after the same time of exposure (3h + 3h + 3h) suggesting a possible loss
of magnetic nanoparticles due to the different signal applications.
In order to valued this hypothesis, after each PEMFs exposures, TEM (Transmission
Electron Microscopy) images were taken as explained in section 5.2.1. It is good
to keep in mind that with the TEM technique it is not possible to determine if the
magnetic nanoparticles are inside or outside the vesicles, because it is a 2D surface
representation. The TEM images were taken right after each exposure (Fig. 5.17). In
figure 5.17 the images of the different exposures time are showed, at the 0 time (before
PEMFs exposure, Fig. 5.17a), after 3h ( Fig. 5.17b), at 3h + 3h (Fig. 5.17c) and 3h
+ 3h + 3h hours(Fig. 5.17d). Before the exposures to PEMFs, the MLs structures is
perfectly integer with the magnetic nanoparticles on the surface or/and presumably
internalized into vesicles (see Fig. 5.17a); after three hours the MNPs are widespread
distributed into solution but still present also on the liposomes surface and also into the
membrane (Fig. 5.17b). When an additional three hour of exposure is done ( 5.17c),
the most part of the MNPs seem to be escaped from the liposomes vesicles, indeed
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Figure 5.16: Results of the CF release from MLs (magnetoliposomes) next to the PEMFs exposure of
3h +3h and 3h + 3h + 3h (with OFF periods of 21 hours).
is possible to highlight how the MNPs visible are out of the vesicles on the liposomes
membrane (see Fig. 5.17c, green circle). This ”MLs escape”could explained the 7 % of
release obtained with the respect to the 17 % of the first 3 hours. Furthermore, after
3h + 3h +3h of exposure (see Fig. 5.17d) no MNPs are present, justifying the 2 % of
CF release.
By the analysis from the TEM images, is possible to conclude that by the PEMFs stim-
ulation, the MLs loss their nanoparticles almost after six hours of exposure, differently
from the AMF system were the release was repeatable for a time up 12 hours [Spera
et al., 2015]. This behaviors could be addressed to the different kind of signal; in the
case of AMF is a sinusoidal signal with a 50 µs duration of one period of the signal,
that could stimulate the MLs at one side and then in the opposite side giving the same
release after the same time of stimulation. While, a single pulse of the PEMF has a
duration of 13.3 ms and could stimulate for a longer time and in the same direction
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Figure 5.17: TEM (Transmission Electron Microscopy) images of Mls before the PEMFs exposure (a),
after 3h, 3h + 3h and 3h + 3h + 3h of B field application (b, c and d).
the MLs, by leading to the loss of the magnetic nanoparticles from the liposomes core.
5.4 Conclusions
In summary, in this chapter a proof-of-concept of the magnetoliposomes release under a
PEMFs exposure has been given. High-Tm magnetoliposomes (MLs) using the HSPC
lipid were prepared and iron oxide nanoparticle MNPs, were encapsulated into the
liposomes aqueous core. To probe the membrane permeation and release behavior of
high-Tm MLs, CF as a model of hydrophilic drug, was loaded into the MLs core, with
satisfactory values of CF-loading efficiency (see Tab. 5.2).
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The Mls and the conventional liposomes (Cls) were exposed to an alternate magnetic
field (AMF) of 70 µT. From our experiments a triggered release was reached with a
58% of CF release after 12 hours by switching ON and OFF the alternate magnetic
field (ON period of 3h and OFF of 21h) until almost complete depleting of the carrier
as already demonstrated in Spera et al. [Spera et al., 2015].
Once, assessed the MLs release next to the AMF application, the goal has been to test
a liposomal drug delivery mediated by PEMFs using the I-One medical device, able to
generate a magnetic field of 1.5 mT of absolute value. Thanks to numerical simulation
the distance at which place the sample, was chosen in order to have a magnetic field
of 100 µT of root-mean square value. The samples were immersed in a thermal bath
at 37 ◦C. The CF release was around the 5 % after 5 minutes of exposure and the
17 % was reached after the first 3 hours of B field application, as happened with the
AMF application. Conversely, switching ON (3h) and OFF (21h) the magnetic field,
only the 7 % of CF was released (3h + 3h) and an additional 2 % was reached by
adding 3 more exposure hours (3h + 3h + 3h). By the TEM images analysis, it has
been possible to asses how after the 3h + 3h of exposure (switching ON and OFF the
B field), the magnetic nanoparticles escaped from the liposomes core, possibly due to
the different signal duration and shape with the respect to the alternate magnetic field
as explained in the result section (see Sec. 5.3). Anyhow, it is important to highlight
how also with PEMFs usually used for the treatment of inflammation status, it seems
possible to have a controlled release from MLs structures, that could be used as future
anti-inflammatory cargo release system from magnetoliposomes to diseased tissues.
Generally, both with the AMF and with PEMFs we have demonstrated the possibility
in two different way to have a controlled CF release from liposomes vesicles due to the
mechanical stimulation and not to the thermal exposure. In fact, these experiments
demonstrated that the cargo release from the high-Tm MLs was due to reversible
and controllable permeability change of the bilayer, rather than the destructure of the
high-Tm MLs, that maintain their structures over the whole experiment duration as
demonstrated by the TEM images and from the dynamic light scattering measurements.
The hypothesis done is a release mechanism due to a mechanical stress on the liposome
membrane due to nanoparticles oscillations in its proximity.

Chapter 6
Versatile exposure system for
laboratory experiments finalized
to therapeutic applications in the
IF range
6.1 Introduction
As already mentioned in the previous chapter (see 5.1), more often researchers are fo-
cusing the attention on the ability of low intensity magnetic fields for the treatment of
different inflammation status, cancer or neuronal disorders. With the wide spread of the
technological progress the use of magnetic field as external stimulus for inflammatory
and neuronal disease therapies and drug delivery systems for nanomedicine has consid-
erably increased [Rodzinski et al., 2016, Ross, 2013]. The progresses in nanomedicine,
as described in the part I ranges from nanoparticles for molecular diagnostics, imaging
and therapy to integrated medical nanosystems [Nune et al., 2009, Shi, 2009] to act at
the cellular level inside the body.
At this purpose, stimuli-response release of a drug from an ad hoc designed nanocarrier
(e.g. liposomes), at a specific time and location is one of the most aimed results of the
drug delivery research (see Ch. 5). Besides the typical triggers used for the liposomes
drug delivery systems (pH, temperature, ultrasound, etc.) some studies and the exper-
iments presented in the previous chapter (Ch. 5) suggested that even magnetic fields
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of low intensities are a good trigger to control the release of the drugs has reported in
the previous chapter (Ch. 5) and in [Nappini et al., 2010, Spera et al., 2015]. The aim,
with this kind of applications, is to achieve the therapeutic efficacy without a thermal
effect, which could affect the patient for prolonged time of the treatment, and to this
regard in-vitro and in-vivo laboratory experiments are required to tune the intensity
and the frequency of the applied field.
On the other side, highly interesting applications of magnetic fields concern non-invasive
stimulation of the central nervous system, such as the Transcranial Magnetic Stimu-
lation (TMS) technique [Corthout et al., 2001] or the low-intensity pulsed magnetic
field stimulation (PEMFs) [Di Lazzaro et al., 2013]. Although TMS efficacy has been
clinically proved [Corthout et al., 2001] to map possible neuronal damages from strokes,
neuronal diseases or amyotrophic lateral sclerosis [Pashut et al., 2014], the action of
magnetic fields on neuronal structures is still poorly known, so that in-vitro and ex-
vivo studies are necessary to explore such effects at molecular and cell level [Di Lazzaro
et al., 2013, Pashut et al., 2014].
In this context, to obtain a precise dose-response relationship, specific exposure systems
are necessary, mainly based on single or multiple coils [Di Lazzaro et al., 2013, Pashut
et al., 2014], that guarantee a uniform and well-known magnetic field within the ex-
posed sample, in terms of peak value, waveform and polarization. The aim of the work
presented in this chapter is to design a versatile magnetic exposure system, suitable for
different in vitro experiments, at the basis of the therapeutic applications of MLs drug
delivery and magnetic stimulation techniques. For the drug delivery application, the
aim is a system able to porate MLs by a mechanical stress without a thermal increase
at the typical experimental frequency of 20 kHz [Spera et al., 2015]. Concerning the
in vitro application the aim is the exposure of brain slices, adherent to the surface of
an exposure chamber, to a low-intensity magnetic field at the frequency of 3 kHz [Paffi
et al., 2015], to stimulate and map the cells avoiding any thermal increase.
The exposure system able to fulfill the requirements of both applications, consists of
two new squared Helmholtz coils, designed to produce a magnetic field with intensity
in the order of mT in a frequency range between 1 and 20 kHz, by analyzing all ge-
ometrical and electrical parameters involved. After the analytic identification of the
geometrical parameters, numerical simulations have been performed for both applica-
tions to calculate the dose on the exposed sample in terms of magnetic induction (B),
electric field (E), and current density (J). Moreover, also a circuital analysis is reported
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to adapt the present magnetic exposure system (see Sec. 5.2.2) to the new coils both for
a sinusoidal or a pulse signal application. This procedure will ensure a multi-purpose
system suitable to validate laboratory experiments at the basis of the most adopted
therapeutic applications using magnetic fields in the IF frequency range.
6.2 Material and Methods: design of the exposure system
Analytical model
The design of the new magnetic field exposure system started from the specific require-
ments of the versatile exposure system as:
• intensity of the B field in the order of up to some mT;
• frequency range [1-20 kHz];
• exposure region able to host either a disposable plexiglas cuvette or a suitable
chamber for brain slices;
• overall impedance adequate to be fed by a commercial low cost chain of generator
and amplifier.
We performed a first analytic study through the standard set of equations of Helmholtz
coils [Wang et al., 2002], dimensioning the geometry and composition of the setup
(Fig. 6.1), in order to reach magnetic field intensities in the order of mT and in a wide
frequency range (from 1 to 20 kHz).
Numerical model
To validate the chosen geometrical and electric parameters, we performed numeri-
cal simulations using the Software Sim4Life 2.1 in the frequency domain for Magneto
Quasi-static simulations. Sim4Life is a simulation platform, combining computable
human phantoms with the most powerful physics solvers and advanced tissue models,
for analyzing biological phenomena and complex technical devices. The Sim4Life is an
interactive environment for modeling and simulating scientific and engineering prob-
lems. Taking into account fabrication requirements indicating a practical easiness in
realizing square coils vs circular ones, we simulated the two coils as squared current
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Figure 6.1: (a) Geometry of the Helmholtz coil, R is the radius and distance between the two coil, I
the current; (b) zoom of the coil section with the wires number N, the coil thickness t and the wire
diameter d.
wire of 15 cm, placed at 7.5 of distance (see Fig. 6.2a) powered with a current of 120
A (the project required current of 0.6 A multiplied per the number of 200 wires). For
both applications, the magnetic field has been applied in the perpendicular direction
with the respect to the current flow.
Concerning the simulations for the MLs exposure system, we performed two simu-MLs exposure
system lations considering a cuvette placed at the center between the two squared coils and
considering the upper and lower bounds of the frequency interval of interest: 1 and
20 kHz (Fig. 6.2b), also according to previous experiments carried out with a different
magnetic exposure system (see Sec. 5.2.2, [Spera et al., 2015]). The cuvette has been
simulated as a cylinder with 7.5 cm of height and a radius of 0.7 cm, filled for a half
with a conductivity solution (0.049 S/m), which represents the magnetoliposome solu-
tion conductivity, experimentally measured. Such solution has been measured thanks
to the dynamic light scattering (DLS) instrument. The conductivity value has been
obtained as mean value on 28 measurements with a standard deviation of 0.005. A fine
grid mesh (0.6 nm of resolution) has been adopted for the coils and a more accurate
resolution has been chosen for the cuvette discretization (0.2 mm of resolution).
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Figure 6.2: (a) Coils geometrical model with coil side of 15 cm placed at 7.5 of distance. In red the
current flow; (b) drug delivery exposure system consisting of a cuvette placed at the center between
the two coils with dimension of 7.5 of height, 0.6 of radius and per 3.5 cm filled with the solution;(c)
in-vitro exposure system with the chamber placed between the Helmholtz coils, to the left of the image
the section for the chamber is reported with a diameter of 2.5 cm, filled with the artificial cerebrospinal
fluid solution.
Regarding the numerical simulations of the magnetic exposure system for the neu- in-vitro neuronal
cells B exposuresronal cells in-vitro experiments, we simulated a chamber placed at the center between
the two coils (Fig. 6.2c) containing a circular section (2.5 cm of diameter) in which
are supposed to be placed the cell slices. We carried out the simulations at frequency
of 3 kHz, typically used for this kind of applications [Di Lazzaro et al., 2013]. The
dimensions of the chamber are 8.9 x 6 x 2.5 cm3. The chamber is made of plexiglass
with the solution simulated as artificial cerebrospinal fluid, typically used in these kind
of experiments, with 1.7 S/m of conductivity and a permittivity value of 66830.8. The
artificial cerebrospinal fluid is present both in the cone representing the slice holder
and in the rest of the plexiglass chamber. A fine grid mesh has been used for the
coils and the chamber while a resolution of 0.5 nm has been adopted for the artificial
cerebrospinal fluid solution.
Circuital Model
In order to match the load impedance of the projected coils to the existing exposure
system (see Sec. 5.2.2), specifically to the Krohn−Hite 7500 amplifier, a circuital study
has been performed by using the LTSpice software. LTSpice is a high performance
spice simulator, which provides a variety of custom design simulation tools and de-
vice models to allow a quickly and easily circuits evaluation using high performance
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Figure 6.3: Datasheet of the Krohn−Hite 7500 amplifier.
switching regulators, amplifiers, data converters, filters. By the data-sheet of the am-
plifier, the working voltage and current of the amplifier are 100 V and 0.6 A and a load
impedance of ZL = 100 Ω (see Fig. 6.3) is required in order to achieve the maximum
current transmission between the amplifier and the coils system at frequencies up to
100 kHz.
6.3 Results
By the analytic model using the formula reported in [Wang et al., 2002], the geometri-Analytical design
cal and electric parameters as coil geometry and shape, coil thickness, number of wires
have been calculated as reported in Table 6.1. The dimension of the Helmholtz coil
system satisfies the requisite of suitable volume available for the sample holder leaving
an overall volume accessible of 12 x 12 x 7.4 cm3.
Once identified the geometrical and electric parameters, a numerical study has beenNumerical model
performed. As a first step, the magnetic field distribution between the two Helmholtz
coils has been evaluated, when an electric current of 120 A is applied at a frequency
of 20 kHz. The data are shown in Fig. 6.4 in terms of a 2D map of the magnetic field
intensity in the xz and yz plane (see Fig. 6.4a and b). The field reaches an intensity of
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Figure 6.4: Magnetic field distribution. (a) 2D map of the magnetic field intensity in the xz and yz
plane (b), a magnetic field up to 2 mT is achieved with a good uniformity. (c) Streamline of the
magnetic field is presented with flow lines going in the field direction.
2 mT near the coils and of 1.4 mT in the volume where the samples are supposed to be
exposed. The magnetic field streamlines are reported in Fig. 6.4c showing the direction
of the magnetic field between the two Helmholtz coils. The magnetic field intensity of
1.4 mT validates the project guidelines identified with the analytic study.
This result is also confirmed from the study of the magnetic field uniformity in the
volume between the coils (see Table 6.2). In Table 6.2 it is possible to notice a homo-
geneity of the magnetic field of 95 % in the exposure volume of 9.12 x 9.12 x 7.5 cm3.
Successively the aim has been to evaluate the electric and current distribution when
the exposure sample was exposed to the magnetic field for a dose-dependent analysis.
Our sample holders are the cuvette (Fig. 6.2b) and the chamber (Fig. 6.2c) respectively
for MLs drug delivery and the TMS in−vitro applications. As for the magnetic field
distribution, the result is the same reported for the coils system without the presence of The exposure
system for Drug
Delivery
applications
the sample (data not shown). To evaluate the electric field inside the cuvette sample,
Diameter 2R 15 cm
Thickness t 0.89 cm
Current I 0.6 A
Number of wires N 200
Distance R 7.5 cm
Resistance R 1.76 ohm
Inductance I 23.5 mH
Table 6.1: Geometrical and electric parameters of the Helmholtz coil.
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Figure 6.5: Magnetic field distribution. (a) Electric field streamlines are reported in the xy plane,
suggesting a high electric field at the cuvette side and lower electric field inside the cuvette as showed
in the 2D map of E (b) at the frequency of 20 kHz. (c) 2D map of the electric field at the frequency
of 1 kHz resulting in a good homogeneity of the electric field inside the solution.
the streamline and a 2D map of the electric field distribution is reported (Fig. 6.5a
and b respectively) for the experimental frequency of 20 kHz compared with the one
of 1 kHz (Fig. 6.5a). It is possible to notice how inside the cuvette the electric field
distribution is not highly homogeneous, highest to the side of the cuvette and lower to
the center (Fig. 6.5a and b), in particular for the frequency of 20 kHz. Nevertheless,
the electric field never reaches the value of 1 V/m, which means that no appreciable
thermal increase can be generated from these electric field distributions, despite their
in-homogeneity. As expected, decreasing the frequency to 1 kHz a higher homogeneity
Magnetic field homogeneity
95 % 90 % 80 %
∆x cm 9.12 10.36 11.86
∆y cm 9.12 10.36 11.86
∆z cm 7.49 8.98 11.60
Useful Volume cm3 622.97 963.52 1631.65
Table 6.2: Magnetic field homogeneity
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Figure 6.6: Magnetic field distribution. (a) Current density streamline inside the cuvette and the 2D
current density map (b) for the frequency of 20 kHz in the xy plane. (c) 2D map of the current density
inside the cuvette at the frequency of 1 kHz.
is reached for the electric field (Fig. 6.5c), with even lower intensities in the order of
some mV/m.
A similar result is observable looking at the 2D maps of the current distribution inside
the cuvette at 20 and 1 kHz (Fig. 6.6a, b and c). In fact, also current density distribu-
tions are more homogeneous at the lower frequency of 1 kHz, with values always below
0.03 A/m2, ensuring a negligible thermal increase to the sample for the magnetic field
exposure.
Moreover, in order to study the electric field variation inside the cuvette sample de-
pending on the samples number and their position between the coils, we performed
simulations at 20 kHz with 8 cuvette (Fig. 6.7a), by using always a conductivity of
0.049 S/m.
No variations were detected for the E field distribution with the respect to the one
cuvette case, and a mean electric field of 0.413 V/m was reached inside of all the cuvette
(Fig. 6.7) with a standard deviation of 0.075 V/m.
The second part of this work is related to an exposure system for in-vitro experiments In-vitro magnetic
stimulation
exposure system
on real cells and in particular on neuronal cell slices stimulation. To reach this objec-
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Figure 6.7: (a)Geometric distributions of the 8 cuvette between the coils, d = 1.7 cm and D = 1.35
cm; (b) E field distribution inside 4 cuvette, the result is the same also for the 4 on the other side.
tive we simulated a plexiglass chamber, i.e. the slice holder, placed between the two
Helmholtz coils (Fig. 6.2c), at the frequency of 3 kHz [Di Lazzaro et al., 2013]. The aim
has been to evaluate the electric and density current distribution inside the chamber to
possibly detect secondary effects due to the magnetic field application. The magnetic
field distribution for this setup is the same (data not shown) presented for the MLs
system, ensuring a good exposure of the slices in a wide frequency range (up to 20
kHz). The results for the electric field distribution are reported in terms of streamlines
(Fig. 6.8a) and 2D maps in three different planes, xz, yz and xy respectively (Fig. 6.8b,
c, d). The electric field results to be higher to the plastic region of the chamber and
lower in the liquid solution (blue color) as expected due to the higher permittivity value
of the artificial cerebrospinal fluid solution. Moreover, looking at the 2D map in the xy
plane (Fig. 6.8d) it is possible to appreciate a homogeneous electric field in the volume
in which are expected to be exposed the slices (blue circle) with an intensity in the
order of mV/m. This result guarantees a negligible effect of the induced electric field
and a good isolation of the solution to the thermal effect.
Regarding the current density inside the exposure system, the results are shown in
Fig. 6.9. The streamlines of the current density are reported confirming the current
flowing in the region where the solution is present (red lines). This behavior is con-
firmed also from the 2D maps presented in Fig. 6.9b, c, d in three different planes
(xz, xy and yz respectively). A good homogeneity of the current is achieved in the
region where the slices are supposed to be exposed (red circle). Anyhow, the current
increment (up to 2 mA/m2) can be considered slight to do not provoke a significant
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Figure 6.8: (a) The electric field streamlines are reported in the xz plane. The electric field results to
be lower where the liquid is present and higher to the plastic region of the chamber (red and yellow
lines); (b,c,d) 2D map electric field distribution in the xz, yz and xy plane, showing an homogeneous
distribution of the field where the slices are supposed to be placed (d, blue circle).
thermal increase.
Figure 6.9: (a) The streamlines of the current density J are reported, in blue the current density in
the plastic region of the chamber and in red the one inside the solution;(b,c,d) 2D maps of the current
distributions in three different planes along the chamber, xz, xy and yz respectively.
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Figure 6.10: (a) Circuital model of the Helmholtz coils represented as two RL branches in series; (b)
impedance values of the coils electric circuit at frequencies between 100 Hz and 100 kHz.
Once numerically evaluated the magnetic and electric distributions inside the twofold
target (cuvette for MLs exposure and cell slices for in-vitro exposure) the matching
problem is faced. As already mentioned in the material and methods section 6.2, inCircuital study
order to adapt the projected exposure system to the existing amplifier, we needed to
match the load impedance for the coils at a value of 100 Ω as required by the amplifier
data-sheet (see Sec. 6.2 Circuital Model). To reach this objective, a circuital analysis
has been performed by using the LTSpice software. The two coils have been simulated
as two RL (resistance and inductance) in series (Fig. 6.10a). The circuit was feed with
an alternate signal (sinusoidal wave) with intensity of 100 V and an internal resistance
of 5 Ω. The inductance and resistance values, simulating the two coils, are the one
shown in Table 6.1 from the analytic study. In Fig. 6.10b the load impedance value
are reported depending on the frequency. The impedance has been calculated using
the formula:
|ZL| =
√
4R2 +
(
2ΩL− 1
ΩC
)2
(6.1)
where R, L and C represent the resistance, inductance and the capacity respectively
and ω the cutoff frequency. As can be noticed in Fig. 6.10b in our frequency of interest
(1−20 kHz) the value of the load impedance ZL is higher than 100 Ω, not satisfying
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Figure 6.11: Electric circuit showing the two coils (R1L1 and R2L2) with the insertion of the capacity
to obtain a load impedance ZL of 100 Ω.
the impedance required from the amplifier. Due to the need of a load impedance ZL of
100 Ω, we inserted a capacity in series to the RL circuit as showed in Fig. 6.11.
In table 6.3 we reported all the capacity values, that provide the requested impedance
of 100 Ω at frequency of 1, 5, 10 and 20 kHz. The capacity values range from 1.32 to
400 nF.
To conclude the circuital study, in order to match the exposure system, not only when
a sinusoidal signal is applied, the circuit has been adapted when a single pulse of 100 V
and an active phase of 1.3 ms is applied (see Fig. 6.12a). Firstly, we verified if also with
a pulsed signal as input, the circuit resulted already adapted with the insertion of the
capacity as done for the alternate signal. The study has been performed considering the
capacity value of 400 nF, founded for the 1 kHz frequency to match the 100 Ω of load
impedance to the previous alternate signal. As is possible to notice in Fig. 6.12, when
a 100 V pulse is applied (Fig. 6.12a) to the RLC circuit, the current does not give the
expected signal amplitude (v 1.5 A) and shape (see the input voltage shape), in fact
a correlation coefficient of 0.17 is founded between the real and the expected output
signal. With the aim to adapt the circuit, a resistance of 50 Ω has been placed in series
f (kHz) C1 (nF)
1 400
ZL = 100 Ω 5 20.2
10 5.21
20 1.32
Table 6.3: Capacity values at frequencies of interest, that match the 100 Ω of load impedance.
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to the RLC circuit, instead of the capacity, as showed in Fig. 6.13. In Fig. 6.13a the
electric circuit is presented with the insertion of the 50 Ω of resistance that is able to
produce an output signal with a correlation coefficient of 94 (Fig. 6.13b), which means
that the circuit is adapted to the input signal.
From this circuital study, it is possible to conclude that in order to adapt the designed
exposure system both to an alternate (sinusoidal) and a pulsed signal, a capacity or a
resistor, respectively, needs to be placed in series to the coils.
Figure 6.12: (a) 100 V input pulse of 1.3 ms of active phase; (b) Electric circuit showing the two coils
(R1L1 and R2L2) with the insertion of the capacity of 400 nF (frequency of 1 kHz) to obtain a load
impedance ZL of 100 Ω; (c) current output signal that arrives to the coils
Figure 6.13: (a) Electric circuit showing the two coils (R1L1 and R2L2) with the insertion of the
resistance of 50 Ω (b) output signal.
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6.4 Conclusions
In the last years, there has been an increasing attention in new medical treatments
which involve the application of magnetic field in a broad category of diseases (i.e.
neuronal disorders, inflammations, gene and cancer therapies, etc.) [Di Lazzaro et al.,
2013]. In this chapter, the design of a versatile magnetic exposure system has been
presented. The designed system is a multipurpose exposure setup able to be used
for experimental applications as MLs poration for drug delivery and in-vitro magnetic
neuronal cells stimulation. The aim has been a dose-dependent analysis for both appli-
cations to verify the generation of a magnetic field intensity in the order of mT with no
secondary effect on the exposed sample, as a thermal increase due to high endogenous
electric field or current density.
The system is based on a couple of squared Helmholtz coils able to provide an intensity
of 1-2 mT at frequencies up to 20 kHz. Firstly an analytic study has been done to
identify the geometric and electrical parameters to fulfill the project requirements. A
dimension of 15 cm and a current of 0.6 A with 200 wires have been identified.
Next to this analytic study, numerical simulations were performed using the software
Sim4Life to validate the geometric and electrical parameters and to analyze the mag-
netic field intensity. A magnetic field intensity of 1.4 mT has been obtained in the
volume between the coils where is supposed to be placed an exposure sample. A homo-
geneity of 95 % has been calculate in a volume of 9.1 x 9.1 x 7.5 cm3 of exposure. Next
to this evaluation, two different simulations have been carried out, one considering a
cuvette filled with a conductivity solution of 0.049 S/m (experimentally measured) for
MLs drug delivery purpose and another one with a chamber placed at the center of the
coils filled with artificial cerebrospinal fluid solution for in-vitro applications.
Regarding the simulations of the MLs drug delivery system, at the frequency of 20 kHz,
we reported the 2D map of the E and J inside the solution obtaining an electric field
below 1 V/m and a current density in the order of mA/m2. With this results it can be
excluded any possible thermal effect acting on the solution during the magnetic field
exposure. This outcome has been confirmed also at the frequency of 1 kHz where a
more uniform and low E and J values have been reached inside the cuvette.
Concerning the exposure system for in-vitro experiments, we simulated a plexiglass
chamber containing an artificial cerebrospinal fluid solution, the typical buffer used for
brain slices in-vitro exposure, placed at the center between the two coils. The simula-
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tion has been made at the typical TMS frequency [Di Lazzaro et al., 2013] of 3 kHz.
Both for the induced E and J the results have been a good homogeneity in the volume
of the slice exposure with low values for both observable in the mV/m and mA/m2
range respectively.
Next to the numerical study, a circuital study has been carried out to match the 100
Ω of load impedance of the amplifier already present in the laboratory experimental
setup. In order to have the maximum current feeding the coils system, a capacity is
needed to be placed in series to our coils when an sinusoidal signal is applied. The
capacity values have been calculated ranging from 1 to 400 nF for frequencies from 1
up to 20 kHz. Moreover, in order to match our system when a pulsed signal is applied
of 1.3 ms of active phase, a resistance of 50 Ω is needed in series to the coils instead of
the capacitor to have the maximum transferred current.
The results obtained suggest that the designed exposure setup could give the possibility
to have negligible thermal increase in two of the principal therapeutic applications of
low intensity magnetic fields in the IF frequency range, with the possibility to reach
intensity in the order of mT without compromising the sample due to secondary effects.
Part IV
Nanosecond pulsed electric fields
for liposomal drug delivery
systems
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As already mentioned in the section Sec.2 smart drug delivery systems represent an
interesting tool to significantly improve the efficiency and the precision in the treatment
of a broad category of diseases.
Because with this Ph.D. thesis the aim is to investigate the application of EM fields
for medical purposes, in this context, a drug delivery mediated by nanosecond pulsed
electric fields is reported since it seems a promising technique, allowing for a controlled
release and uptake of drugs by the synergy between the electropulsation and nanocar-
riers (e.g. liposomes) with encapsulated drugs. The main concern about the use of
electroporation for drug delivery applications is the difference in dimension between the
liposome (nm range) and the cell (µm range). The choice of liposome dimension is
not trivial. Liposomes larger than 500 nm of diameter could be recognized as pathogen
agents by the immune system, while liposomes of smaller size would require external
electric field of high amplitudes for the membrane electroporation that could compromise
the cell viability.
The aim in the Chapter 7 has been to theoretically study the possibility of a simul-
taneous cell and liposomes electroporation. The analytic study of a 12 nsPEF will be
performed by the analysis of its spectral frequency content. Then, the liposomes mem-
brane poration will be explored for liposomes of 100, 200 and 400 nm of diameter. As
latter, numerical simulations of a cell plus 200 nm liposomes are reported to study the
possibility to electroporate the cell and a significant percentage of liposomes with com-
parable values of external electric field, when a 12 nsPEF is used.
Next in the Chapter 8 the design and characterization of a 10 nsPEF exposure system
is presented for liposomes exposure and preliminary experimental data are reported.
The design and the characterization of the applicator have been carried out choosing an
electroporation cuvette with 1 mm gap between the electrodes. The structure efficiency
has been evaluated at different experimental conditions by changing the solution conduc-
tivity. Moreover, with the aim to analyze the influence of device performances on the
liposomes electroporation, microdosimetric simulations have been performed considering
liposomes of 200 and 400 nm of dimension with different inner and outer conductivity
in order to identify the voltage needed for their poration. Then, to perform a more real-
istic microdosimetric model, a non uniformly liposomes population has been simulated
by using the chosen conductivity values. Finally, preliminary experiments have been
carried out on a 250 nm liposomes population applying an electric field of 9 MV/m.

Chapter 7
Exploring the Applicability of
Nano-Poration for Remote
Control Liposomal Smart Drug
Delivery Systems
7.1 Introduction
The application of pulsed electric fields on a cell structure causes the permeability of
its membrane due to the rise of the transmembrane potential with respect to a resting
condition [Kotnik et al., 2010, Joshi and Schoenbach, 2010].
This phenomenon, known as electropulsation, has allowed the development of several
interesting applications, as mentioned in the Section 2.3 such as the anticancer elec-
trochemotherapy [Miklavcˇicˇ et al., 2012, Cadossi et al., 2014], electrofusion [Teissie
and Rols, 1986, Rems et al., 2013], gene electrotransfer [Mir et al., 1999, Calvet et al.,
2014], beverages sterilization and food processing [Saulis, 2010].
As already anticipated in the Section 2.3, with the advancement of technology, the use
of electric pulses of shorter duration (nanosecond) and higher intensity (in the order of
MV/m) (nanosecond pulsed electric fields, nsPEF) allows to directly interact with in-
ternal cell organelles (e.g. nucleus, endoplasmic reticulum, mitochondria, etc.) [Beebe
et al., 2003b, Scarlett et al., 2009, Breton and Mir, 2012, Denzi et al., 2013]. This
aspect expanded the horizon of the scientic experiments [Breton and Mir, 2012] and
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the development of microdosimetric models [Kotnik and Miklavcˇicˇ, 2006, Merla et al.,
2011] helping clarify the not yet completely understood effects of the nsPEF on in-
ternal organelles. The use of nsPEF for potential drug delivery applications can be a
promising technique because it might allow the controlled release of drugs encapsulated
in a nanocarrier (i.e. liposomes) by the application of an appropriate electrical stim-
ulus. The goal is to design, engineer and introduce into the body molecular carriers
of nanoscale dimension (hundreds of nm) that would release drugs close to the target
cells directly at the place where the drugs must act using controlled application of an
external electric field and avoiding any damage to healthy cells and to the surrounding
tissues. Thus, the drugs would act locally, and additionally their release could be sus-
tained over a period of time in a controlled manner.
Liposomes are one of the classical carriers (see Section 2.2) used in medicine for drugs
encapsulation and delivery [Xiang and Anderson, 2006, Seigneuric et al., 2010, Stuart
et al., 2010]. They are widely used in medicine applications thanks to their non− toxic,
biocompatible and biodegradable characteristics [Mitsopoulos and Suntres, 2011], and
they act as physical barriers to protect the internal drug from degenerative enzymes.
As mentioned in the Section 2.2, liposomes can be activated both from endogenous
and exogenous stimuli as pH variation, thermal increase, magnetic or electric stimuli.
Recently, some studies began to evaluate the effects of pulsed electric fields on lipo-
somes of giant dimension (micrometer scale) because they are representative of a good
cell model [Breton and Mir, 2012, Portet et al., 2012, Breton et al., 2015]. However,
their large size does not allow this kind of liposomes to be used for drug delivery appli-
cations because they could be recognized as a pathogen agent by the immune system
[Miyata et al., 2011] and also the liposomes composition is important whenever or not
an immunologic response is generated [Perrie et al., 2001, Watson et al., 2012].
Recently, Retelj et al. [Retelj et al., 2013] studied, by means of a numerical model, a
biological cell containing a nucleus and small internalized artificial lipid vesicles (lipo-
somes) of different nanometer sizes (from 50 to 500 nm) located in different sites in
the cytoplasm. The authors of the paper predicted the selective electroporation of the
liposome and cell membrane as a function of the inner liposome conductivity and/or
the cytoplasm conductivity through the application of electric pulses of different du-
ration (4, 10, 20 and 50 ns). In addition, it was also shown that the position of the
liposomes inside the cell does not play a significant role in the electroporation process.
For the study, the liposomes were placed inside the cell with the aim of an intracellular
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drug release. Conversely with the work presented in this chapter, the idea of using
liposomes placed outside the cell is carried out as it seems a situation easier to achieve.
The novelty in the usage of nsPEFs relies in the possibility to cause both the cells
and the liposomes membranes electroporation; in such a way, the liposome poration
could permit the drugs release in the extracellular medium, close to the cells, and an
easy uptake of the drugs by the electroporated cells can be achieved (concept similar
to the electrochemotherapy one, with the benefit of the increased drug concentration
in the tumor due to its vectorization in liposomes, used as nanocarriers). The size of
the liposomes is a critical parameter that needs a compromise between the amplitude
of the field and the immune system response. The first one has to be intense enough to
allow for the electroporation process, while it is important to avoid the immune system
reaction to liposomes of large dimensions (i.e. with diameter 500 nm) [Miyata et al.,
2011]. Until now, the main concern in the use of liposomes combined with electropo-
ration is that the biological cells are of much larger dimensions than the liposomes,
and, according to the usual Schwan′s equation at steady-state [Postow and Polk, 1996,
Kotnik and Miklavcic, 2000], they are permeabilized by field values much smaller than
the ones needed to permeabilize a liposome [since, under these conditions, there is a
direct proportionality between the transmembrane potential (TMP) and the radius],
as usually is required in electrofusion applications [Ramos et al., 2002, Demange et al.,
2011]. As a consequence of this, the intensity of the electric pulse able to reversibly
permeabilize the liposome would cause, at the same time, too drastic effects on the
biological cell (e.g. irreversible electroporation, cell death, etc.). Here, the idea is to
combine cell and liposomes for drug delivery mediated by electroporation relies on the
high frequency content of the nsPEF signals that cause the steady-state Schwan′s equa-
tion to lose its validity [Pakhomov et al., 2010]. In such case, it is necessary to consider
a second-order model as in [Postow and Polk, 1996, Kotnik and Miklavcic, 2000, Merla
et al., 2012] in which the dimension effect is not as critical and the permittivity and
conductivity values become more important [Silve et al., 2015].
The aim of this chapter is to present the proof-of-concept of the nsPEF inducing a TMP
variation (e.g. 1 V) able to achieve electropermeabilization in the liposome membrane
with electric field amplitudes similar to the ones needed to simultaneously permeabilize
a biological cell membrane. This demonstration would open the way to a feasible use
of nanopulses for smart drug delivery applications where the electric pulse acts as a
remote controller of the drug release by the carrier and as facilitator of the drug loading
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by the cell. To explore this possibility, this work is focused on a theoretical analysis
through a microdosimetric study of liposome vesicles with dimensions up to 400 nm
both alone and in more complex systems such as a 200 nm liposomes distribution sur-
rounding a cell, in order to study the influence of liposomes between each other and
with respect to the cell electroporation.
7.2 Materials and Methods
Microdosimetric Models: Liposome Alone and a Complex System of a
Cell plus liposomes
To demonstrate the possibility to use nsPEF on liposomes with dimension in the range
of hundreds of nanometers, 2D numerical simulations were carried out using the soft-
ware Comsol Multiphysics v. 5.0. The 2D models consist of a rectangular box with
dimensions of 70 x 100 µm representing the extracellular medium in which first a li-
posome alone and then a complex of a cell plus liposomes in different positions were
placed (Fig. 7.1). The field amplitude was set to 1 MV/m and the pulse duration,
considered as width at half height, is of 12 ns (rise and fall time of 2 ns and tON =
10 ns). The simulation was settled considering the right and the left sides of the box
as electrodes, while the upper and the lower sides as electrically insulated. The right
electrode was set to the ground, and the 12 nsPEF excited the left one.
Liposome Model
Considering that in the experiments the dimensions of the liposomes, the ionic con-
centration of the buffer solution and of the vesicle core can be controlled and varied,
the numerical simulations were carried out with a different set of liposome dimensions
and of external and inner conductivity values. Firstly, a single liposome with diameters
(dlip) of 100, 200, and 400 nm (Fig. 7.1a) was placed in the centre of the box, between
the two electrodes. The membrane thickness (dm) was set to 5 nm, and the external
and the inner liposome conductivities (σext and σint) were set from 0.05 to 1.5 S/m.
All the other parameter values are displayed in Table 7.1.
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Figure 7.1: (a) The model of the liposome alone considering different liposome diameters: dlip = 100,
200 and 400 nm. (b) The cell plus the 200 nm liposomes distribution model; the liposomes are placed
at a distance D of 200 nm between each other and up to 1.2 µm from the cell surface; cell dimensions
are a = 3.5 µm and b = 11 µm.
System of the Cell Plus a 200 nm Liposomes Distribution
After the evaluation of the nsPEF effects on liposomes of different dimensions, as will
be discussed in the next section, a system of an ellipsoidal cell (i.e. myocyte), plus a 28
liposome distribution of 200 nm size (Fig. 7.1b) surrounding the cell, was implemented,
in order to analyze the effects of the simultaneous presence of them. Since the ellipsoidal
shape could well represent a number of human cells (i.e. myotubes, retina photoreceptor
cells, etc.) [Hu and Joshi, 2009, Radu et al., 2005], we decided to model the cell with
an ellipsoid with minor and major semiaxes of 3.5 and 11 µm (a and b, respectively,
Fig. 7.1b). The membrane thickness (µm) of the cell was set to 5 nm. At the pole
side, four 200 nm spherical liposomes were placed from tangent position up to 1.2 µm
of distance with respect to the cell. The same set was replicated considering different
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angles starting from the pole to the equator. The simulations were carried out with
the external conductivity fixed at σext = 1.5 S/m (the same for the inner conductivity
of the liposomes σint). The high conductivity medium can induce a more efficient cell
reversible permeabilization [Silve et al., 2015] and hence could permit the auspicated
simultaneous cell and liposome membrane poration with the same E field intensity. The
cytoplasm conductivity was set to 0.3 S/m as in [Denzi et al., 2015]. The permittivity
values for the cell are also reported in Table 7.1.
7.3 Results and Discussion
The Concept
The combination of a liposome of small dimensions and a cell of large ones (ratioCell and liposome
dimension Rcell/Rlip ≈ 100) leads to the analysis of how the dimensions of the liposome and the
cell can influence the electroporation effects on this type of structures. The results for
the TMP in the frequency domain, due to the applied nsPEF (Fig. 7.2a), are reported
in Fig. 7.2b for the ellipsoid cell and a liposome with 200 nm size, described in the
Section 7.2. The figure 7.2 shows how the geometrical and electrical parameters could
influence the TMP response in terms of physical mechanisms that occur in the cell or
liposome. In static conditions and at low frequency values, the well−known Schwan′s
equation, for spherical structures, reports a linear relationship between the TMP and
the dimension of the structures [Postow and Polk, 1996]:
TMP = f sERcos(φ) (7.1)
Dielectric properties r σ (S/m)
External medium 67a 1.5c
Cell and Liposome Membrane 11.7a 1.1x10-7a
Cytoplasm 67a 0.3a
Inner Liposome 67a 1.5c
Table 7.1: Electric parameters for cell and liposomes; a [Merla et al., 2012];a [Denzi et al., 2015]; c
[Silve et al., 2015]
7.3. Results and Discussion 115
Figure 7.2: (a) Applied electric field and its spectrum, (b) TMP in frequency for cell and liposome
structure.
where f s is a function that depends on cell and external medium characteristics [Kotnik
et al., 1997], its value for a spherical shape in physiological conditions is about 3/2,
E is the applied external electric field, R is the radius of the considered structure and
φ is the angle with respect to the electric field direction. The direct proportionality
of the TMP and the radius in Schwan’s equation at low frequency determines that
the ratio between the fields necessary to electroporate the cell and the liposome is
equal to Rcell/Rlip, and this is confirmed from Fig. 7.2b. Moreover, the differences
in terms of liposome and cell radii determine a different validity limit of the static
approximation in the frequency range; in particular, for the cell its validity is for a
frequency value up to hundreds of kHz and for the liposomes it is up to tens of MHz.
This means that a different physical phenomenon occurs in the liposome and cell in the
frequency range [100 kHz v 10 MHz] in which the static approximation is not valid for
the cell but still valid for the liposome. For frequencies above the limits of the static
approximation, the previous formula 7.3 is not valid, and the TMP starts to decrease
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Figure 7.3: Concept of liposomal drug delivery system mediated by nano-electroporation.
with the frequency [Postow and Polk, 1996, Kotnik and Miklavcic, 2000, Kotnik et al.,
1998]:
TMP (ω) = f s(ω)ERcos(φ) (7.2)
where
f s(ω) =
3σ*ext
[
3dmR
2σ*int + (3d
2
mR− d3m)(σ*m - σ*int)
]
2R3(σ*m + 2σ
*
ext)(σ
*
m +
1
2σ
*
int)− 2(R− dm)3(σ*ext - σ*m)(σ*int - σ*m)
(7.3)
and σ*i = σ
*
i + j ω i , with ext referring to the extracellular medium, int for the
internal of the structure and m for the membrane. In this case, the TMP(ω) is a second-
order system with two poles and two zeros as it can be seen by the decay followed by
the plateau in Fig. 7.2b.
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Figure 7.4: Eth is the electric field intensity necessary for the membrane liposome poration of different
dimension.
118
7. Exploring the Applicability of Nano-Poration for Remote Control
Liposomal Smart Drug Delivery Systems
The dependence of these poles and zeros by the cell or liposome parameters is re-
ported in Fig. 7.2b and is analysed in detail in [Merla et al., 2012]. The first pole
that determines the beginning of the β relaxation range depends mainly on the di-
mension of the structures, the membrane characteristics and the internal and external
conductivities. The second pole and the two zeros depend mainly on all the electrical
characteristics (conductivity and permittivity) of the internal and external media. As
widely explained in [Merla et al., 2012] and [Denzi et al., 2013], in the highest fre-
quency range (grey background in Fig. 7.2b), mostly in the GHz region, the main effect
is due to the dispersion of the compartments. In this work, this effect is disregarded
since the pulse duration is of 12 ns [Merla et al., 2012]. Considering the frequency
content of a 12 ns pulsed electric field (first lobe at around 100 MHz, Fig. 7.2a), it is
possible to notice that both the cell and the liposome are above the β relaxation. In
this region, the two curves are very close together and the ratio between the two TMP
values is very close to 1. This means that for a pulse with high frequency content, as
a 12 nsPEF, the electric field necessary to permeabilize a liposome (nanometer size)
and a cell (micrometer size) could be very similar leading to a possible simultaneous
permeabilization without compromising the cell vitality, so that reversible electroper-
meabilization could occur on both membranes facilitating the drugs release from the
liposomes to cell (Fig. 7.3).
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Figure 7.5: Liposome transmembrane potential variation (calculated at the pole of the liposome)
increases with liposome diameter (dlip= 100, 200, 400 nm); Eth lip is the electric eld intensity necessary
for the membrane poration.
Analysis of the Liposome Parameters
Choice of the Liposome Dimension
In order to analyze the influence of the liposome dimension, three numerical simula-
tions considering liposomes with diameters of 100, 200, and 400 nm have been carried
out considering different conductivity values as explained in the material and methods
section. In Fig. 7.4 the results in terms of electric field needed for the liposome pora-
tion are reported, considering that a TMP of ∼ 1 V is needed for the poration [Smith
et al., 2006]. A high inner conductivity value is chosen, for the simulation with the
cell, which facilitates (see Eth values in Fig. 7.4, yellow highlight) the electroporation
of liposome as already reported also in [Tekle et al., 2005]. As expected, by comparing
with equal high internal and external liposome conductivity (σext = σint = 1.55 S/m),
the TMP (calculated for an external electric field of 1 MV/m) increases with the li-
posome dimension (Fig. 7.5). The higher is the liposome dimension and the lower
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are the E field intensities necessary for the membrane electroporation. The 200 nm
liposome seems to be the best compromise between the E field intensity necessary for
the membrane poration and the response of the immune system that could recognize
too large liposomes as a pathogen agents [Miyata et al., 2011].
Figure 7.6: 2D map of electric field (a) and of the current density (b) around the cell and liposomes
excited with an external pulsed electric field of 1 MV/m at time t = 12 ns
Analysis of Results of the Complex of the Cell and the 200 nm Lipo-
somes Distribution
Based on the previous chosen parameters for the liposome (200 nm of diameter), aElectric field 2D
map
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complex system of a cell plus a 28 liposomes distribution was modeled as described in
Fig. 7.1b. In Fig. 7.6 , a 2D map of the electric field and current density distribution
around the cell and liposomes is presented at t = 12 ns (time of the maximum TMP
variation across the membrane). It is possible to notice how the external E field (see
Fig. 7.6a) and also the current density (see Fig. 7.6b) intensity is lower to the equator
and higher to the pole of the cell as well as of the liposomes. The electric field intensity
distribution is symmetric on the other sides of the cell. This behavior could suggest a
more facilitated poration for the liposomes at the cell pole.
In Fig. 7.7, the result in terms of TMP in the time domain is reported for the cell and TMP on
liposomes and
cell
liposomes placed in different angles with respect to the cell (from pole to equator). The
TMP trend shows that the voltage value across liposomes membrane is similar to the
one of the cell when they are placed closer to the cell pole (Fig. 7.7a, b). Moreover, at
the equator, the difference between the cell and liposomes is more significant but still
remaining with a ratio less than 3 (Fig. 7.7c). Besides, the closer is the liposome to
the cell (i.e. tangent), the higher is the TMP across its membrane, showing a strong
interaction between the liposome and the cell. This result confirms the concept that,
due to the high frequency content of the 12 ns pulse (up to 108 Hz with the highest
frequency contribution occurring during the transients and lowest frequency during
the plateau of the pulse), the dimension is not playing a fundamental role: giving
a ratio, between the external E field intensities necessary for the cell and liposome
permeabilization, in the range of 1/2.5, very far from the ratio of ∼100 predicted in
the low frequency range.
In order to study the percentage of porated liposomes with respect to the cell, the Percentage of
porated liposomeselectric field necessary for the membrane poration (Eth poration) has been analyzed
(see Fig. 7.8).
The result, reported in Fig. 7.8, shows almost the 50 % of porated liposomes when
the cell membrane starts to be permeabilized (green arrow). When the cell membrane
reaches the 10 % of electroporated area, the 80 % of liposomes have been porated
(red arrow). This result suggests that in particular electrical conditions (12 nsPEF),
it will be possible to electroporate almost all liposomes when the cell is at the 10 % of
electroporation, considering this cell exposure level to nsPEFS acceptable in order to
prevent the cell viability, possibly avoiding cell permanent damages [Ibey et al., 2011].
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Figure 7.7: TMP variation of the complex of the cell plus the 200 nm liposomes distribution (placed
tangent and at distance up to at 1.2 µm from the cell) in a medium highly conductive (σext = σint =
1.5 S/m) and at different angles, from pole (a) to the equator (c) of the cell.
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Figure 7.8: Eth poration is the E field necessary for the permeabilization of the liposomes (Eth lip) and
cell (Eth cell). The blue line represents the E field necessary to porate liposomes, and the green and
red lines represent the cell poration at beginning and at the 10 % of membrane poration, respectively.
7.4 Conclusions
In this chapter, the feasibility of the use of nsPEFs for drug delivery applications based
on liposomes as nanocarriers is investigated numerically, analyzing the influence of both
the geometrical and the electric parameters on the cell and liposomes electroporation.
The concept is based on the broad spectra content of a 12 ns electric pulse for which
the Schwan′s equation of the TMP becomes a second−order model [Postow and Polk,
1996, Kotnik and Miklavcic, 2000, Merla et al., 2012] in which the dimension effect is
not as crucial as at the low frequency range. This has been elaborated with the anal-
ysis of the influence on the TMP in time domain due to the geometrical and electric
parameters, which can be controlled in an experimental setup. As for the influence of
liposome dimension on its membrane electroporation, the best choice is a liposome with
a diameter of 200 nm as it results in a good compromise between the E field intensity
required for the membrane poration and the absence of recognition by the immune
system. Based on these results, with the same geometric (dlip = 200 nm) and electrical
parameters (σext = σint = 1.5 S/m), we carried out an analysis of a complex system
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with one cell and a 28 liposomes distribution. The aim has been to study the influ-
ence of liposomes between each other and with respect to the cell in electroporation.
Giving an excitation with a 12 nsPEF, it has been demonstrated that it is possible to
permeabilize the liposomes and the cell with comparable E field intensity in particular
when the liposomes are placed near to the cell pole. This result is confirming that the
difference of the dimensions is not so crucial when using nsPEF.
Moreover, studying the percentage of permeabilized liposomes compared to the cell
membrane, it has been proved that when the 80 % of liposomes is porated, the cell
membrane is porated for the 10 % of its area; in this way, the cell viability is not
compromised, and the liposomes and cell poration can occur with the same E field
intensity. With this numerical study, the possibility to use nsPEF for drug delivery
mediated by liposomes, has been proven. The models permit to identify the electric
pulse characteristics, the external solution and the liposome parameters (dlip = 200
nm and σext = σint = 1.5 S/m) to obtain the electroporation of the cell and liposomes
population applying a comparable electric field intensity, with the possibility to simul-
taneously porate both of them without compromising the cell viability, opening the
way for a possible drug delivery system controlled by the electropulsation.
In the next chapter the design of a liposomes exposure systems to nsPEFs and pre-
liminary experiments will be reported concerning a liposomes solution exposed to 10
nsPEF.
Chapter 8
Technological and experimental
aspects for testing
electroporation on liposomes
8.1 Introduction
In the previous chapter (see Chapter 7) a technique has been proposed combining the
application of nanosecond pulsed electric fields(nsPEFs) with liposomes as nanocarriers
in drug delivery applications. The possibility of simultaneously porating cell membrane
and liposomes with nanometer dimension has been numerically demonstrated in the
case of the delivery of a single electric pulse of 10 ns duration and few MV/m of am-
plitude. This could open the way to a liposomal drug delivery system mediated by
nanoelectroporation, facilitating drugs release from the liposomes to the cell.
The application to cells of one or several nsPEF of 10 ns duration is very common
in nanoporation [De Menorval et al., 2016, Pakhomov et al., 2004]. Different types of
applicators and devices can be used without compromising the shape of the applied
pulse [Denzi et al., 2015, Merla et al., 2010]. Moreover, with the advances in micro and
nano fabrication techniques, some micro-devices are proposed for nanosecond exposure,
integrated also with a microfluidic system [Denzi et al., 2015, Dalmay et al., 2011a,b,
Arnaud-Cormos et al., 2011].
A typical applicator is a standard electroporation cuvette consisting of two plate par-
allel electrodes with a gap of 4, 2, or 1 mm [Silve et al., 2016, 2012, Kohler et al., 2012,
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Merla et al., 2010]. In particular, the 1 mm gap cuvette permits generating higher
values of the electric field in the solution,but in such cases the matching with the 50Ω
of the pulse generator can be critical [Silve et al., 2012, Kenaan et al., 2011]. However,
the choice of a 10 ns pulse, due to its frequency content (first lobe at around 80 - 100
MHz depending on the rise and fall times), allows comfortably selecting the cuvette
as applicator, even if the matching conditions of the structure need to be evaluated.
Conversely, for shorter pulse duration (i.e., 3 ns and 1 ns), the complication of a broad-
band matching, up to GHz region, becomes necessary otherwise the cuvette will cause
a significant distortion of the trapezoidal signal. The use of a standard cuvette is also
advantageous in the case of nanometer liposomes exposure late to the necessity to de-
tect a fluorescent release. Indeed, due to their small dimensions, liposomes visibility
under a microscope cannot be possible. In this case the fluorescent measurement is
done with a spectrofluorimeter reader able to detect fluorescent molecule concentra-
tions. This technique requires a minimum volume of solution,easily collected from the
electroporation cuvette [Chen et al., 2006, McNamara and Rosenzweig, 1998].
In this chapter, a methodology for the exposure of liposomes with dimension in the
nanometer scale (in particular 200 and 400 nm liposomes) is proposed in terms of de-
sign of the exposure system combined with theoretical evaluation of the electric field
threshold needed to porate the liposomes with preliminary experimental data on a 250
nm liposome distribution. As a first step, an integrated approach is proposed to deal
with experimental and modeling aspects, with the fundamental role of understanding
and interpreting biological results. Once the specifications needed by the presented
application were clarified, with particular care to the connection with the generator,
the cuvette holder and the transition to the coaxial connector have been designed. A
complete frequency characterization of the final structure, both with numerical mod-
eling and measurements, has been done in order to understand the cuvette response
under different experimental conditions. After the characterization of the exposure
system, a microdosimetry model of the liposomes was also developed to approach the
electric field needed for the poration considering the limitations imposed by the real
experimental setup. As last step preliminary experiments have been settled on a 250
nm liposomes population by applying an electric field of 9 MV/m.
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Figure 8.1: Schematic of the integrated approach necessary to understand the biological results: the
cycle points out the importance of a continuous exchange between the experimental and modeling
aspects.
8.2 Materials and Methods
Integrated approach for biological understanding
The researchers agree that, in biological issues resolution, the cooperation between ex-
periments and modeling must be considered as a fundamental step [Merla et al., 2010,
Apollonio et al., 2013, Denzi et al., 2015, Silve et al., 2016]. In particular, this aspect
is critical and significant when one wants to investigate the interactions between the
electromagnetic fields and the biological objects. In Figure 8.1 a readapted version of
the Kitano cycle proposed for system biology [Kitano, 2002a,b] has been reported and
applied to our issue. The basic concept is the possibility of beginning the cycle at differ-
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ent points of the experimental and model parts. Wherever there is an output from the
cycle,an improvement in our biological knowledge is attained. Two different strategies
exist: ”Model Driven” and ”Experiment Driven”. In the first one, corresponding to the
green part of the cycle, the model part drives the experiments generating a prediction.
In the latter,associated with the red part of the cycle, the process begins from the ex-
perimentation with useful information to build a model able to explain what observed.
When the access to the cycle begins from a particular biological hypothesis or issue(red
arrow in the Figure 8.1 with reported initial hypothesis) or comes from the previous
step of experimental data analysis, starting points and data for the model are provided.
It is possible to build a simulation (that is called the ”dry” experiment) to take into
account the biological aspects, and this can be done at different levels of complexity
(atomistic level and from the cell (micro level) to the tissue and organs levels(macro
level)) [Apollonio et al., 2013, Marracino et al., 2016, Denzi et al., 2015, Casciola and
Tarek, 2016]. The simulation results can be used to formulate hypothesis about the
biological issues or to simulate the behavior of a particular device that then can be used
for the experiments. At this point it is possible to get out from the cycle and compare
the modeling results with the experimental data analysis or alternatively keep cycling
to use the prediction to set up a ”wet” experiment. To setup a ”wet” experiment,a
technological step is needed starting from modeling results. Next, the analysis of the
”wet” experimental results is provided, and a direct comparison is possible with mod-
eling outcomes getting out from the cycle. Alternatively, this analysis can be reused as
a starting point for a new or upgraded model in a continuous exchange of information
and knowledge.
Towards ”Wet” experiments for electroporation on liposomes
The starting points for electroporation applications regard the feature of the pulse andStarting point
the target of the stimulation.
The study of liposomes poration can be the first step for the use of this kind of nano-
carriers in drug delivery applications driven by nano-electroporation. In the previous
chapter (see Chapter 7), it has been numerically demonstrated the possibility to porate
liposomes of dimension up to 400 nm with a 10 ns electric pulse [Denzi et al., 2017].
Starting from these results, here an ideal 10 ns pulse (Fig. 8.2a) has been considered in
the simulations as a good model of the one that our high voltage 50 Ω pulse generator
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Figure 8.2: Electrical stimulus(ideal and measured pulses)and target for nanoelectroporation of lipo-
somes.
(High Voltage Pulse Generator FPG 10-1NM10) is able to produce (i.e., Fig. 8.2b,
example of a measured pulse). The target is represented by liposomes of 200 and 400
nm of diameter (see Fig. 8.2(c)). The selected stimulus and target drove the choice for
the design of the experiments and of the experimental device (following the cycle in
Fig. 8.1). In case of the 10 ns pulse, the spectral content (Fig. 8.2) is mainly contained
in the first lobe (from 80 to 100 MHz) and hence a standard cuvette for electroporation
can be selected as applicator without causing significant distortion on the pulse shape
[Silve et al., 2012, Kohler et al., 2012, Kenaan et al., 2011]. The necessity to reach high
electric field values for the poration of such small liposomes has led to the choice of a
cuvette with 1 mm gap distance between the electrodes (1002561E, BioGenerica, ITA)
and a particular attention has been taken regarding the connection of this cuvette to
our 50 Ω pulse generator (High Voltage Pulse Generator FPG 10-1NM10).
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Figure 8.3: Modeling of the cuvette connection to the 50 Ω generator.
Design of the Applicator
Now, the design of the structure for the connection with the 50 Ω generator has been
reported. In particular, the final proposed structure is shown in Fig. 8.3.
The idea is not to connect directly the coaxial cable to the cuvette [Kenaan et al.,
2011] but to use the coaxial cable as a lateral feed of the cuvette holder.
The device consists of two brass electrodes with an area of 33 x 10 mm2 and a thickness
of 2 mm (Fig. 8.3). The gap between the electrodes is 11 mm and permits the perfect
insertion of the electroporation cuvette between them. The central pin of the coaxial
cable is connected with one of the two parallel electrodes (Fig. 8.3a) and the other
is connected to the external sock (Fig. 8.3b). To mechanically stabilize the structure
but also to avoid a central pin without any protection, a box of Teflon is placed at
the bottom of the structure (Fig. 8.3b). In Fig. 8.3c the complete structure with the
cuvette placed between the electrodes has been reported. The cuvette is a standard
one (1002561E, BioGenerica, ITA), with dimension of active electrodes of 10 x 8 mm2
and gap between them of 1 mm. In the first simulations the cuvette is filled with a
solution with a conductivity of 0.25 S/m calculated, in order to obtain an impedance
of 50 Ω, following the formulation in [Kenaan et al., 2011] for lower frequency in which
the resistive behavior is predominant, Zcuvette = d/(Aσext).
Furthermore, the characterization of the applicator response, for different conduc-
tivity values of the solution filling the cuvette, has been carried out in order to under-
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stand the effect of this parameter on the structure performances. In particular different
conductivity values have been considered: 0.25, 0.55 and 1.6 S/m. It is worth to notice
that the impedance of the cuvette depends on external conductivity values (σext) and
hence the matching with the 50 Ω generator. The change of conductivity determines,
at lower frequencies, a variation of the impedance from 50 Ω to around 23 and 8 Ω for
0.25, 0.55 and 1.6 S/m respectively. As a first step the cuvette is considered fully filled
to guarantee the maximum exposure volume and to avoid sparks in air with higher
input voltage.
To evaluate the performance both in frequency and time domains, the complete struc-
ture has been numerically simulated with finite element software ANSYS HFSS 2015.
A wave port, applied to feed the coaxial cable, is used as input in the frequency domain,
conversely a lumped port with the pulse as excitation is applied in the time domain.
Realization and characterization of the applicator
After the design and characterization of the structure by numerical simulations, the
fabrication process has been performed following the specifications obtained from the
model results.
The electrodes are made in brass; the one connected with the pin of the coaxial cable
has been perforated to allow the insertion of the pin and an easy weld. The second one
has a hole of larger dimension for the insertion of the dielectric. The connection with
the external sock is made wrapping a cylinder of brass previously weld to the second
electrode in proximity of the hole (Fig. 8.4a). The central pin has been passed through
a box of Teflon to be covered. This step has been made also to obtain a stronger
mechanical stability during the application of the pulse. In Fig. 8.4b the complete
structure with the cuvette is reported. The cuvette can be perfectly inserted between
the two electrodes and can lean on the Teflon box. In order to guarantee even more
mechanical stability and a good contact between the holder and the cuvette electrodes,
a further Teflon cover has been designed (Fig. 8.4c). The cover allows to insert the
cuvette and the coaxial cable.
Because the cuvette is disposable, the use of a structure as the one here proposed can
be very useful instead of a direct connection of the coaxial cable with the electrodes
of the cuvette to be renewed at any cuvette usage [Kenaan et al., 2011]. In order to
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Figure 8.4: Realized Structure
characterize the structure, measurements in the frequency domain have been carried
out with an Agilent Techonologies PNA Network Analyzer E8363C (10 MHz - 40 GHz)
with the cuvette filled with solutions at different conductivity values (0.25, 0.55, 1.6
S/m) hence it is possible to obtain the efficiency of the structure under different ex-
perimental conditions. The conductivity values of the solutions were confirmed with
measurement with a Precision LCR Meter E4980A from Agilent.
Microdosimetry model of nanoelectroporation of liposomes
Due to the possible different experimental conditions selectable in the use of liposomes
(e.g. dimensions, inner conductivity and external conductivity), the microdosymetry
analysis carried out on a single liposome (see Ch. 7) have been riconsidered here in order
to understand the voltage needed at the generator for liposomes nano-poration. The 2D
numerical simulations have been carried out using the software Comsol Multiphysics v.
5.0. as explained in the subsection 7.2. All the electrical and geometrical parameters
of the model presented in the Chapter 7 are reported in Table 8.1.
Moreover, since the designed applicator is for liposomes exposure and in order to have a
more realistic model of the solution that experimentally can be exposed to nsPEFs, after
the efficiency evaluation and the chosen inner and outer liposome conductivity values,
two simulations have been carried out considering a randomly distributed liposome
population of 200 and 400 nm of diameter (see Fig. 8.5). As for the simulations on
the single liposome (see Sec. 7.2), the 2D models consist of a rectangular box with
dimensions of 70 µm x 100 µm representing the extracellular medium, in which 30
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liposomes of 200 and 400 nm of diameter and membrane thickness of 5 nm, have been
randomly placed in an area of 5 x 5 µm2 (see Fig. 8.5). The electric field has been
applied with two electrodes on the box boundaries; in particular on the upper and the
lower edges the excitation of 12 ns pulse and the ground are respectively modeled. The
other boundaries are electrically insulated.
The electric and geometrical parameters remain the same reported in Table 8.1
except from the external and inner liposomes conductivity values ranging from 0.25 to
1.6 S/m.
”Wet” experimental setup
By following the proposed cycle in Figure 8.1 preliminary ”wet” experimental data have
been carried out in collaboration with the the laboratory of Prof. Stefania Petralito,
from the Pharmaceutical Chemistry and Technology (PCT) Department of ”Sapienza”,
University of Rome.
The exposure cuvette is reported in Figure 8.6. The liposomes solution has been pre-
pared with the thin-lipid hydration method as explained in the Section 5.2.1 exception
for the magneto-nanoparticles step. The lipid used for the liposomes film is the EGG
PC. Initially the aim was to create a 400 nm liposomes in order to have more chance
to reach the poration with our 10 kb V pulse generator, but not a uniform popula-
tion was obtained, so with the extrusion step a uniform liposome population of 250
nm of diameter has been obtained as confirmed by the DLS (dynamic light scattering,
see Section 5.2.1) measurements (see Fig. 8.7). The inner and the outer liposomes
conductivity values of 0.33 and 1.6 S/m respectively, have been obtained by using a
PBS (phosphate buffer solution) buffer adjusted with the NaCl to reach the desired
conductivity values. The osmotic pressure have been adjusted in order to avoid any
Electrical and Geometrical parameters
r σ (S/m) d(µm)
External medium 67a,b 0.05 − 1.6 100 − 70
Liposome membrane 11.7a,b 1.1x10-7 (a,b) 0.005a,b
Inner liposome 67a,b 0.05 − 1.6 0.2/0.4a
Table 8.1: Electric and geometrical parameters. (a) [Denzi et al., 2017], (b) [Merla et al., 2012]
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Figure 8.5: Non uniformly distributed liposome population model. The electric stimulus has been
applied to the upper electrode and the ground to the lower electrode. Both sides are electrically
insulated.
disruption of the vesicles due to the different inner and outer conductivity values.
An electric field of 9 MV/m have been applied to the liposomes solution using an FPG
10-1SM10 generator (FID Technology, Burbach, Germany) with 56 pulses at the fre-
quency of 1 Hz. The signal has been monitored with a Rohde & Schwarz RTO2014
oscilloscope. In order to monitor a possible thermal increase during the 10 nsPEF ex-
posure a Luxtron 3100 fiber optic probe have been used but no thermal increases have
been detected. Moreover, the CF (5-(6)carboxyfluorescein) dye has been used as probe
of the porated liposome membrane and the fluorescence before and after the nsPEF
exposure have been measured as explained in the section 5.2.1.
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Figure 8.6: 1 mm gap exposure cuvette used for the experiments.
Figure 8.7: DLS (dynamics light scattering measurements) of the 250 nm of the EGG PC liposomes
solution. Three different measurements with a peak at 250 nm.
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8.3 Results and Discussions
Applicator frequency performances
As a first step in the analysis of the impedance behavior of the applicator, the real
and the imaginary part have been numerically evaluated. The results are reported in
Fig. 8.8 for the holder with the cuvette placed and filled with a solution 0.25 S/m of
conductivity. As expected, at the lower frequency the resistive behavior is predominant,
leaving for a capacitive one at the highest frequencies. It is worth to notice how this kind
of coaxial connection reduces inductive parasitic effects; avoiding resonances within the
range of the frequencies of interest (see resonance at around 350 MHz in [Kenaan et al.,
2011]).
In the same frequency range the S11 has also been evaluated; the results are shown
in Fig. 8.8 (black solid line). From both the impedance and the S11 parameter, it is
possible to see an acceptable frequency behavior up to 100 MHz (hence up to the first
lobe of 10 ns pulsed electric field). The S11 value is ≤ - 5 dB up to this frequency value.
At frequencies higher than 100 MHz the mismatching of the impedance cuvette is more
evident and this limits the use of this kind of applicator only for pulses with duration
≥ 10 ns. The results achieved are comparable with the ones reported in [Kohler et al.,
2012, Kenaan et al., 2011] for a cuvette with 4 mm gap distance.
Frequency characterization for different solution conductivities
Starting from the results obtained in the Chapter 7, in which the importance of the
external conductivity on the efficiency in liposomes nano-electroporation has been re-
ported, a characterization of the applicator behavior varying the conductivity of the
solution placed inside the cuvette has been carried out. Simulations were run with dif-
ferent solution conductivities and compared with measurements in frequency domain
of the holder with the cuvette placed and filled with solutions at the same conduc-
tivity as the one simulated (Fig. 8.9). The measurements and the simulations are in
perfect agreement for all the considered solutions. As expected, the performances of
the applicator strongly depend on the solution parameters, with best behavior for the
less conductivity value (the best value according to the formula reported in [Kenaan
et al., 2011]). Increasing the conductivity, the mismatch of the applicator increases,
in particular for 0.55 S/m, with an S11 value always higher than -10 dB and for 1.6
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Figure 8.8: Impedance in terms of real and imaginary part of the holder with the cuvette placed and
filled with a solution 0.25 S/m of conductivity.
S/m with values even higher than -5 dB. In this last case, the behavior of the structure
is very close to a short connection and hence with a high negative reflection when a
connection with a 50 Ω generator is made.
In order to better understand how this parameter affects the pulse transmission inside
the cuvette, in the next paragraph the analysis of the cuvette response in time domain
has been numerically performed.
Time domain characterization for different solution conductivities
The 10 ns pulse has been applied to the coaxial cable of the structure (Fig. 8.3c). The
cuvette has been filled with solutions at different conductivities and the transmitted
signal has been evaluated in the center of the cuvette gap. In Fig. 8.10 the results of
transmitted electric field pulse for the different conductivity values are reported. As
expected from the frequency results, for the conductivity of 0.25 S/m the amplitude of
the transmitted pulse is 1000 V/m for 1 V input pulse. This is the maximum achievable
value of electric field for 1 V applied to the 1 mm gap. The efficacy in transmission (η)
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Figure 8.9: Measured (dashed lines) and simulated (solid lines) S11 parameters of the holder with the
cuvette placed and filled with solution σ = 0.25 S/m (black line), 0.55 S/m (blue line) and 1.6 S/m
(red line).
is defined as the ratio between the electric field obtained in the gap, in kV/m, and the
applied voltage at the generator, in V. In case of 0.25 S/m of conductivity, η is equal
to 1. The rise and fall times of the transmitted pulse, as predictable by the S11 trend,
appear distorted with a value around double (≈ 3 ns) respect to the one imposed on
the generator (1.5 ns). Increasing the conductivity value, the efficacy of the structure
decreases assuming values of 0.62 and 0.27 for 0.55 and 1.6 S/m respectively.
Once completely characterized the behavior of our applicator, a microdosimetry model
of the liposomes is needed to derive all the necessary parameters to drive a final ex-
periment of liposome solution exposed to a 10 ns pulse. In particular microdosimetry
should provide values of liposome poration for different experimental conditions, as
vesicles dimensions or inner and outer conductivity, and with regards to the efficacy of
the real structure that will be used for the experiments. Hence, the results of the model
have to be combined with the information about the efficiency of the real applicator
here developed.
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Figure 8.10: Electric field amplitude in the center of the cuvette gap. The efficiency value of the
structure, η, defined as the ratio between the electric field obtained in the gap, in kV/m, and the
applied voltage at the generator, in V, at different conductivity values is also reported.
Combining generator experimental results with microdosimetry on li-
posome
The microdosimetry model of the single liposome presented in the Chapter 7 has been
used to evaluate the electric field threshold value necessary to obtain the membrane
liposome poration combined with the efficacy of the generator. In particular, 1 V has
been considered as the threshold value for the electroporating transmembrane poten-
tial [Joshi and Schoenbach, 2010, Breton and Mir, 2012] as already done in the previous
chapter (see Ch. 7) and the field threshold has been evaluated for different conductivi-
ties of the inner liposomes medium (σINT) and of the external medium (σEXT) ranging
from 0.05 S/m to 1.6 S/m. In Fig. 8.11 a 2D map of the electric field value necessary for
liposomes electroporation with a diameter of 200 nm and 400 nm is shown. The maps
appear perfectly symmetric at the changes of external or internal conductivities. The
lower inner and outer conductivity values causes the highest intensities of the electric
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Figure 8.11: Electric field threshold for 200 nm and 400 nm liposomes poration changing the internal
and external liposome conductivity.
field necessary for the liposomes poration, and the larger is the liposome dimension the
lower is this value. If one considers only microdosimetry evaluation, the best conditions
to obtain the liposome electroporation are those achieved with the highest inner and
outer conductivity values.
Considering the designed applicator, this information has been combined with its ef-
ficacy at each external conductivity. Indeed the efficacy of the structure is higher for
the 0.25 S/m conductivity and lower for the 1.6 S/m one. The value of the efficacy is
also reported on the Fig. 8.11 in order to point out that the maximum efficacy is in the
range in which the microdosimetry model predicts the most inconvenient conditions.
To weight the results of the microdosimetry model with the real experimental setupInput voltage vs
generator efficacy characteristics, we have taken into account not only the efficacy of the designed struc-
ture but also the capability of our generator in terms of the maximum output voltage
able to generate. For the High Voltage Pulse Generator FPG 10-1NM10 we are able to
provide a pulse with amplitude in the range of 2-10 kV, fixing our maximum capability
to obtain 10 MV/m in 1 mm gap distance applying the highest intensity available.
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Figure 8.12: Input Voltage needed at the generator weighted with the effective efficacy of the structure.
Figure 8.13: Electric field map distribution of 200 nm liposomes randomly distributed.
In Fig. 8.12 the results in terms of voltage necessary at the generator in order to
obtain the poration of liposomes are reported. The results are reported for liposomes
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Figure 8.14: Electric field needed to porate the 200 (red) and the 400 (blue) nm liposomes population.
with dimension of 200 nm (solid line) or 400 nm (dashed line) and for all the external
conductivity values tested in the structure. The voltage results are weighted with the
efficacy of the structure (η = 1, 0.62 and 0.27((kV/m)/V)) at the different conductivity
values in order to understand the real amplitude needed during the experiments (Fig.
8.12).
Since the designed applicator is for liposomes exposure and in order to have a morenon-uniformly
distributed
liposomes
population
realistic model of the solution that experimentally can be exposed to nsPEF, after the
efficiency evaluation and the chosen inner and outer liposome conductivity values (σINT
= 1.6 S/m and σEXT = 0.25 S/m), two simulations have been carried out considering
a randomly distributed liposome population of 200 and 400 nm of diameter with inner
and external conductivities ranging from 0.25 to 1.6 S/m. In the Fig. 8.13 the 2D
map of the electric field distribution outside the liposomes population is reported for
the 200 nm liposomes. It is possible to notice how with a lower external conductivity
(0.25 S/m) and an higher internal conductivity (1.6 S/m), the highest electric field is
experienced outside liposomes membrane.
In Fig. 8.14 the electric field needed to porate liposomes in function of their dimension
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is reported. The electric field needed to porate the liposomes has been calculated
considering a threshold of 1 V of the transmembrane potential as mentioned in the
Section 7.3 [Smith et al., 2006]. From Figure 8.14 it can be noticed how the liposomes
poration starts with a E field intensity of 5.4 and 7 MV/m respectively for the 400
and 200 nm liposomes. An intensity higher than 7.5 MV/m is required for the 100
% of 200 nm porated liposomes. Furthermore, the gap between the threshold for
starting liposomes poration and the 100 % of porated liposomes, for both population,
is minimum (v 0.3 MV/m) when the medium conductivity is lower than the inner
liposomes one [Della Valle et al., 2017].
Preliminary experimental data on a 250 nm liposomes population
Keep following the cycle reported in Figure 8.1, after the model and the technological
part, a preliminary ”wet” experiment has been settled.
In Figure 8.15 the results of the CF fluorescent release are shown for the first day (Day
0, 1 sample) and for the second day (Day 1, 2 samples). On the first day (Day 0) as
it can be noticed from the Figure 8.15, the exposed and the shame sample released
the 44 and the 22 % of CF respectively. Since, the first day the nsPEF exposure and
the CF release measurements have been done in two different places, both samples
have experienced an high temperature of almost 35 ◦C due to the hand transportation
between the two different departments. This could explain the high release from the
shame sample. After that, the second exposure day (Day 1) it was possible to transport
all the experimental equipment to the PCT department in order to perform the nsPEF
exposure and the CF release measurements in the same place. Indeed, a release of 15
% for the exposed sample and of the 2 % for the shame has been reached.
These preliminary experimental data suggest the possibility to porate liposomes of 250
nm of diameter with an E field of 9 MV/m, which is higher than the predicted one (∼ 7
MV/m) but it is important to keep in mind that the electric field calculation to porate
the liposome membrane is an optimistic prediction, because the evaluation is done on
one point of the liposome membrane, where the highest transmembrane potential is
experienced.
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Figure 8.15: Preliminary ”Wet” Experimental results on the 250 nm liposomes at the Day 0 (1 sample)
and Day 1 (2 samples).
8.4 Conclusions
In this chapter, the design and characterization of an exposure system for liposomes
drug delivery experiments, using a 10 nsPEF, has been carried out and preliminary
experimental data have been reported. This project has been carried out with the
integrated approach proposed in Fig. 8.1, with a readjustment of the cycle proposed
by Kitano [Kitano, 2002a,b] for systems biology taking into account both theoretical,
technological and experimental issues.
In the design of the structure the first step was to consider the features of the excitationDesign of the
exposure system and of the target. Since the excitation is a 10 ns pulsed electric field and the target are
liposomes with 200 or 400 nm diameter the use of a standard electroporation cuvette
with 1 mm gap has been considered advantageous [Denzi et al., 2017]. The design
of an appropriate cuvette holder structure proceeded, taking particular attention to
the connection of the 1 mm gap electroporation cuvette to a 50 Ω high voltage pulse
generator. Further analysis demonstrated the capability of the proposed structure to
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deliver a 10 ns pulse without a significant signal distortion in particular for media with
a 0.25 S/m of conductivity value. This structure is suitable for numerous experimental
exposures, due to the indirect connection with the cuvette. Furthermore, the device
guarantees a very strong mechanical stability and a good contact with the electrodes
of the cuvette thanks to the Teflon box presence under it and as cover.
The structure has been completely characterized in time and frequency domain to Characterization
of the exposure
system
understand its capability and performances in different experimental conditions. In
particular, the analysis has been performed for different conductivity values of the so-
lution inside the cuvette both with numerical models and measurements. A perfect
agreement has been found between them. The higher is the solution conductivity, the
lower is the efficacy of the structure and hence the lower is the amplitude of the trans-
mitted pulse to the cuvette.
In order to analyze the impact of the real performances of the device on the liposomes Microdosimetric
modelselectroporation, a microdosimetry model of liposomes with 200 or 400 nm dimension
has been reported. The simulations have been carried out considering different inner
and outer liposome conductivities and the results have been combined with technolog-
ical outcomes. Combining microdosimetry and technological information permits to
predict that the optimal condition for a 400 nm liposome is with 0.25 S/m and 1.6
S/m for external and internal liposome conductivities respectively, differently from the
indications that one would follow on the basis of the microdosimetry alone (highest
internal and external conductivity values). This discrepancy is due to the higher effi-
ciency of the structure for the conductivity of 0.25 S/m. Moreover, since the exposure
system has been designed for the exposure of a liposomes population, microdosimetric
simulations have been carried out considering a non uniformly distributed liposomes
population of 200 and also of 400 nm, with conductivity values ranging from 0.25 S/m
to 1.6 S/m for external and internal liposome conductivities. By these simulations, a
gap of 0.3 MV/m has been appreciated (with 0.25 S/m and 1.6 S/m for external and
internal liposome conductivities respectively) between the starting of liposomes pora-
tion and when then 100 % of liposomes is porated for both simulations. An electric
field of 7 MV/m is needed to porate the 200 nm liposomes, while 5 MV/m are sufficient
to porate the 400 nm liposomes.
Finally, the ” wet ” experiment has been carried out with preliminary data of the expo-
sure of 250 nm liposomes by applying an electric field of 9 MV/m with 56 E pulses at 1
Hz of frequency. A conductivity of 0.33 and 1.6 S/m has been used for the external and
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inner liposomes. A release of 15 % of CF has been detected for the exposed samples,
while the 2 % has been reached from the sham sample.
These results suggest a good agreement between the predicted possible liposomes po-
ration from the microdosimetric models using an E field ∼ 7 MV/m and the one used
experimentally of 9 MV/m. It is good to keep in mind that the numerical prediction
in terms of electric field needed for the poration is optimistic since is done on one
point on the transmembrane membrane. Moreover when prepared there is not only the
lipid but also the presence of chloroform and of the dye fluorescent that could slightly
change poration conditions. In fact if during the experiments, a change of some param-
eters becomes necessary, e.g. different volumes of solution (keeping particular attention
to avoid sparks in air) or a different value of inner or outer conductivities, a charac-
terization with new simulations and measurements has to be performed in order to
understand the real transmitted signal to maximize the chance to reach the liposomes
poration.
Part V
Direct EMF effects investigation
on proteins structure by
molecular dynamics simulations
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As mentioned in the introduction (see part I), the technological progress has in-
creased the use of magnetic fields as external stimulus for many therapies as the treat-
ment of inflammatory diseases [Varani et al., 2002, 2017], neurologic disorders [Di Laz-
zaro et al., 2013] and for drug delivery research [Spera et al., 2015]. For some of these
diseases it has been demonstrated how the application of pulsed magnetic fields (PEMFs)
can induce anti-inflammatory effects on cells trough the interaction with protein re-
ceptors as the adenosine A2A [Varani et al., 2002, 2017], an important regulator of
neurotransmissions signals released from a variety of cells in response to the metabolic
stress.
Starting from the experiments of Varani et al. [Varani et al., 2002, 2008], in the first
chapter of this part (see Ch. 9) a study about the interaction mechanism of the magnetic
B field action on the adenosine A2A receptor will be presented, through the molecular
dynamics simulations (MD) approach. The project has born in collaboration with the
Igea institution of the Dr. Ruggero Cadossi with the aim to possibly identify the inter-
action mechanism between a magnetic field and the adenosine A2A receptor.
We performed our simulations with the Gromacs package, usually used to simulate the
action of an external electric field acting on a molecular target. Here, the integration
of the Newton’s motion equation is presented by introducing the Lorentz force for the
magnetic field action. Firstly, the implementation and validation of the B field into
the Gromacs package [Van Der Spoel et al., 2005] are reported. Latter, preliminary
results are presented for MD simulations of a buffer solution (DMEM concentration)
and the adenosine A2A immersed in the buffer solution exposed to 1 T of magnetic field.
Because of the capability of nsPEFs to interact with intracellular organelles (see Sec. 2.3)
in the second chapter of this part the possible effects of cytosolic enzyme exposed to high
intense electric fields of ultra short duration have been investigated. A theoretical study
based on molecular dynamics simulations, using Gromacs, is proposed choosing an im-
portant enzyme involved in the cellular antioxidant defense mechanism: the superoxide
dismutase (SOD,Cu-Zn or SOD1). In the Chapter 10, the effects of the 100 nanosec-
ond pulsed electric fields, with intensities ranging from 108 to 7x108 V/m, on a single
SOD1 enzyme are presented to study both the effects on the structure or the electrostatic
effects on the active site, thanks to the dipolar response analysis and the (2D) electric
field distribution around the active site. This project has born in collaboration with
the laboratory of Prof. Olga Pakhomova from the Old dominion University, Norfolk,
Virginia.

Chapter 9
Magnetic molecular dynamics
simulations with Velocity Verlet
algorithm on the Adenosine A2A
receptor
9.1 Introduction
Several studies have shown how the use of low frequency magnetic pulses (PEMFs) may
have biological effects on different cells functions. It has been reported that PEMF
application on bone structures can stimulate osteoblast growth and modulate bone
metabolism [Chalidis et al., 2011]. Indeed, several studies have shown that the use of
PEMFs increases the anti-inflammatory effect of different types of cells such as neu-
trophils granulocytes, chondrocytes and osteoblasts, with significant reduction in some
of the most significant inflammatory cytokines [Varani et al., 2002, Vincenzi et al.,
2013]. Vincenzi at al. [Vincenzi et al., 2013] reported an increased anti-inflammatory
effect of A2A and A3 adenosine receptors in human T/C-28a2 chondrocytes and in
hFOB 1.19 osteoblasts next the application of a PEMF exposure ranging from 1.5 up
to 2.5 mT of magnetic field intensity. In addition, Fini et al. [Fini et al., 2005] pre-
sented a complete review of ant inflammatory PEMFs effects on articular cartilage and
Kaszuba-Zwoinska et al. [Kaszuba-Zwoin´ska et al., 2008] showed how PEMFs of 5 mT
of intensity were able to decrease IFN-gamma proinflammatory and increased IL-10
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anti-inflammatory cytokine production on human peripheral blood mononuclear cells
(PBMC) from Crohn’s disease patients (CD).
One aspect that researchers are focusing on is the interaction between PEMFs and
membrane receptors, such as adenosine (Ars), belonging to the G protein-coupled pro-
tein receptor family (GPCR).
GPCRs are proteins that perceive molecules outside the cell and transmit the sig-GPCRs protein
nal inside by activating the cell response. The GPCR arranges itself into a tertiary
structure with 7 TM (transmembrane) α-helices forming a cavity within the plasma
membrane with a N terminal that serves as ligand-binding domain. When an agonist
or antagonist tries to bind to the receptor then the internal cavity begins to reorganize.
The agonist produces an activation of the receptor by generating the maximum cellular
response, while the antagonist makes no cell physiological response. It is estimated that
GPCRs are the target for about 50 % of the drugs present on the market, mainly due
to their involvement in reporting pathways for many diseases such as mental, metabolic
or cardiovascular disorders [Trzaskowski et al., 2012].
The adenosine is a GPCR protein, regulator of neurotransmission signals and it isA2A receptor
used for drug targeting in many inflammation statuses as cancer, ischemia or neuronal
disorders [Fuxe et al., 2007, Jorg et al., 2014]. It is released by a variety of cells in
response to metabolic stress [Varani et al., 2002] and interacts with four GPCRs (A1,
A2A, A2B and A3). A2A stimulates the activity of adenylated cyclase enzyme and cAMP
accumulation (cyclic adenosine monophosphate) [Varani et al., 2002]. The importance
of the A2A adenosine study lies in its response when different types of cells are exposed
to PEMFs action. It has been experimentally proven [Varani et al., 2002, 2008] that
the A2A receptor, under exposure to a magnetic field of about 3 mT for a duration of
2 hours, increases its response by providing a more effective anti-inflammatory effect
on neutrophilis cells. Moreover, an increased enzyme activity of adenylate cyclase and
a reduction of radical superoxide anion has been reported.
The aim of the project presented in this chapter, has been to perform molecular dy-
namics simulations (MD) to understand if it would be possible to directly interact with
proteins or enzymes using pulsed magnetic field stimulation.
From several decades, by the time of the first studies of Pilla and Chiabrera [PillaB field
interaction
mechanisms
et al., 1997] the mechanism that undergoes the B field action on living objects is not
fully elucidated. Several models have been advanced to explain the possible mech-
anisms; almost all have been essentially based on classical or quantistic description
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of an ion in a binding site, and have studied the problem through the precession of
ion thermal motion in magnetic fields [Muehsam and Pilla, 2009]. The basic premise
of such models is that the effect of the magnetic field can energetically overcome the
perturbing influences of thermal noise, moreover in almost all, a rigorous interaction
between the ion and its binding site is lacking due to the inability to describe the target
at molecular level.
Lately, Binhi and Prato [Binhi and Prato, 2017] presented a review about the possible
action of ”hypomagnetic fields” (HMF, µT range) on biological effects by proposing
different mechanisms. They compared experiments and theories related to the exposure
to an hypomagnetic field, in order to possibly find a relation between the magnetic field
characteristics and a biological effect. No measured correlations of the HMF effects with
its magnitude and inhomogeneity and type or duration has been found. Moreover, they
also suggest that magnetoreception is not only associated with the magnetoreceptors
in migrating animals and magnetotactic bacteria but others mechanisms could explain
a magnetic field action. Among the different action proposed mechanisms [Binhi and
Prato, 2017], a molecular gyroscope mechanism is presented by hypothesizing the ro-
tation of residues with distributed electric charges that generates a magnetic moment
that interacts with an external B field applied. Another proposed mechanism from
Babaei et al. [Babaei et al., 2017] is a diamagnetic anisotropy in membrane proteins
with higher percentage of amino acids and aromatics residues which could explain their
rotation and response to an external magnetic field application.
Anyhow, the issue related to the inability to describe the target (e.g. ions, proteins, Molecular
dynamics
simulations
water molecules, etc.) at molecular level, seems an unavoidable requirement to pro-
duce affordable results, therefore simulations based on Molecular Dynamics (MD) to
study molecules behavior, under different physical conditions of magnetic or electric
fields, seem to become a strategic challenge. Molecular dynamics simulations are a use-
ful tool for understanding the interaction between atomic molecular structures. MD
simulations are usually used to analyze protein structures, membrane patches or ionic
solutions subjected to the action of external agents such as thermal or electric incre-
ments [Marracino et al., 2013b, 2016].
The introduction of an external electromagnetic field into a MD simulation requires a
time-dependent forcing function in Newton’s second law equation, to describe the forces
exerted on the charge sites by the field. For the constituent electrical and magnetic
fields E and B, the forces acting on each charge site are incorporated, through Lorentz
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force, as follows:
mir¨i = f i + qiE(t) + qivi ×B(t) (9.1)
where qi is the charge and fi is the force on the site i. The electric and magnetic fields
are taken to be uniform and plane-polarized. Actually, several works have considered
only the electric field component in the Lorentz force [Casciola et al., 2014, Marracino
et al., 2013b, Apollonio et al., 2008, English and Waldron, 2015]. The motivation was
that the magnetic field, being normal to the velocity of the particle, ”does not work”,
hence it cannot heat the charged particles, giving them energy. It follows that the
magnitude of the velocity of a charged particle is not affected by the presence of a
magnetic field. However, the magnitudes of the velocity components perpendicular to
B can vary, as can be shown for the cyclotron motion.
Before our implementation, few works have been carried out with a magnetic fields
implemented into molecular dynamics simulations (not gromacs package) [Chang and
Weng, 2006, 2008, Murad, 2006, Moosavi and Gholizadeh, 2014]. In Chang et al. [Chang
and Weng, 2008], MD simulations have been done considering high magnetic fields from
1 to 10 T by analyzing diffusivity values of water and ions (Na+ and Cl-), with a time
of simulations of 150 ps. No statistics significant results have been highlighted (be-
low 10 %). Moreover also in a work of Mura [Murad, 2006] a magnetic fields with
intensity of 3x106 T has been applied across of a membrane, no significant differences
were appreciated with the respect to the resting condition by the analysis of ions radial
distribution functions. However data reported seem not to be highly reproduced nor
extremely solid from a statistical point of view.
In this project, for the first time, we implemented into the Gromacs package [Van
Der Spoel et al., 2005], one of the most used tools for MD simulations, a static homo-
geneous magnetic field. The core of the numerical solution solved by Gromacs has been
modified to take into account the magnetic force acting on a charged particle and the
results have been compared with the analytic expected behavior for the very simple
case of an ion in vacuum and then also with water molecules. Next, simulations of a
NaCl buffer solution (DMEM concentration [Varani et al., 2002]) without and with the
adenosine A2A receptor have been performed applying a magnetic field of 1 T.
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9.2 Materials and Methods
Update of velocities and positions with the Velocity Verlet algorithm
into Gromacs package
The difficulty in implementing the B field lies in changing the velocities and positions
to introduce the term of the Larmor frequency and thus generate a magnetic field.
Spreiter and Wlaker [Spreiter and Walter, 1999], identified three different ways to
introduce the B field in MD simulations by adding the term of the Larmor frequency
Ω = (q x B)/m in the update of velocities and position through the Verlet Algorithm.
They basically proposed three different ways:
• Inverse algorithm for weak B field with a limit about Ω ∆T  2pi, which means
to find a good comprise between the intensity of the B field and the duration of
the simulations
• Velocity transformation for strong B field
• Taylor expansion for strong B field
Since for the simulations a time step sufficiently small has been used (0.1 and 1 fs), the
inversion algorithm has been adopted to solve the equations of positions and velocities,
in which the strength of the magnetic field is dependent on the value of the time step.
Moreover, since Gromacs is not a software designed for the application of a magnetic
field, the first part of the work has been to fully control atom velocities and positions
update by the Verlet integration and understand how to introduce the magnetic field
component. Velocity Verlet [Swope et al., 1982] integration is a numerical method used
to integrate Newton’s equations of motion. In particular the Gromacs code it has been
implemented through the update at each time step of particle positions r and velocities
v (eq. 9.2 and eq. 9.3):
r(t+ ∆t) = r(t) + ∆tv +
∆t2
2m
F(t) (9.2)
v(t+ ∆t) = v(t) +
∆
2m
[F(t) + F(t+ ∆t)] (9.3)
where F = mxa is the force applied, m the mass of the particles and ∆t the time
step used to perform the simulations. We applied the magnetic field in the z direction
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Figure 9.1: Molecular dynamics model of the Na+ ion in vacuum (a) and with water molecules (b) in
a box of 30 x 30 x 30 nm3 and 10 x 10 x 10 nm3 respectively.
introducing the Lorentz force along the x and y axis for both positions and velocities
equations (eq. 9.4 and eq. 9.5):
r(t+ ∆t) = r(t) + ∆tv +
∆t2
2m
[F(t)− Ωez × v(t)] (9.4)
v(t+ ∆t) = v(t) +
∆
2m
[F(t)− Ωez × v(t) + F(t+ ∆t)− Ωez × v(t+ ∆t)] (9.5)
where ez = (0, 0, 1) is the unit vector in the z direction and the Larmor frequency Ω
= (q x B)/m , where B is the magnetic field intensity.
To validate our implementation, MD simulations have been performed considering anValidation of the
Magnetic field
implementation
Na+ ion in vacuum and in presence of water molecules in order to verify the ion cy-
clotron motion.
MD simulations have been carried out considering a charged particle Na+ in vacuum,
to verify the cyclotron motion of the ion when an external magnetic field is applied.
We used an NVT (number of particles, volume and temperature constants) ensembleNa+ Ion in
vacuum at a temperature of 300 K using the Nose-Hoover thermostat in a box of 30 x 30 x 30
nm3 of dimension (see Fig. 9.1a). Due to the limit of the algorithm related to the time
step (Ω ∆T  2pi) and the magnetic field intensity, a magnetic field B = 105 T has
been applied, for the ion in vacuum, in order to be able to see the particle motion in
the picosecond time scale with a time step ∆t = 0.1 fs, for a 35 ps of simulation. The
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Figure 9.2: (a) Period (T), radius of curvature (R) and the pitch (h) of the Na+ displacement in the
x and y direction; a table is also reported for the matching between numerical and analytical results;
(b) x displacement of the Na+ ion obtained with MD simulation and the analytical result from the
Muehsam and Pilla thermal model.
initial velocity of the particle has been settled to v = 0.37 nm/ps with an angle Θ =
1◦ with the respect to the magnetic field application.
The displacement (T), the radius of curvature (R) and the pitch (h) of the Na+ ion
are reported (see Fig. 9.2) due to the magnetic field application of 105 T. In order to
verify these numerical results, an analytical model has been settled implementing the
equations 9.4 and 9.5 to reproduce the Na+ particle motion under a B field of 105 T
of intensity. It is possible to notice in Fig. 9.2a how the analytical and numerical model
match perfectly. The charged particle exhibits a sinusoidal motion in the x and y di-
rection during the MD simulation as predicted by the analytical formula T = 2pim/qB,
where q and m are the charge and mass for the Na+ ion respectively.
As next step the ion cyclotron motion of the Na+ ion in presence of water molecules Na+ ion in water
has also been verified, with a density of 100 kg/m3 (Fig. 9.1b) in a box of 10 x 10 x 10
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nm3, the box dimension is smaller because of computational cost. The initial velocity
of the particle, also in this case, has been settled to v = 0.37 nm/ps. The low water
density has been required in order to see the motion in ps time, due to thermal noise
generated by the water molecules collisions. Moreover, because of the presence of H2O
molecules the magnitude of the B field has been increased to 3x107 T for a time of 3.5
ps, also to overcome the thermal collisions and possibly appreciate the ion cyclotron
motion. In Fig. 9.2b the Na+ displacement, in the x direction, is reported. A field of
3x107 T has been applied with an integration step of 0.02 fs for a time of 3.5 ps. It is
possible to appreciate how there is a perfect matching between the numerical and the
analytic results based on the Muehsam and Pilla thermal model [Muehsam and Pilla,
2009].
MD simulations parameters
Concerning the simulations of the NaCl buffer solutions (DMEM concentration [VaraniBuffer solution
et al., 2002]) we worked with an NVT (number of particles, volume and temperature
constants) ensemble at a temperature of 300 K using the Nose-Hoover thermostat in a
box of 12 x 12 x 12 nm3 of dimension and with an integration step of 1 fs (Fig. 9.3a).
The gromos45 force field has been used simulating 114 Na+ and Cl- ions (DMEM
concentration, 110mM [Varani et al., 2002]) and 57577 H20 molecules.
For the adenosine A2A molecular model, the 3PWH PDB structure has been chosenA2A receptor
but in the unbound configuration in order to firstly analyze the protein behavior with
no ligand binded (see Fig. 9.3). The adenosine A2A molecule was immersed in the
NaCl buffer solution and because of its positive charge (+6e) 6 more Cl- ions were
added to the simulations box to neutralize the system.
Numerical Observables
Self diffusion coefficient
Studying the transport properties of liquid water or free molecules (e.g.ions) is an im-
portant topic, both in fundamental science and in its applications. The mobility of
water molecules is indicated by the value of the self-diffusion coefficient, which depends
on the environment parameters as temperature, pressure or the structure [Levitt et al.,
1997]. The value of the self-diffusion coefficients have been obtained through the com-
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Figure 9.3: (a) Molecular dynamics model of the Buffer solutions with 114 Na+ and Cl- ions and
57577 H20 molecules. (b) the adenosine A2A receptor (7 transmembrane protein) immersed in the
buffer solution. The dimension of the box is 12 x 12 x 12 nm3.
mand line of the Gromacs software, gmx msd command, following the Einstein relation
based on the mean-square displacement function.
RMSD
In order to asses the atoms positions during the MD simulation, the rmsd has been
computed. The RMSD (root-mean-square deviation) of atomic positions provides a
quantitative measure of the protein structural variations, comparing the magnetic field
exposure and the equilibrium state. The goal has been the understanding of possible
changes in shape and size of the protein under the influence of the B field.
Secondary Structures
To evaluate possible structural changes induced by the external signals considered, the
number of α-helix secondary structures has been calculated through the command line
of the GROMACS package using the do dssp command. The Adenosine is mainly an
α-helix secondary structure with 7 transmembrane α-helix which arrange themselves
depending on the lingand bonded to the N terminus. It is a regulator of neurotrans-
mission next to a metabolic stress [Varani et al., 2002]. The calculation has been made
in terms of PDF (probability density function) with 0 and 1 T of B field application.
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Figure 9.4: Side and top view of the adenosine receptor, highlighting the residues involved in the
ligand binding process (black for histidine264, red for alanine265, purple for the proline266, green for
the leucine267, orange for the glutammate169 and yellow for the serine67).
Dipole Moment
Proteins, due to their secondary structure conformation (α-helices, β-sheets, turns,
coils, etc.) possess an electric dipole moment. For this reason the dipole moment of
chosen residues, has also been analysed, involved in the hydrogen bond during the
ligand binding (see Fig. 9.4 ), that could orient themselves when an external force is
applied as a magnetic field.
Ramachandran plot
An extremely useful method for studying protein conformation is the Ramachandran
plot [Ramachandran et al., 1963]. Ramachandran plot is a way to visualize energetically
allowed regions for backbone dihedral angles ψ against φ of amino acid residues in
protein structure (Fig. 9.5a) [Richardson, 1981]. The ω angle at the peptide bond is
normally 180◦, since the partial-double-bond character keeps the peptide planar (see
Fig. 9.5b). Basically depending on the stability and on the value of the torsion angles is
possible to distinguish different regions. As is possible to see in Fig. 9.5c, three different
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Figure 9.5: (a) Topology of the adenosine A2A receptor with 7 TM α-helix with the 6 chosen residues;
(b) the peptide binding concept for each peptide of the chain with the two torsion angles ψ and φ; (c)
concept of the possible conformations for each residues by distinguishing three different energetic region
depending on the stability of the rotation (from stable with the deep blue to the unstable rotation on
light blue) and four different allowed conformations depending on the value of the torsion: β-Sheet,
α-helix right handed and left handed and the a disfavored region.
stability regions can exist. The deep blue zone means that the rotation is really stable,
the blue indicates a limit stability on the rotation that could led the peptide to be in
different conformations and the light blue zone which means there is an high flexibility
of the peptide structures. Based on that, it is possible to assign, depending on the value
of the rotation, four different conformations: β-Sheet, α-helix right-handed and left-
handed and a disfavored region, which indicates some angle distortions preferred under
compulsions imposed by local constraints suggesting that unfavorable local interactions
may be offset by other compensating factors [Jia et al., 1993, Stites et al., 1994]. As for
the dipole moment, the ramachandran plot, have been computed for the six residues
involved in the hydrogen bond during the ligand binding process, both with zero and
1 T of magnetic field.
9.3 Results
Once, validated the implementation of the magnetic field B in the Gromacs software Buffer solution:
DMEM
concentration
(see Sec. 9.2), the complexity of the target has been increased addressing first a box con-
taining a NaCl buffer solution with DMEM concentration [Varani et al., 2002], which
means 114 Na+ and Cl− ions hydrated with 57577 water molecules. To analyses the
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Figure 9.6: Self diffusion coefficient D, for water (blue), Na+ (yellow) and Cl- (green) particles.
mobility of water and ions molecules the self diffusion coefficient D in zero and with 1
T of B field, has been computed. From Fig. 9.6 can be observed the results at the last
nanosecond of the simulations (t = 20 ns). For water molecules no changes occurred
(see Fig. 9.6, blue label). Regarding the charge particles, in the no field conditions the
diffusivity values of the Cl− and the Na+ ions are perfectly according to the theoretical
values predicted by in a theoretic work of Salih et al. [Salih and Matthai, 2017] using
NAMD, were a value of 2.2 and 1.6 is identified for the Cl− and Na+ diffusivity values.
Here with no B field applied a value of 2.5 and 1.5 is reached for the Cl− and Na+
ions respectively. When the B field acts on charged particles, a decrease of 10 % is
appreciated for the Na+ ions and an increase of 18 % is reported for the Cl- particles
diffusivity (Fig. 9.6). This result suggest an interaction between the applied B field
and the free charged molecules.
Afterwards the adenosine A2A receptor has been included in the buffer solution, addingAdenosine A2A in
the buffer
solution
six more Cl- ions to neutralize the environment, and MD simulations have been done
with 0 and 1 T of B field.
The first result is shown in Fig. 9.7 where the diffusivity D value is reported for the
water, the ions and the protein target. For the water also in this case no changes
occurred. Then we focused the attention on the protein diffusivity due to the impor-
tance of understanding the characteristics of protein self diffusion in solution, where no
change of intramolecular structure as well as aggregation occurs is of great importance.
With the no field application the diffusivity value is ∼ 2x10−9 m2/s which is in ac-
cordance to the diffusivity values measured experimentally for other protein structures
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Figure 9.7: Self diffusion coefficient D, for water (blue), protein (pink), Na+ (yellow) and Cl- (green)
particles.
Figure 9.8: Root mean square deviation (RMSD) and α-helix secondary structures in zero field and 1
T of B field application
(myoglobin, lysozime) in a work of Nesmelova et al. [Nesmelova et al., 2002]. When the
B field is applied the protein was subjected to a decrease of 80 % in its mobility. This
is possible due to the action of the B field not only on charged protein residues but also
on charged free particles as the ions present in the solution. Indeed, an increase of 28
% and decrease of 12 % has been detected for the Na+ and Cl- ions respectively. The
opposite trend of the D values for the ions with the respect to the previous results (see
Fig. 9.2), it may be coming from the presence of the positive charged protein and the
interaction with the B field application.
In order to ensure that no structural changes where obtained due to the B field ex-
posure the Root mean square deviation (RMSD) and the α-helix secondary structures
(Fig. 9.8) have been studied. No significant differences were appreciated for both ob-
servable, meaning no protein disruption occurred next to the B field application.
Now the attention will be focused, not on the whole protein structure, but on the
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Figure 9.9: Dipole moment for the HIS264 and GLU169 residues (a and b), in time (upper panel)
domain and with a PDF (lower panel) distribution calculated in the time range 8 - 20 ns.
charged residues involved in the hydrogend bond during the ligand binding process
(Fig. 9.4) [Lebon et al., 2015].
To possibly detect interaction mechanisms of the B field with chosen residues of the
A2A, firstly the dipole moment has been computed (Fig. 9.9) of residues. In Fig. 9.9 the
main results are reported for the residues histidine264 (Fig. 9.9a) and glutamate169
(Fig. 9.9b) both in time domain and with a PDF distribution. Almost, from the half of
the simulation the residues seem to reorient due to the B field application, specially for
the glutamate residue. This effect is confirmed looking to the PDF of dipole moment
calculated between the 8th and 20th ns of the simulation. The significant effect of the
glutamate residue could be due to its high charge of +1e that could respond to the
B field application. No effects were appreciated for the other residues of the ligand
binding site.
As last observable, taking a look to the A2A topology, the ramachandran plot have
been analysed. Ramachandran plot, as previous mentioned, (see sec. 9.2) represents
the energetic regions and possible conformations permitted to peptides. In Fig. 9.10,
it can be noticed how in zero field condition the residue, during the simulation (spots
represent the rotation values from 0 to 20 ns) are mostly in the stability region assuming
a configuration between the β-Sheet and the α-helix right-handed conformation. An
exception is highlighted for the leucine residue (green spots in Fig. 9.10) founded in
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the disfavored region, that as mentioned in sec. 9.2, could be due to particular state as
folding state or it can indicates a different secondary structures (e.g. coil or turn).
When a B field of 1 T is applied, all the residues are subjected to rotations towards
different conformation with the respect to the no field application (Fig. 9.10 right side).
Almost all the residues go to the α-helix right-handed conformation exception for the
serine going towards a β-Sheet structures. No changes were detected for the glutamate
residue. These results in terms of residues rotations suggest a B field effects in terms
of charge re-distribution on the receptor surface.
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Figure 9.10: Ramachandran plot for the HIS264, ALA265, PRO266, LEU267, GLU169, SER67 in zero
field (left side) and under the exposure of 1 T (right panel).
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9.4 Conclusions
More often researchers are focusing their attention on the B field interactions on living
objects [Varani et al., 2002, Di Lazzaro et al., 2013, Varani et al., 2017]. Recently,
from Varani et al. [Varani et al., 2002, 2008, 2017] experimental studies have presented
regarding the enhancing of the anti-inflammatory effects of the adenosine A2A on cells
next the application of a magnetic field with intensity between 0.5 and 3 mT [Varani
et al., 2002].
In this chapter, the analysis of the interaction mechanism between the adenosine A2A
receptor and a magnetic field application has been presented.
The implementation in the Gromacs software of a static external magnetic field, for
the first time, has been carried out by introducing the Lorentz force with the Larmor
frequency component into the Velocity Verlet algorithm. In the update of velocities
and positions the term of the Larmor frequency has been introduced to insert a mag-
netic field applied in the z direction. To validate the code, preliminary simulations of
a charged particle, Na+ ion, in vacuum and with water molecules have been done. A
perfect matching has been obtained between the Na+ displacement from the numerical
MD simulations and the analytic models as reported in the results section 9.3. These
results confirmed the expected behavior of the magnetic field acting on the single par-
ticle, giving a first validation of the method implemented.
After testing the implemented code, we performed MD simulations considering a NaCl
buffer solution (DMEM concentration [Varani et al., 2002]) exposed to 1 T of magnetic
field. From the diffusivity (D) analysis, no changes for water molecules occurred and
a variation of 10 % and 18 % for the Na+ (decrease) and the Cl- ions (increase) was
observed. This effects can be explained as result of the interaction of the B field with
free charged particles.
Simulations of the Adenosine A2A receptor in the buffer NaCl solution, highlighted a
decrease of the protein diffusivity D, by the 80 %; no changes occurred for the water
diffusivity and an increase of 28 % and a decrease of the 12 % was reveled for the
Na+ and the Cl- ions. The opposite behavior for the ions diffusivity in presence of the
protein can be due both to the presence of the charged adenosine A2A (+6e) and to the
interaction with the magnetic field which could explain the immobility of the protein
with the respect the zero field application (see Fig. 9.7).
From the RMSD and the α-helix secondary structures study no changes were detected,
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ensuring no protein disruption due to the B field application.
In order to analyse the ligand binding site of the adenosine A2A, the Dipole moment
and the ramachandran plot have been computed for six residues involved in the hy-
drogen bond during the ligand binding process (HIS264, ALA265, PRO266, LEU267,
GLU169 and SER67, Fig. 9.4). By the dipole moment analysis a reorientation of some
binding residues (GLU169 and HIS264) has occurred next the application of 1 T of B
field.
To study the energetic regions allowed to single residues we calculated the Ramachan-
dran plot, by detecting changing in bond residues torsion angles ψ and φ when a B field
of 1 T is applied for the ligand-binding residues (HIS264, ALA265, PRO266, SER67,
LEU267). A trend towards the α-helix right-handed conformation has been detected
when the B field is applied (see Fig. 9.10) for almost all the residues, exception for
the serine67 going towards β-Sheet structures. No changes were observed for the glu-
tamate residue. These residues rotations suggest that our data seem to be in line with
the molecular gyroscope mechanism and diamagnetic anisotropy mechanism proposed
by Binhi and Prato [Binhi and Prato, 2017] and by Babaei [Babaei et al., 2017] re-
spectively.
As whole these data advise a direct interaction between the B field applied and the
charged residues of the protein surface.
Chapter 10
Molecular modeling of the
metallo-enzyme superoxide
dismutase exposed to nanosecond
pulsed electric signals
10.1 Introduction
In the previous chapter (see Ch. 9), a molecular dynamics simulation study has been
presented to explore the interaction between a magnetic field and a protein structure.
Anyhow, recently many researchers have also focused the interest on intracellular en-
zyme modifications induced by the application of nanosecond pulsed electric fields,
observing enzymatic activity loss in proteins, supported also with theoretical predic-
tions from molecular dynamics simulations, focusing on significant variations in protein
secondary structures. Here a protein has been chosen, the SOD1 enzyme, due to its
important biochemical activity as an antioxydant molecule and also due to the pecu-
liar characteristics of its active site, having an electrostatic environment particularly
responsive.
The superoxide is generated by many life processes, which include aerobic metabolism,
oxidative phosphorylation and photosynthesis, in addition to the respiratory burst in
the immune response of stimulated macrophages and neutrophils [Fridovich, 1986].
Superoxide − dependent formation of hydroxide radicals are important in oxygen tox-
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icity [Halliwell, 1982, Carlioz and Touati, 1986], if unchecked, reactive oxygen species
(ROS) including the superoxide radical can result in inflammation and inflict cell injury
that includes DNA damage [Imlay et al., 1988, Imlay and Linn, 1988] being implicated
in many human pathologies, including ischemic reperfusion injury, cardiovascular dis-
ease, cancer, aging and neurodegenerative disease [Perry et al., 2007, Halliwell, 1992].
The enzyme superoxide dismutase (SOD) takes part to the cellular antioxidant defence
mechanism, repairing cells from damages caused by the toxic reactive oxygen species
(ROS) including the superoxide radical O2
- [McCord and Fridovich, 1969, Fridovich,
1998]. SODs are enzymes that disproportionate superoxide anion radicals at some of
the fastest enzyme rates known. They essentially act as a master key, controlling cel-
lular ROS levels, with a potential use as therapeutic agents in oxidative stress-related
diseases [Kawakami et al., 2009, Peixoto et al., 2009, Abdallah et al., 2009]. Specifically,
the Cu-Zn,SOD (or SOD1) [Getzoff et al., 1983] is a homodimeric metalloenzyme con-
taining a couple of copper (Cu) and zinc (Zn) metal ions that dismutate the superoxide
radical O2
-. To prevent the accumulation of the O2
- radical, in the first step of the
dismutation reaction, the O2
- is oxidized by Cu2+ to molecular oxygen(O2) and sub-
sequently a second superoxide anion is reduced by Cu+ to produce hydrogen peroxide
(H2O2).
Recent studies experimentally investigated the role of the SOD1 in ALS, finding an
alteration of the glutamate release from the enzyme in the mice spinal cord [Bonifacino
et al., 2016], while other ones found expression of the SOD1 in patients affected by
neuronal disorders [Beqollari et al., 2016, Ayers et al., 2016]. Moreover, it has been
found [Cleveland and Rothstein, 2001, Wood et al., 2003] that the accumulation of the
O2
- radical, resulting in oxidative stress, is implicated in neurodegenerative diseases
as is the ALS (Amyotrophic lateral sclerosis) [Kaur et al., 2016] or in the Parkinson
disorder causing neuronal apoptosis [In et al., 2016].
Because the mechanism of the SOD1 enzymatic reaction has not been fully elucidated,
molecular dynamics simulations (MD), providing protein conformational changes at
the atomistic level, have been used as tool for the understanding of the protein sta-
bility both in physiological conditions and under external stimuli [Falconi et al., 2001,
Schmidlin et al., 2013, Ding et al., 2012]. Falconi et al. [Falconi et al., 2001] analysed
the differences between the wild-type and mutant a single site mutant Val29Gly-SOD1
both experimentally with spectroscopy and with MD simulations, highlighting a more
accessible active site and dynamic copper accessibility for the mutant SOD1. In another
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study [Schmidlin et al., 2013] MD simulations have been used to analyse the thermal
SOD1 denaturation at a temperature of 498 K in 200 ps by confirming the experi-
mental evidences. To this regard, different researchers have explored the possibility to
destabilize the SOD1 protein by the application of an external stimulus as thermal or a
pH variation [Schmidlin et al., 2013, Dolashka et al., 2011, Auclair et al., 2010], indeed
Auclair et al [Auclair et al., 2010] founded that at melting temperature in a range
between 25 ◦C and 45 ◦C, a more stable protein structure is obtained, by cross-link
the two SOD1 monomers with cysteine and in this way preventing the aggregation also
responsible of neuronal diseases.
However not only a pH variation or a thermal stimulus have been applied in the past
to destabilize molecular enzymes as SOD1 but also external electric fields. The de-
velopment of tools to map intracellular electric fields is beginning to suggest that a
significant fraction of cytosolic proteins are, like the majority of membrane proteins,
exposed to strong electric fields [Koo Lee et al., 2009]. In addition, there is evidence
for an increasingly use of electric fields to manipulate proteins in bio-nanotechnology
applications. For example, nanosecond pulsed electric fields (nsPEF) with intensities
up to 2x107 V/m able to permeabilize the plasma membrane due to a large population
of small pores (i.e. nanopores), have been shown to directly interact with internal
cell organelles [Breton and Mir, 2012, Denzi et al., 2013], or internal proteins [Beebe,
2015, Azan et al., 2017b, Carr et al., 2017]. Given the master key role in controlling
cellular ROS levels of SOD1 enzymes and given their sensitivity to destabilization due
to external physical agents, it is particularly interesting to elucidate the mechanism of
action of intense electric fields acting on SOD1.
Therefore, the goal here is also to observe SOD1 response to electric fields, studying
whether this enzyme results sensitive to the application of a 100 nsPEF with different
intensities (in line with literature from 108 to 7x108 V/m) and different shapes with a
first aim to verify a possible transition to an unfolding state. In addition, we studied
the pattern of the electrostatic distribution at the reaction site of the enzyme, as a
marker of a facilitated or impeded reaction.
The hypothesis is the possibility to create a sort of electric environment which could
enhance the interaction between the superoxide anion O2
- and the Cu2+ of the SOD1
active site. In fact, the structural biology of the SOD1 enzyme reveal important fea-
tures as hydrogen-bonding and metal-binding motifs making possible a mechanism
known as ’electrostatic guidance’ [Perry et al., 2010], that promotes the catalysis with
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time scales faster than O2
- diffusion rate. Such mechanism, firstly proposed by Getzoff
and colleagues in 1983 [Getzoff et al., 1983], hypothesizes that the arrangement of
electrostatic charges in the active site of SOD1 promotes productive enzyme-substrate
interaction through the substrate guidance and charge complementary. More recently
such electrostatic interaction has been experimentally measured for another human en-
zyme, showing that the organization of charged and polar groups in the folded state
of proteins produces large electric fields, and that the magnitude and direction of such
fields may have a substantial effect on the rate of reaction [Suydam et al., 2006]. In line
with this, electric fields are being considered able to modulate enzyme catalysis: recent
experiments utilizing the vibrational Stark effect made possible to measure the electric
field experienced by a substrate molecule when bound inside its enzyme’s active site.
These experiments have provided compelling evidence supporting a major electrostatic
contribution to the enzymatic catalysis [Fried and Boxer, 2017].
Moreover, very recently it has been proven that an electric field stimulation combined
with X-ray crystallography of protein crystal can reveal protein mechanics using elec-
tric field strength in the order of 108 V/m.
For these reasons, we numerically evaluated maps of the electrostatic field distribution
at the active site of the SOD1 when a 100 nsPEF of 108 V/m of intensity is applied
looking for a modulation of the electrostatic environment of the enzyme active site.
Such interaction can be considered as a first step of a cascade of events culminating in
an overall cell response.
10.2 Materials and Methods
Protein Structure
To perform MD simulations we used the structure of a crystallized mutant SOD,Cu-Zn
(PDB code: 1SPD23) with the biochemical activity considered equivalent to the wild-
type one [Amadei et al., 2007, 2006]. The structure is a dimer with the active site
present in both monomers. Moreover, in the absence of the O2
--SOD,Cu-Zn complex,
we considered the structure as reported in [D’Alessandro et al., 2004], where for the
purpose of modeling of the enzyme core, an available structure of bovine SOD,Cu-Zn
complexed with an azido group (PDB code: 1SXZ) has been equilibrated and minimized
replacing the azido group with O2
- [Amadei et al., 2007, 2006].
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The enzyme superoxide dismutase (SOD) has the main role to defend the enzyme
in the body’s response to the toxicity of metabolic by-products of oxygen. To do
this it eliminates the superoxide anion radical O2
- by transforming it in hydrogen
peroxide H2O2 after a bond with two H
+ ions. The SOD,Cu-Zn enzyme accomplished
this role through its active site (Fig. 10.9b) formed by the Zn2+ ion, the Cu2+ and
the superoxide anion O2
- with which takes place in the enzymatic reaction plus three
histidines coordinated by the copper ion. The environment in which the SOD1 enzyme
was immersed consists of a rectangular box (10 x 11 x 9 nm3) containing inside 32292
single point charge (SPC) water molecules with 9 Na+ counterions, for a total of 99659
atoms (Fig. 10.1a). Resulting system density was 1000 kg/m3.
Molecular dynamics simulations
Molecular dynamics simulations were performed with Gromacs 4.6.5 package [Hess
et al., 2008], employing the GROMOS96 (ff43a1) force field [van Gunsteren et al.,
1996]. All complexes were energy relaxed with 1000 step of steepest descent energy
minimization. MD simulations were performed using the LINCS algorithm [Hess et al.,
1997] to constrain bond lengths and periodic boundary conditions were applied in all
directions. Long range electrostatic forces were treated using the Fast Particle-Mesh
Ewald method (PME) [Essmann et al., 1995]. Van der Waals forces and Coulomb
potential were treated using a cut-off of 0.9 nm and the simulation time step was set
to 2 fs. An initial velocity obtained according to a Maxwell distribution at 300 K
was given to all the atoms. All simulations were run in NVT environment employing
V-rescale as temperature coupling algorithm, with reference temperature set at 300 K.
The trajectories were propagated up to 150 and 200 ns in a NVT (number of particles,
volume and temperature are constants) ensemble using an integration step of 2 fs
for exposure and no exposure condition respectively, fixing the SOD1 center of mass,
preventing translations but with no constraints on its related rotation. For the no field
exposure, also four different simulations were carried out (50 ns of duration) in order
to have significant statistic data.
Possible effects due to the intensity and the specificity of an applied nsPEF have been
evaluated by the application of monopolar and bipolar electric pulses with rise and fall
time of 2 ns. We performed the implementation of the analytic form of the trapezoidal
monopolar and bipolar signals inside MD simulations by modifying the source code
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sim util.c in the GROMACS package [Van Der Spoel et al., 2005]. The E field intensity
for both signals was settled from 108 to 7x108 V/m, acting in the simulation box as
explained in [Marracino et al., 2013b].
Besides, the application of the electric field takes place in continuity at the last frame
of the unexposed simulation, thus allowing a direct evaluation of the protein response
due to the switch on of the external electric field application.
Molecular dynamics observables
Secondary Structure analysis
To evaluate possible structural changes induced by the external signals considered,
we calculated the number of secondary structures through the command line of the
GROMACS package using the do dssp command. The SOD1 is mainly a β-Sheet
structure, which constitute a fundamental form of bio-molecular recognition (like DNA
base pairing) and are involved protein-protein interactions, and peptide and protein
aggregation [Nowick, 2008].
The calculation has been made in terms of mean value of β-Sheet and Coil number
during the on phase of both monopolar and bipolar pulses, with the respect to the
equilibrium condition (no E field applied). P-value statistics calculations have been
carried out using the student t test.
RMSD, Radius of Gyration and Solvent Accessible area
To quantify the protein atoms positions during the MD simulation we computed the
rmsd. The RMSD (root-mean-square deviation) of atomic positions provides a quanti-
tative measure of the protein structural variations, comparing the electric field exposure
and the equilibrium state. Moreover, in order to quantify the distribution of the atoms
in the space relative to their center of mass, we computed the radius of gyration, which
provides an understanding of the changes in shape and size of the protein under the
influence of an external stress. To analyse the interaction of the SOD1 protein with the
environment in which is immersed, we calculated the solvent accessible area (SASA),
that estimates the solvent accessible surface to the protein structure, to interact with
solvents or with other molecules of similar size. It provides the hydrophobic and hy-
drophilic area available for the protein. All these observable have been calculated with
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the GROMACS command line.
Dipole Moment Spectrogram
Usually proteins, due to their secondary structure conformation (α-helices, β-sheets,
turns, coils, etc.) possess an electric dipole moment and when an external electric field
is applied, the protein orients itself in the direction of the field application. Firstly, we
analyzed the dipole moment of the protein in time domain both under the monopolar
and bipolar pulse.
Moreover, the analysis has also been conducted in the frequency domain. The spec-
trogram is a time-frequency representation, able to describe the spectral content of a
signal, obtained as the square modulus of the short time Fourier transform algorithm.
This algorithm implying the windowing of the temporal signal under analysis and the
fast Fourier transform of each time sequence. Here, temporal sequences 4.0 x 10-11 s
long filtered through a Hamming pass-band filter [Hamming, 1989], with 50 % overlap
between adjacent segments has been chosen. We obtained a frequency resolution of
0.25 GHz and a time resolution of 6 ns. The electric field was applied in the y-axis
(Fig. 10.1a). The analysis of the frequency spectral content of the dipole moment of
protein and water molecules have been performed. This outcome has been evaluated
both considering the application of an electric field of 108 V/m and a temperature in-
crease of 35 degrees (335 K, SOD1 melting temperature [Ding et al., 2012]) to compare
the different molecules response.
Electrostatic distribution at the active site
With the aim to study the charge distribution of protein molecules around the active
site, the electric field maps have been performed, along two main directions of the
active site Cu-O2, comparing the equilibrium condition and the one perturbed with
an electrical external stimulus. As electrical stimulus, the effects of a monopolar and
bipolar 100 nsPEF with intensity of Ey = 10
8 V/m, have been investigated.
The local electric field (Eq. 10.1) has been computed, due to the contribution of all
charges related to all molecules (protein, water and Na ions) in two different planes of
4.7 x 4.7 nm2 of dimension (centered in the Cu position), in the Cu-O2 (x’) direction
and the one (y’) perpendicular to x’ (see pi’ plane in Fig. 10.9c) and the other plane
(see pi” plane in Fig. 10.9c) is in the Cu-O2 (x’) direction and the other one, y”, is the
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Figure 10.1: (a) SOD,Cu-Zn molecular model showing the simulation box (10 x 11 x 9 nm3) containing
32292 water molecules, the SOD1 model and 9 Na+ counterions. The SOD,Cu-Zn model is formed by
two monomers, each one containing a reaction centre. The electric field is applied in the y direction.
(b) The RMSD of the SOD1 enzyme during the equilibration (t = 200 ns).
one perpendicular to y’. The discretization step of the map has been ∆ = 0.05 nm (see
Fig. 10.9c).
Eri =
∑
n
qn
4pi0| (rn − ri) | 3 (rn − ri) (10.1)
The effects of the presence of charged residues (i.e. glutamic acids, Fig. 10.9c purple
color) surroundings the SOD1 active site (Fig. 10.9c) have been evaluated to study a
possible electrostatic guidance of the O2
- ion to interact with the copper Cu2+ mediated
by the external electric field application. Finally, to validate our electric field maps and
to quantify the difference between the equilibrium and exposed condition we calculated
the SMAPE (Eq. 10.2) (Symmetric mean absolute percentage error) as follows:
SMAPE =
200%
n
n∑
t=1
|Ft −At|
|Ft| − |At| (10.2)
where Ft and At are the mean value of the Electric field for the zero field condition and
the exposed one, respectively; n is the number of points used for the maps construction.
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Figure 10.2: (a) SOD1 molecular structure in equilibrium condition (no field applied). Each of the
two dimers hosts the reaction center defined by Cu and Zn atoms. In yellow β-Sheet structures are
shown, coil in white, turn in chain and α-helix in pink. The active site is reported (Cu2+ in red, Zn2+
in blue and O2
- in green). (b) The 7x108 V/m 100 Bipolar pulse induces a remarkable loss of β-Sheets
at the end of the pulse excitation suggesting an SOD starting unfolding state. The others secondary
structures show a similar behavior.
10.3 Results and discussion
Equilibration of the system
The present work includes a total of 1500 ns all-atom, explicit-solvent MD simulations
for the complete SOD1 enzyme. During equilibration in the water box (Fig. 10.1a),
the root-mean-square deviations (RMSDs) of the structure is leveled off at a value <
178
10. Molecular modeling of the metallo-enzyme superoxide dismutase
exposed to nanosecond pulsed electric signals
0.5 nm (Fig. 10.1b), indicating that equilibrium had been reached. The equilibrated
system representing the ”No Field” condition, considered as a control of the protein
at the equilibrium state, had a time length of 200 ns. Moreover, in order to give a
statistical analysis, 4 further equilibrated systems have been simulated in ”No field”
condition with a duration of 50 ns each.
Conformational effects
A comparative analysis is carried out between the physiological condition of the SOD1
enzyme and the ones exposed to the external electric field to define a threshold for the
intensity of the field able to interact and manipulate the SOD1 enzyme.
A first indisputable result is related to the effect of a pulse with intensity of 7x108 V/m,
the highest one considered for this work. The structural changes, that the protein un-
dergoes, are visibly marked and can be appreciated in Fig. 10.2 showing the SOD1
secondary structures at the end of the ”No field” simulation (t=200 ns) and at the
end of the ”Bipolar 7x108 V/m” simulation (t = 106 ns). A visible loss of the β-Sheet
(yellow) is detectable with a loss of α-helix (pink), accompanied by a simultaneous
increase of the coil complex (white). This result suggests a protein unfolding state and
hence a induced indirect effect on SOD1 enzyme activity.
To have a more detailed picture of enzyme unfolding, β-Sheet secondary structures are
evaluated over time (see Fig. 10.3). Looking at the dynamic behavior it is possible to
observe that for both the Monopolar and the Bipolar pulses there is a marked decrease
in the β-Sheet structure during the time course of the signal applied. The final unfold-
ing state seems to be related to the kind of signal applied. In particular, the Bipolar
pulse during the reverse polarity of the signal (from 100 to 150 ns) is able to induce
even a higher effect on secondary structures of the SOD1 if compared to the Monopolar
one (Fig. 10.3a and 10.3b).
Such rearrangements are shown to be irreversible in 50 ns after the application of the
pulse, hence predicting an unfolded state. In fact, a recovery of the physiological struc-
ture of the enzyme is not achieved as can be seen from 50 ns OFF of the Bipolar pulse
(Fig. 10.3b, pink curve) where no recovery occurs for the β-Sheet, suggesting a protein
change that is not reversible after the removal of the external E field. Similar trend is
shown for the Monopolar pulse even if less marked (Fig. 10.3a, red curve).
10.3. Results and discussion 179
The probability density function (PDF) of the β-Sheet structures during the OFF
state computed for the two signals (Monopolar and Bipolar), evidences a difference of
60% for the Bipolar with respect to the No field state (Fig. 10.3c, purple line) while a
30% is reached when a Monopolar pulse is applied (Fig. 10.3c, red line).
Looking for a threshold in the electric field amplitude able to structurally modify the
SOD1 enzyme, the average values of Coil and β-Sheet secondary structures have been
evaluated for decreasing intensities of the field applied (7x108, 5x108, 2x108, and 108
V/m) comparing the ”No field” condition with the Monopolar and the Bipolar pulses
(Fig. 10.4).
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Figure 10.3: (a,b) SOD1 secondary structures recovery. (a) β-Sheet trend in time domain in no
exposure condition (black line) and under a monopolar (red line, a) and bipolar (violet line, b) electric
pulse with intensity of 7x108 V/m. (c) The β-Sheet probability density function is reported during the
off state of 50 ns after the monopolar and bipolar pulse application. The distribution highlights the
not reversible condition for the β-Sheet structures specially under the bipolar pulse exposure.
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Figure 10.4: SOD1 secondary structures analysis. Coil and β-Sheet secondary structures mean values.
The results are presented in no exposure condition and under monopolar and bipolar 100 nsPEF with
intensity from 108 to 7x108 V/m. The asterisk (∗) indicates p value smaller than 0.05 (p<0.05) which
means a variation statistically significant, and the circle (◦) indicates no statistical significance. The
statistical analysis has been performed with the Student t test. Bars on graph indicate the standard
error.
We obtain at maximum (for the intensity of 7x108 V/m) a loss of β-Sheet up to
37% and an increase of the coil secondary complexes up to 28% while decreasing the
intensity we have been able to identify three different structural states:
1. SOD1 unfolded state under the application a pulse of 7x108 V/m and not re-
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versible in 50 ns following the switch off of the field;
2. initial SOD1 unfolding (variation of about 23 % in secondary structures) with
intensity of 5x108 V/m of intensity, partially reversible in 50 ns after the electric
pulse removal;
3. slightly reversible changes (< 5%) related to the application of field intensities
equal to 108 and 2x108 V/m.
Figure 10.5: RMSD, radius of gyration and SASA analysis for the SOD1 protein. In the panel above
four different main protein observables are presented: the probability density function (PDF) of RMSD
(a); the PDF of the Radius of gyration (b); the PDF of the Hydrophobic (c) and Hydrophilic area
(d) available for the protein structure in equilibrium condition (black line) and under an external
monopolar pulse of 108 (yellow line) and 7x108 V/m (red line).
By applying the p-value statistics calculations, almost all the variations, compared
with the equilibrium state, result to be statistically significant suggesting that the
starting threshold for SOD1 conformational marked changes is about the electric field
intensities of 5x108, while the intensity of 7x108 V/m is causing definitive protein
structural rearrangements. Only in the case of 108 and 2x108 V/m the variation either
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for the coil structures or for β-Sheet ones resulted to be not statistical significant.
For this reason, Monopolar and Bipolar pulses of 108 V/m in amplitude, not able to
determine any conformational change on the enzyme, have been chosen to check if they
could be able to interact somehow with the protein.
Therefore, a first comparison in terms the RMSD (root-mean-square deviation), the
radius of gyration and the solvent accessible surface area (SASA hydrophobic area and
hydrophilic area) have been reported in Fig. 10.5 comparing the lowest (108 V/m) and
the highest (7x108 V/m) values of the Monopolar pulse. In Fig. 10.5a the probability
density function (PDF) of the RMSD is presented, showing for the ”No-field” situation,
a bimodal distribution with peaks of 0.2 and 0.3 nm, indicating that the system is
fully equilibrated as also reported in Fig. 10.1a. The PDF profile for the case of 108
V/m is quite similar, indicating that the structure remains in the same condition of the
equilibrium state, while for the highest intensity of 7x108 V/m the PDF is broader with
range of variability between 0.2 nm and values higher than 0.9 nm. This increment
is due to the partial loss of the secondary structures and denotes a protein elongation
and an unfolding of the structure.
The previous results have been also confirmed by the radius of gyration (Fig. 10.5b),
which quantifies the distribution of the atoms in the space relative to their center of
mass, providing an insight of the protein changes in terms of shape and size under the
influence of external stresses. Under the influence of a Monopolar pulse of 108 V/m of
intensity, the SOD1 does not show significant variations with respect to the reference
condition, while the loss of secondary structures already detected in Fig. 10.2 for an
intensity of 7x108 V/m is the one responsible of the higher and wide distributed value
of the radius of gyration. Finally, the total solvent accessible area has been calculated:
results have been reported in Figs. 10.5c and 10.5d, split as the PDF of hydrophobic
and hydrophilic area accessible for the protein, respectively. No noticeable changes
have been observed for the intensity of 108 V/m in both cases, confirming that the
lowest intensity considered in this work is not able to induce relevant changes in any of
the parameter usually observed in MD of proteins. For the higher E field intensity of
7x108 V/m it has been observed an increase of surface hydrophobicity (Fig. 10.5c) of
about 10% suggesting a decrease in protein - solvent molecules interaction, which could
suggest a protein denaturation as reported in [Xiang et al., 2011]. Conversely, for the
accessible hydrophilic area no changes were observed when an external electric field is
applied, indicating that, differently from the hydrophobic regions which become more
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exposed to water when the electric filed is applied, conversely the overall surface already
exposed to water is not affected by the field (see Fig. 10.5d). Similar results have been
obtained for the Bipolar pulse (see Fig. 10.6) for all the classical MD observable.
Figure 10.6: RMSD, radius of gyration and SASA analysis for the SOD1 protein. In the panel above
four different main protein observables are presented: the probability density function (PDF) of RMSD
(a); the PDF of the Radius of gyration (b); the PDF of the Hydrophobic (c) and Hydrophilic area (d)
available for the protein structure in equilibrium condition (black line) and under an external bipolar
pulse of 108 (light blue line) and 7x108 V/m (blue line).
Electrostatic coupling
Despite that the lowest intensity of 108 V/m is not able to induce changes in the struc-
ture of the protein, there is still a not negligible coupling with the protein electrostatics,
due to the dipolar mechanism, either mediated by the solvating water or directly with
the enzyme. In fact, under the influence of an external electric field the protein residues
as well as water molecules are subject to a reorientation quantified by the dipole mo-
ment.
We compared the physiological behavior of the enzyme (No-field case) with Monopolar
and Bipolar pulses application of 108 V/m intensities, calculating both the protein and
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the solvation-water ’dipole moment’ alignment.
Figure 10.7: Time domain trend of the protein dipole moment in no field (black line) and when a
monopolar (yellow line) and a bipolar (light blue line) pulse of 108 V/m is applied.
In Fig. 10.7 such coupling is reported as first in terms of time domain trend of the
y component of the protein dipole moment. It is possible to notice how the protein,
despite its dimension is able to follow the external field application, by suggesting a
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reorientation of the protein (containing charged residues) depending to the external
field applied.
Figure 10.8: Frequency spectral content of all molecules (first column), the SOD1 and water dipole
moment (second and third column respectively). Frequency spectral content of the dipole moment
y-component of Cu,ZnSOD1 and water reported in no field condition (black label, first raw), with an
increment of 35 K (second raw) and exposed to a 100 ns, 108 V/m of intensity for the Monopolar pulse
(yellow label, third raw) and Bipolar one (green label, forth raw).
Successively, in Fig. 10.8 the dipolar coupling is also evaluated by means of the
spectrogram of the total absolute value (MTOT) and the y-component of the dipole
moment.
Since a spectrogram is a visual representation of the spectrum of frequencies of a signal
as it varies with time, it is built from a sequence of spectra stacking them together in
time and by compressing the amplitude axis into a ’color map’. The final graph, as
represented in Fig 10.8, has time along the horizontal axis, frequency along the verti-
cal one, and the amplitude of the y-component dipole moment at any given time and
frequency shown as color level. In the following spectrograms, the frequency dynamics
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up to 1 GHz is compatible with the time scales of the dipole moment reorientation due
to the external field applied, while the time axis is related to the signal used.
In No-field condition, as it is possible to appreciate looking at Fig. 10.8 (1st raw, 3rd
column), the frequency content of water dipole alignment reaches 1 GHz for the whole
observation time, while a lower frequency of about 700 MHz or less is observed for
the protein (Fig. 10.8, 1st raw, 2nd column). This reflects the fact that the dynamics
of water dipole moment alignment is more rapid than the one of the protein, as ex-
pected. When Monopolar or Bipolar pulses of 108 V/m are applied, water molecules
are highly reoriented by the external E field with a frequency content always up to 1
GHz but perfectly following signal polarity changes; hence in the case of Monopolar
pulse (Fig. 10.8, 3rd raw), after a first time length of 50 ns where the signal is still OFF,
the rise and fall times of the signal are clearly visible in the increase of the frequency
spectral content of the water dipole moment at the beginning and at the end of the
signal course, while for the Bipolar one (Fig. 10.8, 4th raw) the reverse of the signal
polarity is clearly observable in the increase of the spectral content also at the middle
of the signal course (t=100 ns). When considering the behavior of the protein dipole
moment, a similar trend is observed although with a marked decrease in the intensity of
the dipole alignment, essentially due to the higher dimensions of the target. Therefore,
SOD1 needs more time to reorient, but still is able to follow the external polarization
(Fig. 10.8, 2nd column, 3rd and 4th raw), thanks to the electric coupling between the
electric field and the protein. As last observation, by increasing the temperature of 35
K (experimental melting SOD1 temperature [Ding et al., 2012] ,Fig. 10.8, 2nd raw) no
differences where appreciated with respect to the no field condition.
Such coupling of the protein electrostatic environment with 108 V/m Monopolar and
Bipolar pulses may in principle have an effect on the SOD1 enzymatic activity. In
fact, it is by now assessed that the SOD1 physiological pattern of electrostatic poten-
tial, where a positive potential region emanates from the active site and the repulsive
negative potential barrier surrounds the protein, seems designed to provide a large
cross-sectional area for O2
- productive collisions [Klapper et al., 1986], hence giving
an electrostatically guidance to the superoxide.
For this reason, to fully exploit the potentialities of the external electric field to affect
the electrostatic guidance of the O2
- towards the Cu2+, the local electric field distribu-
tion on the active site of one of the two dimers (Fig. 10.9 a and b) has been investigated,
due to the overall enzyme and water surrounding the enzyme. 2D maps have been com-
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puted selecting a plane centered in the Cu2+ atom and with the first direction along
the Cu-O2 distance (x’, Fig. 10.9c) and with the second one perpendicular to it (y’,
Fig. 10.9c) for the pi’ plane. The second plane (pi” plane), is centered in the Cu2+
atom and with the first direction along the Cu-O2 distance (x’, Fig. 10.9c) and with
the second one perpendicular to y’ (y”, Fig. 10.9c). Both planes have been densely
meshed and at the nodes of each grid the electric field due to the overall charges from
the protein and from water molecules has been calculated.
Figure 10.9: SOD,Cu-Zn dimer and active site (2D) grid for the local E field distribution calculation.
(a) Molecular model of the SOD1 dimer viaβ-sheet ribbon representation. (b) Active site of one of the
two dimers centered in the copper ion.(c) Two planes of 4.7 x 4.7 nm2 with x’-axis oriented on (Cu2+-
O2
-) direction and y’-axis normal to it for the pi’ plane and along the x’-axis oriented on (Cu2+- O2
-)
direction and the y” normal to y’.
Results for the (2D) maps of the local electric field distribution are reported in
Fig. 10.11 for the pi’ plane and in Fig. 10.12 for the pi” plane, for which the front view
is reported in Fig. 10.10 to better understand the atoms position. In No-field condition
(Fig. 10.11a and Fig. 10.12a) the local electrostatic field distribution appears almost
circular around the center quite elongate to be higher along the y’ and y” direction
respectively for both planes, due to the presence of the surroundings charged residues
(Fig. 10.9c, i.e. the coils (white) and turn (chain) secondary structures along the y’
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Figure 10.10: 2D Representation of the pi’ and pi” planes in the frontal view to better comprehend the
active site postion.
directions and the glutamate residue (GLU133), purple color, along x’).
Figure 10.12: (2D) maps of the local electrostatic field around the active site on the pi” plane. (a)
No-field condition. (b) Monopolar (108(V/m), 100 ns). (c) Bipolar (108(V/m), tON−negative = 50 ns).
The local electrostatic field is given in units of 109(V/m)
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Figure 10.11: (2D) maps of the local electrostatic field around the active site on the pi’ plane. (a)
No-field condition. (b) Monopolar (108(V/m), 100 ns). (c) Bipolar (108(V/m), tON−negative = 50 ns).
The local electrostatic field is given in units of 109(V/m)
Figure 10.13: Distribution of SMAPE. (a) Bipolar pulse for the pi’ plane (108 V/m, tON-negative = 50
ns). (b) Bipolar pulse (108 V/m, tON-negative = 50 ns) for the pi” plane.
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Figure 10.14: Distribution of SMAPE. (a) Monopolar pulse for the pi’ plane (108 V/m, 100 ns). (b)
Monopolar pulse(108 V/m, 100 ns) for the pi” plane.
By looking at the results for the pi’ plane, when the field is applied (Fig. 10.11c
and 10.11d), the environment surrounding the CuO2
- is subject to a general increase
of the amplitudes of the local electrostatic field, particularly in the direction of the
glutamate residue (GLU133, purple color), which has a strong electric negative charge
and in the direction of the two turns along y’. Moreover, also for the pi” plane, when
the electric field is applied (see Fig. 10.12b and c) there is a more higher electric field
more concentrated at the active site. Moreover, in the case of the Bipolar pulse, the
whole area surrounding the reaction center becomes site of a higher local electrostatic
field suggesting possible rotation of the protein residues due to the external field action
(see Fig. 10.11 and 10.12) in both planes.
In order to quantify these effects, we computed the SMAPE [Armstrong, 1985](Sym-
metric Mean Absolute Percentage Error), comparing the exposure and the not expo-
sure condition for both planes. Fig 10.13 and Fig. 10.12 report the distribution of the
SMAPE for each of the pixels of the (2D) map of Fig. 10.11 in a region more focused
on the active site (2.5 x 2.5 nm2 of dimension) for the Bipolar and the Monopolar pulse
respectively, in both planes. The maps show that both the application of Bipolar and
Monopolar pulses induces a substantial variation of the local electrostatic field pattern
with an average SMAPE value of 59% and 58 % for the Monopolar pulse in the pi’ and
pi” planes respectively (Fig. 10.14) and a value of 72% and 148 % for the Bipolar (see
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Fig. 10.13) in the pi’ and pi” planes, calculated considering the full map.
Therefore, the intensity of 108 V/m is a threshold intensity able to affect the electro-
static environment of the enzyme active site. Such electrostatic variation, modulating
the guidance of the superoxide radical O2
- towards the active site of the SOD1 enzyme,
may as a final step influence the SOD1 enzymatic activity. This, without irreversible
modifications or impact on protein functions, as derived from the dipole moment anal-
ysis, showing a protein that can reorient itself following the external field applied at
the threshold intensity of 108 V/m.
10.4 Conclusions
It is something already known that intense electric fields are needed to act on biomolec-
ular processes inside cells. Voltages corresponding to v 100 mV across a cell membrane
(about 0.125 MV cm-1), consistent with biological relevance, can influence conforma-
tional transitions in proteins such as ion channels [Tao et al., 2010] and G-protein-
coupled receptors [Ben-Chaim et al., 2006]. In mitochondria, where the negative
interior dipole potential is used as the energy source to produce ATP, the electric field
across the inner membrane is as high as 3x107 V/m [Hu and Webb, 2011] which cor-
responds to 120 mV for a membrane that is 4 nm in thickness.
Moreover, it is well known that the majority of membrane proteins are exposed to
strong electric fields that range in strength from 104 to 107 V/m [Tyner et al., 2007]
and that the ability of electric fields to modulate the structure of integral membrane
proteins is a central dogma in voltage gating [Jensen et al., 2012].
However, few studies can be found for external field effects on water-soluble proteins
[Ojeda-May and Garcia, 2010, Solomentsev et al., 2010]; in fact, at the atomistic level,
protein responses and changes due to imposed electric fields can only be observed by
computer simulations. To this regard, apart from few studies that have an experimen-
tal validation, the majority of the investigations are realized on the basis of molecular
simulations. In particular, the effects of external electric field on the stability of protein
conformations [Lugli et al., 2010, Astrakas et al., 2011, Ojeda-May and Garcia, 2010,
Toschi et al., 2008, Yang, 2013, Wang et al., 2014] as well as on the stability of β-sheet
structures, dependence of the field on the polarization of water molecules, mean force
on the charged atom in a water cluster, and interaction forces between two charged
or neutral atoms in a water cluster, have been explored using MD simulations [Yang,
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2013, 2014]. Pulsed electric fields of 3.5 x 106 V/m induced structural changes in the
secondary structure of lysozyme that are not equivalent to those caused by thermal
stress [Zhao et al., 2007], illustrating that the electromechanical properties of proteins
have a different physical origin at the atomistic level to their thermodynamic stabil-
ity. Lysozyme and synapse associated protein are the few examples of water-soluble
proteins that have been reported to undergo conformational changes in response to ex-
ternal electric fields [Bekard and Dunstan, 2014, Freedman et al., 2013]. These induced
field effects are poorly understood but are attributed to rotational and translational
movement of dipolar residues (or domains) in response to external electric fields. Al-
most all the papers reporting effects on the coupling of electric fields and proteins refer
to quite intensities much higher than 108 V/m, even in the case of a recent paper giving
a contribution in comprehending the complete unfolding process of a protein [Avena
et al., 2015, Amadei and Marracino, 2015, Zanetti-Polzi et al., 2013, Marracino et al.,
2015, 2017, 2016, Reale et al., 2013].
With the research project presented in this chapter, the effects of Monopolar and
Bipolar nsPEFs acting on the SOD,Cu-Zn enzyme have been explored, by using MD
simulations, in order to define a threshold for the intensity of the field able to interact
and manipulate the SOD1 enzyme.
For the first time, a Monopolar and Bipolar electric pulse have been implemented in the
Gromacs environment. By the analysis of the Coil and β-Sheet secondary structures,
we identified three different electric field thresholds: (i) with E field intensities from 108
and 2x108 V/m slightly reversible changes (5 %) were appreciated; (ii) when a E field
of 5x108 V/m is applied, variations around the 23 % are reported partially reversible in
50 ns after the electric pulse removal; (iii) SOD1 unfolding when the protein is exposed
to an electric pulse of 7x108 V/m of strength with a loss of β-sheet and an increase
of Coil, not reversible in 50 ns after the application of both monopolar and bipolar E
pulses.
The protein structural rearrangements have been also quantified through the computa-
tion of the RMSD, the radius of gyration and the solvent accessible area. These results
confirm that the SOD1 unfolds with an increment of all these parameters (meaning
loss of secondary structures) when the external electric field increases to 7x108 V/m.
To explore the SOD1 molecules polarization under a weak external E field, we studied
the spectrogram of the protein and water molecules dipole moment. We compared the
reference not exposed with a thermal increase of 35 degrees (see Fig. 10.8) and with the
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application of a monopolar and bipolar electric pulse of 108 V/m of strength. Under
the external electric stimulus, the SOD1 protein, despite its size, results to follow the
external signal applied in its shape, showing a high dipole moment with the respect
to the not exposed condition. This result suggests an electric coupling between the
external E field applied and the SOD1 protein. Conversely, the reference ”No field”
and the one with the thermal increase show a very behavior, confirming no water and
protein molecules reorientation under a thermal external stimulus.
Due to the electric coupling between the protein dipole moment and the E field ap-
plied and based on previous studies [Getzoff et al., 1992] regarding the electrostatic
recognition, we investigated a possible electrostatic guidance of the O2
- ion towards
the Cu2+ by analysing the electric forces acting on the SOD,Cu-Zn active site next
the application of monopolar and bipolar electric pulses of 108 V/m. We carried out
this study in terms of 2D maps of the electric field distribution on two planes passing
through the Cu-O2. By the investigation of the electric field maps, a larger electric
field distribution has been obtained when an external field was applied with the respect
with the not exposed reference in both planes (pi’ and pi”, see Fig. 10.11 and Fig. 10.12
respectively). To quantify the difference between the different exposure states we cal-
culated the SMAPE obtaining a value of 59 and 72 % of the monopolar and bipolar
pulse respectively for the pi’ plane and of 58 and 148 % for the pi” plane, suggesting a
significant difference with the respect to the No field condition with a possible facili-
tated reaction between the copper and oxygen ion.
With this numerical study it is possible to conclude that with the application of a
weak electric field (108 V/m) is feasible to have protein molecules reorientation and an
electrostatic guidance at the active site, which could enhance the enzymatic activity
of the protein, by responding to the external field applied without causing structural
irreversible changes. While, when intensities starting from 5x108 V/m are applied
structural changes occurred. This numerical study can be considered as starting point
for possible prediction of future experiments on the superoxide dismutase protein.
Part VI
Summary and Conclusions
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Chapter 11
Summary and Conclusions
In this Ph.D. thesis, collocated in the nanomedicine panorama, the feasibility of liposo-
mal drug delivery systems mediated by electromagnetic fields (EMFs) has been studied
both by the theoretic and experimental point of view. In parallel EMFs interaction
with molecular structures (e.g. protein) has been studied and well explored in order to
theoretically prove the possibility to directly interact by means of EMF with proteins
and/or enzymes.
As introduced with the scheme reported in the introduction (see Ch. 1, Fig. 1.2),
the nanomedicine is a science that combines the medicine with the nano-technological
progress. Among its different fields application (Fig. 1.2), in this thesis the attention
has been focused on the therapeutic area. Generally, nanotherapeutics improve and
optimize the action of a drug agents, by increasing their accumulation at pathological
sites and their therapeutic efficacy [Lammers et al., 2008a, Davis et al., 2008, Ganju
et al., 2017]. Particularly, stimuli-response release of a drug loaded into a nanocarrier
(1-1000 nm of dimension), in a precise time and location is one of the most aimed
results of the drug delivery research.
More in detail, in this research the aim has been twofold, from one side the feasibility
of drug delivery systems mediated by liposomes as nanocarriers under the action of an
external magnetic or electric fields has been explored. On the other side the possible
interactions mechanism of electromagnetics fields with protein structures have been
investigated due to their importance in cell processes and to their potential to monitor
specific physiological events [Giuliano et al., 1995, Zhang et al., 2002, Provenzano et al.,
2009, Niesner and Hauser, 2011].
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The first step has been to give an overview of the drug delivery systems medi-
ated by liposomes and the different activation agents, by exploring the possibility to
activate them with an endogenous or external stimulus [Ganta et al., 2008, Karanth
and Murthy, 2007, Pradhan et al., 2010, Preiss and Bothun, 2011] (see Sec. 2.2). The
goal with this technique is to introduce into the body a nano-carriers capable to load,
carry and release the drug in the place where it must act, avoiding any damage to
the surrounding healthy tissue. Since the use of liposomes for drug delivery started
shortly after their invention by Bangham and coworkers in 1965 [Bangham et al., 1965,
Lindner and Hossann, 2010], in the section 2.2 the liposomes properties and their first
use in the medical research has been reported. Moreover, among the external stimulus
that can be used to activate the cargo release from these vesicles, the magnetic and the
electric fields have been considered. In the Section 2.4 a survey of the existing research
on low intensity magnetic fields activating liposomes release has been given. Indeed,
some studies suggested that magnetic fields of low intensities are a good trigger to
control the release of the drugs without causing a thermal increase to the surrounding
healthy tissues [Nappini et al., 2010, Spera et al., 2014]. Nevertheless, recently the
use of PEMFs for the treatment of inflammation status has become of frequent use,
especially in the neurodegenerative diseases and in the bone healing.
Starting from that, in the Chapter 5 experimental data concerning magnetolipo-MLs drug
delivery systems somes (MLs) exposed to a low intensity alternate (AMF) or pulsed magnetic fields
(PEMFs) have been reported. The aim has been to test the potential of a magneto-
liposomal drug delivery system to release a fluorescent dye (5(6)- carboxyfluorescein,
CF in our study), loaded into the liposomes core, by the application of magnetic fields
with intensities lower than 100 µT. To perform this study, firstly after the MLs prepa-
ration, the results obtained from Spera et al. [Spera et al., 2015] were reproduced, to
asses the capability of AMF (alternate magnetic field) of low magnetic field intensity
(70 µT) to trigger the CF fluorescent release from high-Tm MLs prepared with the
HSPC lipid. From our experiments a triggered release was reached with a 58 % of CF
release after 12 hours of exposure by switching ON (3h) and OFF (21h) the magnetic
field.
Once, assessed the MLs release next to the AMF application, experiments were carried
out exposing MLs to PEMFs with a magnetic field intensity of 100 µT by using the
I-One medical device. The CF release was around the 26 % after switching ON and
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OFF the magnetic field for a total of 9 hours of exposures (ON = 3h and OFF =
21h). By the PEMFs application it was not possible to trigger the CF release, indeed
the 17 % was released in the first 3h and a release of 7 and 2 % was reached in the
following PEMFs exposures. To study this effect, by the TEM (transmission electron
microscopy) images analysis, it has been possible to see how after the 6 hours of ON
- OFF exposures (3h + 3h) the magnetic nanoparticles escaped from the liposomes
core explaining the 7 % of release, possible due to the different characteristic of the
magnetic field application with the respect to the AMF experiments as explained in
the result section (see Sec. 5.3).
Anyhow, it is important to highlight how with these experimental data a proof of con-
cept of a magnetoliposomes drug release has been given by the application low intensity
magnetic fields (AMF and PEMFs) due to the mechanical liposomes stimulation and
not to the thermal exposure.
Next to the experimental data, with the aim to have a magnetic exposure system
able to trigger the CF release (as shown for the AMF exposure, see Sec. 5.3) but with
an higher magnetic field intensity (mT range), the design a powerful magnetic expo-
sure system for magnetic field intensities higher than 100 µT has been reported in the
Chapter 6. The designed system is a multipurpose exposure setup able to be used
both for experimental applications as MLs poration for drug delivery and for in-vitro
magnetic neuronal cells stimulation. The aim has been a dose-dependent analysis for
both applications to verify the generation of a magnetic field intensity in the order
of mT at frequencies up to 20 kHz. Firstly an analytic study has been performed to
identify the geometric and electrical parameters of a pair of Helmholtz coils to fulfill
the project requirements. A dimension of 15 cm of the two coils and a current of 0.6 A
with 200 wires have been identified. Next, a numerical simulations using the software
Sim4Life, was done to validate the geometric and electrical parameters and to analyze
the magnetic field intensity, obtaining a B field of 1.4 mT with an homogeneity of 95
% between the coils, where is supposed to be placed an exposure sample. Next to this
evaluation, two different simulations have been performed, one considering a cuvette
filled with a conductivity solution of 0.049 S/m (experimentally measured) for MLs
drug delivery purpose at a frequency of 20 kHz and another one with a chamber placed
at the center of the coils filled with artificial cerebrospinal fluid solution for in vitro
applications, at a frequency of 3 kHz (typical TMS frequency [Di Lazzaro et al., 2013]).
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In both cases, by the analysis of 2D map of the electric and current density inside the
solution no relevant values were obtained, (E < 1 V/m and a J in the order of mA/m2)
excluding any possible thermal effect acting on the solution during the magnetic field
exposure.
Next to the numerical study, a circuital study has been carried out to match the 100
Ω of load impedance of the amplifier already present in our experimental setup. In
order to have the maximum current feeding the coils system, a capacity is needed to
be placed in series to our coils when an sinusoidal signal is applied with values ranging
from 1 to 400 nF for frequencies from 1 up to 20 kHz. Moreover, in order to match
our system when a pulsed signal is applied of 1.3 ms of duration, a resistor of 50 Ω is
needed in series to the coils instead of the capacity to have the maximum transferred
current.
The results obtained suggest that the designed exposure setup could give the possibility
to have negligible thermal increase in two of the principal therapeutic applications of
low intensity magnetic fields in the IF frequency range, with the possibility to reach
intensity in the order of mT without compromising the sample due to secondary effects.
Since the goal with this Ph.D. is to explore not only a magnetic but also an electricDrug delivery
mediated by
nsPEF
field application as external trigger for drug delivery purpose, the possibility to use
electric pulses of short duration (ns) and high intensities (MV/m) as external trigger
has been evaluated due to the existing applications of nsPEF in different medical ar-
eas, as electrochemotherapy [Miklavcˇicˇ et al., 2012, Cadossi et al., 2014], electrofusion
[Rems et al., 2013, Teissie and Rols, 1986], gene electrotransfer [Mir et al., 1999, Calvet
et al., 2014] and food processing [Saulis, 2010] (see Sec. 2.3).
In the Chapter 7 a theoretical study has been presented for testing the feasibility of
a simultaneous cell and liposomes electroporation. The concept is based on the broad
spectra content of a 12 ns electric pulse for which the Schwan′s equation of the TMP
becomes a second−order model [Postow and Polk, 1996, Kotnik and Miklavcic, 2000,
Merla et al., 2012] in which the dimension effect, between the liposome (nanometer
range) and the cell (micrometer range), is not as crucial as at the low frequency range
(see Fig. 7.2). This has been elaborated with the analysis of the influence on the TMP
in time domain due to the geometrical and electric parameters, which can be controlled
in an experimental setup. As first step, simulations have been carried out considering
one liposome alone of different dimensions (100, 200 and 400 nm of diameter) exposed
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to a 12 nsPEF and the best choice has been a liposome with a diameter of 200 nm as it
results in a good compromise between the E field intensity required for the membrane
poration and the absence of recognition by the immune system. Based on these results,
with the same geometric (dlip = 200 nm) and electrical parameters (σext = σint = 1.5
S/m), we carried out an analysis of a complex system with one cell and a 28 liposomes
distribution. Giving an excitation with a 12 nsPEF, it has been demonstrated that
it is possible to permeabilize the liposomes and the cell with comparable E field in-
tensity and it has been proved that when the 80 % of liposomes is porated, the cell
membrane is porated for the 10 % of its area; in this way, the cell viability is not com-
promised, and the liposomes and cell poration can occur with the same E field intensity.
To explore experimentally this possibility in the Chapter 8 the design, realization
and characterization of a 10nsPEF exposure setup for liposomes, has been reported
and preliminary experiments on 250 nm liposomes poration have been presented.
Since the excitation is a 10 ns pulsed electric field and the target are liposomes with
200 or 400 nm diameter the use of a standard electroporation cuvette with 1 mm gap
has been considered advantageous [Denzi et al., 2017]. The design of an appropriate
cuvette holder structure proceeded, taking particular attention to the connection of the
1 mm gap electroporation cuvette to a 50 Ω high voltage pulse generator. The structure
has been completely characterized in frequency domain to understand its capability and
performances in different experimental conditions. Indeed, the study demonstrated the
capability of the proposed structure to deliver a 10 ns pulse without a significant signal
distortion in particular for media with a 0.25 S/m of conductivity value. In particular,
the higher is the solution conductivity, the lower is the efficacy of the structure and
hence the lower is the amplitude of the transmitted pulse to the cuvette. Moreover,
by combining microdosimetry (regarding 200 and 400 nm liposomes) and technological
information permits to predict that the optimal condition for a 400 nm liposome is with
0.25 S/m and 1.6 S/m, in order to guarantee the higher efficiency of the structure (0.25
S/m) and the lowest electric field needed to porate the liposomes (at 1.6 S/m). Indeed
from simulations of non uniformly distributed liposomes, an electric field of 7 MV/m
has been identified to porate the 200 nm liposomes, while 5 MV/m are sufficient to
porate the 400 nm liposomes with a gap of 0.3 MV/m between the starting of liposomes
poration and when then 100 % of liposomes is porated for both simulations. Finally,
preliminary experimental data of the exposure of 250 nm liposomes by applying an
202 11. Summary and Conclusions
electric field of 9 MV/m with 56 E pulses at 1 Hz of frequency, have been reported. A
conductivity of 0.33 and 1.6 S/m has been used for the external and inner liposomes.
A release of 15 % of CF has been detected for the exposed samples, while the 2 % has
been reached from the sham sample.
From the modeling analysis we can conclude that a proof of concept has been given
of the potentiality of nsPEF to activate a liposome release and to possible porate the
cell with comparable E field intensities to the one of liposomes. Moreover from the
technological and experimental aspects we demonstrate the poration of liposomes of
250 nm of diameter opening the way for a possible drug delivery system controlled by
the electropulsation.
In the Medical research besides new nanotechnologies for the diseases treatment,
another major challenge is the accurate measurement of cells signals in order to pos-
sibly prevent the upcoming of inflammations or serious illnesses as cancers or cardiac
disorders. For this reasons, researchers started to perform methods to measure pro-
tein biomarkers, cells, and pathogen agents in biological samples [Cheng et al., 2006,
Wulfkuhle et al., 2003].
Due to the importance of proteins in the signaling from the cells and due to the medical
applications mediated by electromagnetic fields, in the chapter 9 and 10 molecular
dynamics (MD) simulations are reported regarding the exposure of proteins under the
electromagnetic fields action.
In detail, in the chapter 9, MD simulations have been reported for the action of aMD simulations
on adenosine
A2A receptor
magnetic field of 1 T of intensity on the receptor adenosine A2A. The Adenosine A2A
is an important receptor involved in the transmission of the signals from the neuronal
cells in response to a metabolic stress. From the experiments carried out from Varani et
al. [Varani et al., 2008], an increase of the receptor activity has been highlighted under
the action of a magnetic field of 3 mT for exposures time up two hours. Since, experi-
mental evidences, the aim has been to study the interaction between the magnetic field
and adenosine A2A. The Gromacs package has been used to perform MD simulations
and for the first time a magnetic field has been implemented by the modification of the
update of atom positions and velocities following the Verlet algorithm (see Sec. 9.2).
Firstly, the validation of the B field implementation with simulations of a sodium ion
in vacuum and with water molecules has been done. Latter, MD simulations consid-
ering a NaCl buffer solution (DMEM concentration [Varani et al., 2002]) have been
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performed exposed to 1 T of magnetic field and a variation of 10 % and 18 % for the
Na+ (decrease) and the Cl- ions (increase) was observed. This effects can be explained
as result of the interaction of the B field with free charged particles.
After that, the simulations of the Adenosine A2A receptor in the buffer NaCl solu-
tion, highlighted a decrease of the protein diffusivity D, by the 80 % and no structural
changes occurred by the analysis of the RMSD and the α-helix secondary structures
(the adenosine A2A is an α-helix protein), ensuring no protein disruption due to the B
field application.
In order to analyse the ligand binding site of the adenosine A2A, the dipole moment and
the ramachandran plot have been computed for six residues involved in the hydrogen
bond during the ligand binding process (HIS264, ALA265, PRO266, LEU267, GLU169
and SER67, Fig. 9.4). By the dipole moment analysis a reorientation of some binding
residues (GLU169 and HIS264) has occurred next the application of 1 T of B field. By
the study of the energetic regions allowed to single residues (the Ramachandran plot),
a trend towards the α-helix right-handed conformation has been detected when the B
field is applied (see Fig. 9.10) for almost all the residues, exception for the serine67
going towards β-Sheet structures.
For the first time with this work a magnetic field has been implemented into the gro-
macs package giving the possibility to study the interactions between a magnetic field
and a molecular target. Moreover, the residues rotations suggest that our data seem to
be in line with the molecular gyroscope mechanism and diamagnetic anisotropy mech-
anism proposed by Binhi and Prato [Binhi and Prato, 2017] and by Babaei [Babaei
et al., 2017] respectively, were the rotations of the charged residues seems to be the
response of the proteins residues to the external magnetic field applied.
Since, the aim with this thesis has been to investigate the interaction mechanism be- SOD,Cu-Zn
exposed to 100
nsPEFs
tween molecular structures and electromagnetic fields, in the last chapter (see Ch. 10),
MD simulations have been reported regarding the enzyme SOD,Cu-Zn exposed to
monopolar and bipolar electric pulses of 100 ns of duration and intensities from 108 to
7x108 V/m. The superoxide dismutase is an important enzyme involved in the body
response to the oxidative stress produced by the toxic oxygen products (e.g. free radi-
cals). With this numerical study, for the first time, a Monopolar and Bipolar electric
pulses have been implemented in the Gromacs environment. Thanks to the analysis of
secondary structures and the classical MD observable (RMSD, radius of gyration and
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the hydrophilic and hydrophobic area), three different threshold have been identified in
order to detect structural rearrangements. With an electric field of 108 V/m no struc-
tural changes occurred, while when intensities starting from 5x108 V/m are applied
structural changes were observed and with 7x108 V/m the SOD1 is in an unfolding
state not reversible in 50 ns after the signal application.
On the other side looking to the electrostatic environment, with the application of a
weak electric field (108 V/m) is possible to have protein molecules reorientation and an
electrostatic guidance at the active site as highlighted by the dipole moment and the
electric field maps on the SOD,Cu-Zn active site, which could enhance the enzymatic
activity of the protein, by responding to the external field applied without causing
structural irreversible changes. Indeed by performing two electric field maps, in two
different planes at the SOD1 active site, an overall effects of 59 and 72 % has been ob-
tained for the monopolar and bipolar pulses respectively, in terms of symmetric mean
absolute percentage error (SMAPE) with the respect to the no field application. This
numerical study can be considered as the basis to investigate the interaction of nsPEFs
electric fields with enzyme molecules also in terms of electrostatic effects and not only
in terms of protein conformational changes.
As whole, this Ph.D. thesis wants to be a multidisciplinary and multiscale approach
for the investigation of both low intensity magnetic fields and nanosecond electric pulses
interactions with nanosystems target. The goal has been to explore the use of electro-
magnetic fields as remote activators of lipid-nanosystems used as drug carriers for the
treatment and the prevention of inflammations status and disease thanks to a mod-
eling, technological and experimental standpoint. A proof of concept, has been given
theoretically and experimentally of the feasibility of liposomal drug delivery systems
mediated by electric or magnetic fields. An analysis with experimental data have been
done for both studies. As latter, because the proteins represent the major pathway of
the signals transmission to the cells and they could prevent the upcoming of inflamma-
tions, thanks to molecular dynamics simulations the interaction between the magnetic
field on the adenosine A2A and of the nsPEFs on the SOD,Cu-Zn protein, have been
explored. With both numerical studies the interaction between the electromagnetic
fields and the protein have been explored and demonstrated, highlighting in both cases
the response of the protein to the external stimulus without corrupting the protein
structures and with a dipolar response from charged residues on proteins surface.
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